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Cysteine is a thiol containing amino acid that readily undergoes oxidation by reactive oxygen 
species (ROS) to form sulphenic (R-SOH) sulphinic (RSO2H) and sulphonic (RSO3H) acids. 
Thiol modifications of cysteine have been implicated as modulators of cellular processes and 
represent significant biological modifications that occur during oxidative stress and cell 
signalling. However, the different oxidation states are difficult to monitor in a physiological 
setting due to the limited availability of experimental tools. Therefore it is of interest to 
synthesise and use a chemical probe that selectively recognises the reversible oxidation state 
of cysteine sulphenic acid to understand more about oxidative signalling. The aim of this 
thesis was to investigate a synthetic approach for novel fluorescent probe synthesis, for the 
specific detection of cysteine sulphenic acids by fluorescence spectroscopy and confocal 
microscopy. N-[2-(Anthracen-2-ylamino)-2-oxoethyl]-3,5-dioxocyclohexanecarboxamide 
was synthesised in a multistep synthesis and characterised by nuclear magnetic resonance 
spectroscopy. The optimisation of conditions needed for sulphenic acid formation in a 
purified protein using human serum albumin (HSA) and the commercially available biotin 
tagged probe 3-(2,4-dioxocyclohexyl)propyl-5-((3aR,6S,6aS)-hexahydro-2-oxo-1H-
thieno[3,4-d]imidazol-6-yl)pentanoate (DCP-Bio1) were identified. This approach was 
extended to detect sulphenic acids in Jurkat T cells and CD4+ T cells pre- and post-stimulus. 
Buthionine sulfoximine (BSO) was used to manipulate the endogenous antioxidant 
glutathione (GSH) in human CD4+ T cells. Then the surface protein thiol levels and 
sulphenic acid formation was examined. T cells were also activated by the lectin 
phytohaemagglutinin-L (PHA-L) and formation of sulphenic acid was investigated using 
SDS-PAGE, western blotting and confocal microscopy. Resting Jurkat cells have two 
prominent protein bands that have sulphenic acid modifications whereas resting CD4+ T cells 
have an additional band present. When cells were treated with BSO the number of bands 
increased whereas activation reduced the number of proteins that were modified. The 
identities of the protein bands containing sulphenic acids were explored by mass 
spectrometry. Cysteine oxidation was observed in redox, metabolic and cytoskeletal proteins.  
In summary, a novel fluorescent probe for detection of cysteine sulphenic acids has been 
synthesised alongside a model system that introduces cysteine sulphenic acid in primary T 
cells. This probe has potential application in the subcellular localisation of cysteine oxidation 
during T cell signalling.  
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1.1 Reactive oxygen species: 
 
 
Reactive oxygen species (ROS) until recently were considered only to be toxic by-products of 
metabolism (1). They encompass a wide range of molecules and are mainly produced in the 
cells as by-products from the mitochondria during electron transport and from activated 
phagocytic cells. The sequential reduction of oxygen through the addition of electrons leads 
to formation of other species of ROS including hydrogen peroxide (H2O2), superoxide ion 
radicals (O2
.-
) and hydroxyl radicals (OH
.
). When the balance between the production and 
clearance of these species is disrupted and ROS are overproduced the cells are said to be in 
oxidative stress. ROS can mediate effects such as cell proliferation and activation as well as 
consequences such as growth inhibition or cell death. Oxidative stress has been implicated in 
many human diseases such as atherosclerosis, cancer, neurodegenerative diseases and ageing 
(1, 2, 3). Many biomolecules including lipids, DNA and amino acid residues in proteins are 
susceptible to oxidation by various forms of ROS. Proteins containing more cysteine, 
tyrosine, tryptophan and methionine are especially vulnerable to oxidation. 
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1.2 Cysteine: 
 
 
Cysteine (Cys) is a sulphur containing amino acid with the chemical formula of 
HO2CCHNH2CH2SH. It has been found that the cysteine content of species is varied and that 
it increases with the complexity of the organism. This may be attributed to its relative 
reactivity compared to other amino acids especially with regards to oxidation (4, 5). The 
importance of cysteine lies in its sulphur containing functional group thiol or sulphydryl 
group (-SH), which is unique to cysteine amongst other amino acids
 
(6). Although the main 
components of all living organisms are carbon, nitrogen, oxygen and phosphorus, sulphur 
also plays an important role in biological systems. It occurs in all major classes of bio 
molecules including proteins, nucleic acids, sugars and metabolites (7). Sulphur is a group 
VIa second row element of the periodic table with an electronic configuration of [Ne]3s
2
3p
4
. 
It shares many similarities in chemical reactivity with oxygen as they are of the same periodic 
group. However it can expand its valence shell to hold more than eight electrons owing to the 
availability of empty d-orbitals. This gives sulphur many distinct properties that are exploited 
in proteins and other molecules. The combination of low electronegativity and lone pair 
availability makes thiols better nucleophiles compared to alcohols. Therefore disulphide 
bonds (RS-SR) are more stable than peroxide bonds (RO-OR), which make disulphide bonds 
a key structural feature of proteins. Sulphur has many different oxidation states ranging from 
+6 to -2 in an oxidative environment
 
(8). In cysteine, the sulphur atom is fully reduced with 
an oxidation state of -2. Therefore the thiol side chain is readily oxidised to give a variety of 
different post-translational modifications, some of which are shown in Figure 1.1 below (9). 
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Figure 1.1: Different oxidation states of cysteine in a biological system. Sulphur has many 
different oxidation states ranging from +6 to -2. In cysteine sulphur is fully reduced and has 
an oxidation state of -2.When the cysteine thiol is oxidised if forms reversible modifications 
such as sulphenic acids and disulphide bonds or gets over oxidised to form irreversible 
modifications such as cysteine sulphonic acids. 
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The sulphur atom in a thiol group is electron rich and nucleophilic. Its reactivity is further 
increased in the deprotonated thiolate anion (RS
-
) form. In this respect the thiol group is 
mildly acidic with a pKa value ranging from ~4-9 depending on the structure of the protein 
and the local environment
 
(8, 10). The thiolate anion reacts with ‘hard’ electrophilic centres 
such as carbonyl or phosphoryl groups as well as with ‘soft’ electrophiles like saturated 
carbon. Due to its high reactivity the thiol group of cysteine plays a major role in many 
biological activities like catalysis, metal binding and in acting as a ‘molecular switch’ 
activating or deactivating cellular functions
 
(8). One of the most commonly known oxidation 
reactions is the formation of the disulphide bond. The formation of disulphide bonds can 
progress via two general pathways. They can either be formed by condensation of a thiol with 
a sulphenic acid (RSOH) or by a thiol-disulphide exchange. Disulphide bonds are stable 
intermediates and are often involved in the conservation of the protein structure and function. 
However, disulphides can undergo nucleophilic cleavage, which is an important biological 
reaction
 
(8, 10, 11). As the oxidation number of the sulphur atom in cysteine increases it 
becomes more positively charged, hence becoming less nucleophilic in nature. Therefore the 
higher oxidation states of cysteine are less stable energetically. The first product of cysteine 
oxidation is the formation of sulphenic acid (12). 
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1.2.1 Cysteine sulphenic acids: 
 
 
The cysteine sulphenic acids (RSOH) (Figure 1.1) are unstable and have highly reactive 
functional groups, which have been viewed as intermediates to other higher oxidation state 
groups such as the sulphinic (RSO2H) and sulphonic (RSO3H) acid groups
 
(2, 8, 11). Since 
they are generally too unstable to isolate it has been a challenge until recently to detect which 
was the correct tautomeric structure of sulphenic acid. According to spectroscopic evidence 
the prominent tautomer is the divalent sulphur tautomer 1 over the sulphoxide structure 2 both 
of which are shown in Figure 1.2. Studies using infrared spectroscopy on 1-
anthraquinonesulphenic acid and 1,4-anthraquinonedisulphenic acid in solution have shown 
that the S-O bond is longer than that of the sulphoxide thus favouring the formation of 
tautomer 1 (13).  
 
 
 
 
 
Figure 1.2: Tautomers of sulphenic acid. Sulphenic acids favour the formation of tautomer 
1, which has been confirmed by infrared spectrometry. 
 
 The oxidation state of sulphur in sulphenic acid is 0 and therefore it displays both 
electrophilic and nucleophilic reactivity. Even though the nucleophilic nature is weak in 
sulphenic acids, when there is a possibility for intermolecular hydrogen bond formation it can 
play an important role. The electrophilic nature of the sulphur atom in sulphenic acids can be 
demonstrated by several reactions. One of the most important discoveries was the reaction of 
5,5-dimethyl-1,3-cyclohexanedione also known as dimedone which was discovered by 
Allison and co-workers in 1974. It reacts specifically with sulphenic acids in a condensation 
reaction where the sulphenic acid acts as an electrophile to yield the thioether derivative as 
shown below (Figure 1.3, 1) (14). Although the exact mechanism for this reaction is not 
1 2 
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known it could proceed via a 1,4-addition or a direct substitution reaction (8). Sulphenic acids 
could also react with amines to form sulphenamides (Figure 1.3, 2). When the nitrogen atoms 
of the amides are in close proximity with the sulphur atom, the nitrogen can act as a 
nucleophile to form cyclic sulphenamides (Figure 1.3, 3) (15, 16). This five-member ring 
represents another form of a cysteine oxidation state that is resistant to further oxidation. The 
initial evidence for this species was crystallographic
 
(17), therefore leaving some doubts to its 
relevance in a biological system. However, studies using model chemistry have better defined 
this cyclization reaction in the constrained setting of a protein active site (18). Recent studies 
of the peroxide sensitive transcriptional regulator, organic hydroperoxide resistance regulator 
(OhrR) from Bacillus subtilis support stable formation of the sulphenamide species in 
solution (19).  
Sulphenic acids also react with other nucleophilic thiols to form disulphide bonds (4). The 
sulphenic acids, due to their instability can undergo rapid changes like condensation with 
another thiol group or with a small molecule thiol like glutathione (GSH) to form disulphide 
bonds. If two cysteinyl residues are close to each other within a molecule they will form 
intramolecular disulphide bonds. An intermolecular disulphide bond will form during the 
oxidation of different protein sulphydryl groups if they are located in an environment on the 
surface of the protein, which will allow them to approach each other (20). Sulphenic acid 
formation and disulphide bond formation are reversible reactions which are important in 
maintaining a reduced cellular environment and are also a major component of the ROS-
linked modulation of cell signalling pathways (2). Disulphide bond formation can stabilize 
extracellular proteins, protect against irreversible inactivation, modify structures to create, 
destroy or modulate functional sites, and ultimately regulate enzymatic or transcriptional 
activity of the proteins
 
(1, 3, 8). 
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Figure 1.3: Electrophilic reactions of sulphenic acids. Sulphenic acids act as electrophiles 
and react with 1,3-cyclohexanedione to form a thioether product 1. They can also react with 
the amines to form sulphenamides 2 and can form cyclic sulphenamides 3 with neighbouring 
nitrogen atoms. Disulphide bond formation 4 is an important biological function where 
sulphenic acids act as electrophiles. 
 
 
In a number of reactions sulphenic acids act nucleophiles. In the case of sulphinic acid 
formation sulphenic acid acts as a nucleophile in its reaction with hydrogen peroxide (Figure 
1.4, 1) (21). One important reaction that has also been used in the identification of sulphenic 
acids in biological systems is the nucleophilic substitution reaction on 4-chloro-7-nitrobenzo-
2-oxa-1,3-diazole (NBD-Cl) (Figure 1.4, 2). Based on its unique spectral properties the 
identification of both thiols and sulphenic acids can be discriminated; this will be discussed in 
detail later in the chapter (7).  
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Figure 1.4: Nucleophilic reactions of sulphenic acids. Sulphenic acids can act as 
nucleophiles and react with hydrogen peroxide and form sulphinic acids 1 or react with 
halogenated compounds such as with NBD-Cl 2. 
 
 
Sulphenic acids are formed by the reaction of a thiol or a thiolate anion with many oxidants 
due to sulphur’s nucleophilic character. One-electron oxidants such as O2
 .-
 can react with the 
thiolate anion to produce thiyl radicals (R-S
.
), which then can form disulphide bonds with 
another thiolate accompanied by superoxide formation (21). Two electron oxidants such as 
hydrogen peroxide, peroxynitrite and hypochlorous acids also generate sulphenic acids (22, 
23). Sulphenic acids may accumulate or undergo further oxidation to form more stable 
products such as sulphinic or sulphonic acids depending on the microenvironment and the 
level of oxidants present (2). 
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1.2.2 Cysteine sulphinic and sulphonic acids: 
 
 
In addition to being key intermediates in the formation of disulphides sulphenic acids are also 
intermediates in the oxidation of thiols to sulphinic and sulphonic acids (Figure 1.1). Unlike 
sulphenic acids, sulphinic or sulphonic acid species do not undergo self-condensation 
reactions or react with thiol groups. They are stable oxidation products, which can be isolated 
and crystallised. The oxidation of sulphenic acids to sulphinic acids can occur enzymatically 
as well as in the presence of oxidants. For example, when the enzyme cysteamine oxygenase 
reacts on the thiol cysteamine it forms the sulphinic acid hypotaurine (24). Sulphinic acids 
have gained importance in the redox regulation of peroxiredoxin (25, 26, 27). It has two 
cysteines (peroxidatic and resolving) which are redox active, in its catalytic site which 
decompose hydrogen peroxide. When hydrogen peroxide is present, the peroxidatic cysteine 
at the active site is oxidised to sulphenic acid and then forms a disulphide bond with the 
resolving cysteine. However, when concentrations of hydrogen peroxide increase the 
sulphenic acid will oxidise further to form a sulphinic acid that inactivates the enzyme (25, 
26, 27). Until recently it was thought that sulphinic acid formation was an irreversible protein 
modification. Although cysteine sulphinic acids cannot be reduced back to a thiol by 
molecules such as glutathione or thioredoxin (28) a highly selective enzyme called 
sulfiredoxin, which has been isolated from yeast can reduce the sulphinic acids back to the 
thiols (29, 30). 
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1.3 Cysteine sulphenic acids in proteins: 
 
 
Recent research suggests that protein sulphenic acids can spontaneously form in unfolded 
proteins even in the absence of exogenously added oxidants with just the presence of oxygen 
and trace metals. These sulphenic acids act as intermediates in the formation of disulphide 
bonds in protein folding (31). The antioxidant properties of many proteins can be attributed to 
cysteine oxidation to sulphenic acids. Peroxiredoxins (Prxs) are the most abundant 
antioxidant enzymes in the cytosol and belong to the family of peroxidases.  Prxs are very 
specific in recognising hydrogen peroxide, peroxynitrite and organic hydroperoxides. They 
are classified into six subfamilies consisting of Ahpc/Prx1, BCP/PrxQ, Prx5, Prx6, Tpx and 
AhpE (32). Over the years extensive research has been done to recognise their role as 
antioxidant and signalling molecules and their mechanism of action (33, 34). It has been 
predicted through kinetic experiments that under physiological conditions eukaryotic Prxs are 
responsible for the removal of about 90% of mitochondrial hydrogen peroxide (35) and 
reduction of almost all of the cytoplasmic H2O2 (36). Another important antioxidant enzyme 
is the glutathione peroxidase (GPx) (37) which play a role in the detoxification of hydrogen 
peroxide in the cells (38). The vast majority of non-vertebrate GPxs are cysteine homologues 
(2-CysGPxs) whereas mammalian GPxs are selenoproteins (SecGPxs) (39). Both of these 
families have similarities in that they share a common enzyme substitution system. The 
catalysis occurs between the enzymes and their substrates in a sequence of reactions rather 
than with the involvement of a central enzyme complex where all the substrates are bound at 
the same time. Normally a 2-cysPrx/2-cysGPx consists of 2 cysteine molecules. One cysteine 
is present in the active site known as the peroxidatic cysteine while the other is known as the 
resolving cysteine. When hydrogen peroxide is present in cells, initially the peroxidatic 
cysteine is oxidised to a cysteine sulphenic acid. But as it is highly reactive with other thiols it 
will rapidly form a disulphide bond with the resolving cysteine. These disulphides can be 
reduced back to cysteines residues by molecules such as thioredoxin (Trx), which is important 
to maintain the cellular antioxidant system (40). In addition to being intermediates in the 
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catalytic cycle of many antioxidant enzymes they also play a role in cell signalling and 
sensing oxidative stress (41). It has been proposed that sulphenic acid formation is involved 
in the inactivation of protein tyrosine phosphatases (PTP) by hydrogen peroxide. Tanner et al 
have demonstrated that purified PTPs such as vaccinia H1-related (VHR) and PTP1 are 
inhibited by hydrogen peroxide and that this inhibition is reversible with reducing agents such 
as dithiothreitol (DTT) or glutathione. Utilizing the electrophilic reagent 7-chloro-4-
nitrobenzo-2-oxa-1,3-diazole (NBD-Cl), it was shown that a cysteine sulphenic acid 
intermediate (Cys-SOH) is formed after attack of the catalytic thiolate on H2O2 (42). Once 
formed, sulphenic acid modifications can act as a molecular switch to activate/deactivate 
proteins. For example, Zheng et al have shown that a redox sensitive disulphide is present in 
the active site of the transcription factor OxyR in E.coli, with both Cys199 and Cys208 being 
essential for transcriptional activation of OxyR (43). Disulphide bond formation between 
these two cysteines leads to a conformational change in the OxyR-DNA complex that in turn 
activates transcription. Hydrogen peroxide-oxidized Cys199 forms a Cys199SOH, which is 
condensed rapidly with the thiol of Cys208 to form the disulphide. It appears that this protein 
has the ability to detect hydrogen peroxides and other peroxidases (43).  
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1.4 Tools to detect cysteine sulphenic acid formation in proteins: 
 
 
Interest in the identification of the cysteine sulphenic acids in proteins has grown over the last 
few decades as their importance in biological activities is becoming better known. Despite 
their importance in cellular processes such as redox regulation and enzyme catalysis
 
only a 
limited set of tools are present to identify these species and most are only applicable to in 
vitro studies of isolated proteins. The fact that SOH is unstable and undergoes oxidation to 
higher oxidation states, absence of any UV-visible spectral properties and its small size makes 
it a challenge for detection. The majority of the data presented thus far rely on the reactivity 
of sulphenic acids with chemically selective probes. Both direct and indirect methods have 
been used for the detection of suphenic acids in proteins (44). 
Indirect methods rely on the changes in the redox state of cysteine by the loss of reactivity 
with thiol modifying reagents. The free thiol groups are blocked by alkylating agents such as 
N-ethylmaleimide (NEM) and iodoacetamide (IAM), two thiol specific alkylating agents that 
react readily with cysteine thiolate anions
 
(45). The biotin-switch method, which was first 
developed to detect protein S-nitrosation (SNO) (46) consists of blocking the free cysteine 
thiol with methyl methanethiosulphonate, reduction of RSNO with ascorbate and labelling of 
thiols with biotin-HPDP which is a pyridyldithiol-biotin compound for labelling protein 
cysteines and other molecules that contain sulphydryl groups. An adaptation of this method 
was used by Eaton and coworkers to detect protein sulphenic acids indirectly. Their method 
involved blocking the thiols with NEM, reduction of SOH with RSOH reducing agent sodium 
arsenite (47) and labelling of reduced thiols with biotin maleimide. This enables isolation of 
labelled proteins to be identified with SDS-PAGE and western blotting as well mass 
spectrometry analysis. The limitations of this method are that the selectivity of sodium 
arsenite has not been extensively studied and the fact that proteins undergo extensive 
treatments under denaturing conditions which could lead to false identifications of 
modifications (48). Another method used to identify protein sulphenic acids indirectly uses 
blocking thiols with alkylating agent iodoacetamide and the oxidising of remaining sulphenic 
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acids to sulphonic acids. These sulphonic acids are then identified using pervanadate. 
Sulphenic acids present on protein tyrosine phosphatases have been identified using this 
technique. Some of the drawbacks of using this method are that if all the thiols have not been 
blocked, this could lead to false positive signals (49, 50). The electrophilic probe NBD-Cl has 
also been used to detect sulphenic acid formation. The disadvantage to using this probe is that 
it is not selective as it can also react with thiols and in some instances with amines and 
phenols. NBD-Cl forms a sulphoxide with sulphenic acids, which has an absorbance 
maximum at 347 nm. The thiol reacts with NBD-Cl to form a thioether, which has an 
absorbance max at 420 nm. This shift in absorbance has been used to confirm the presence of 
sulphenic acids (51). However, there have been many cases where it has not been possible to 
detect this protein modification via the absorption maxima and the only way to positively 
identify sulphenic acids was via mass spectral analysis (52). Poole et al have used this 
technique to observe that sulphenic acid are formed as an intermediate in the C165S mutant 
of the AhpC peroxidase protein from Salmonella typhimurium as well as the flavoprotein 
NADH peroxidase of Enterococcus faecalis (52). A genetically-encoded probe has been used 
by Wood and researchers to trap sulphenic acid modified proteins in E.coli. The probe was a 
modification of the transcription factor yes associated protein 1 (Yap1) consisting of 85 
amino acids of the cysteine rich C-terminal domain along with a His-tag for affinity 
purification. Of the three native cysteines, two were mutated leaving Cys598 to form 
disulphides with sulphenic acid modifications. With this method gluthathione peroxidase3 
(GPx3) has been identified as a redox sensing protein with an active cysteine Cys36, which 
forms a sulphenic acid intermediate (53).  
Direct methods use small molecular probes that selectively react with one class of oxidative 
cysteine modification. The key challenge to this approach is to design a probe that is selective 
to the detection of the desired functional group. Investigating the role of sulphenic acids in 
proteins requires reagents for their detection (44). In 1974, Benitez and Allison presented the 
first evidence that adduct formation with 5,5-dimethy-1,3-cyclohexadione (dimedone) could 
be used as a diagnostic tool to detect sulphenic acids in proteins
 
such as glyceraldehyde-3-
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phosphate dehydrogenase (GAPDH) (14). Although the exact mechanism for this reaction is 
not known it is believed to proceed via a direct substitution (Figure 1.5). Although chemical 
modifications of cysteine sulphenic acids by dimedone provide a useful way to tag these 
species, the lack of any spectral or affinity label associated with dimedone requires that 
detection be undertaken by mass spectrometry
 
(3). 
 
 
Figure 1.5: S-alkylation of a sulphenic acid by dimedone. Dimedone reacts with sulphenic 
acid via a direct substitution reaction. 
 
 
In 2005, Poole et al provided a new tool for the isolation and identification of protein 
sulphenic acid by synthesis of a functionalised derivative of 1,3-cyclohexadione which is a 
dimedone like compound and linking this to two different fluorophores, isatoic acid and 7-
methoxycoumarin to yield fluorescent probes. The synthesis of the two fluorescent probes 3-
(2,4-dioxocyclohexyl)propyl-2-(methylamino)benzoate (DCP-MAB) and 3-(2,4-
dioxocyclohexyl)propyl-7-methoxy-2-oxo-2H-chromen-3-ylcarbamate (DCP-MCC) are 
shown in Figure 1.6 below (54). 
+ H2O
SOH
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Figure1.6: Schematic for the synthesis of DCP-MCC (7) and DCP-MAB (6). The protected version of 1,3-cyclohexadione, 3-ethoxy-2-cyclohexen-1-one 
(1) is alkylated with tert-butydimethysilyl ether (TBDMS) protected 3-iodo-1-propanol yielded 3-ethoxy-6-(3-tert-butyldimethylsiloxypropyl)-cyclohex-2-
enone (2). Treatment of 2 with tetra-n-butylammonium fluoride (TBAF) removed the silyl group to give the alcohol, 3-ethoxy-6-(3-hydroxypropyl) cyclohex-
2-enone (3). Condensation of 3 with N-methylisatoic anhydride produced 3-(4-ethoxy-2-oxocyclohex-3-enyl) propyl-2-(methylamino)benzoate (4). Heating 
7-methoxycoumarin-3-carboxylic acid in the presence of diphenyl phosphorazidate (DPPA) yielded 3-(4-ethoxy-2-oxocyclohex-3-enyl) propyl-7-methoxo-2-
oxo-2H-chromen-3-ylcarbamate (5). Treatment of products 4 and 5 with 3 M hydrochloric acid (HCl) yielded 6 (DCP-MAB) and 7 (DCP-MCC) respectively
.
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The protected version of 1,3-cyclohexadione, 3-ethoxy-2-cyclohexen-1-one (Figure 1.6, 1) 
was used by Poole et al as the starting material for both fluorescent probes. Alkylation of 1 
with tert-butydimethysilyl ether (TBDMS) protected 3-iodo-1-propanol yielded 3-ethoxy-6-
(3-tert-butyldimethylsiloxypropyl)-cyclohex-2-enone (Figure 1.6, 2). Treatment of 2 with 
tetra-n-butylammonium fluoride (TBAF) removed the silyl group to give the alcohol, 3-
ethoxy-6-(3-hydroxypropyl)cyclohex-2-enone (Figure 1.6, 3). This alcohol group provides 
the attachment site for the fluorophores. Condensation of 3 with N-methylisatoic anhydride 
produced 3-(4-ethoxy-2-oxocyclohex-3-enyl) propyl-2-(methylamino) benzoate (Figure 1.6, 
4). Heating 7-methoxycoumarin-3-carboxylic acid in the presence of diphenyl 
phosphorazidate (DPPA) yielded 3-(4-ethoxy-2-oxocyclohex-3-enyl)propyl-7-methoxo-2-
oxo-2H-chromen-3-ylcarbamate (Figure 1.6, 5). Treatment of products 4 and 5 with 3 M 
hydrochloric acid (HCl) yielded 6 (DCP-MAB) and 7 (DCP-MCC) respectively (54). 
Once the probes were synthesised, Poole et al examined the reactivity toward protein 
sulphenic acid. The C165S mutant of AhpC, a cysteine based peroxidase from Salmonella 
typhimurium was purified and rapidly titrated with hydrogen peroxide of known 
concentration to convert the cysteine thiol group to its sulphenic acid form. The advantage of 
using the C165S mutant is that it only has one cysteine (Cys46), keeping the essentiality of a 
single active site cysteine for the reduction by peroxides as opposed to the wild type, which 
has a second cysteine (Cys165). Removal of the second cysteine allows sulphenic acid 
formation whereas if two thiol groups were present the Cys165 could react with the recently 
formed sulphenic acid of Cys46 to form the more stable disulphide bond of the oxidised 
enzyme (2, 54, 55). Both compounds formed adducts with the sulphenic but not the sulphinic 
or sulphonic acid forms of the peroxidase. This was confirmed by results from electrospray 
ionisation mass spectroscopy (ESI-MS). The sulphenic acid form of the protein either reacted 
with the reagents or were further oxidised and were therefore not observed. Although this was 
an advance towards sulphenic acid detection the absence of any affinity tags such as biotin 
meant that these probes could not be used in western blotting techniques as the probes could 
not be visualised. 
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The synthesis of seven new reagents through the attachment of fluorescein, rhodamine and 
biotin moieties to an alcohol functional group on a linker attached to 1,3-cyclohexadione was 
reported by Poole et al in 2007 (56). One major advantage over the previous two probes is 
that these probes are useful for detecting labelled proteins in polyacrylamide gels. The 
fluorescent probes can directly be observed both in solution and after gel electrophoresis. The 
reagents were also compatible with mass spectroscopic approaches to confirm covalent 
attachment and identify the specific site of modification. Furthermore the biotin-linked probes 
could be detected through western blotting type approaches as well as enabling affinity 
techniques for the isolation of modified proteins (56). Figure 1.7 below shows the seven 
reagents based on 1,3-cyclohexadione. 
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Figure 1.7: Fluorescent and affinity based probes to detect cysteine sulphenic acid. Four 
fluorescent probes DCP-FL1, DCP-FL2, DCP-Rho-1, DCP-Rho2 and three biotin tagged 
probes DCP-Bio1, DCP-Bio2 and DCP-Bio3 were synthesised and utilised to detect sulphenic 
acids in various proteins. 
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The experiments carried out to synthesise each of the probes by Poole and her colleagues are 
described below. The treatment of fluoresceinamine isomer with p-nitrophenyl chloroformate 
yielded fluoresceinamine-5’-N-(p-nitrophenyl)carbamate. This product was filtered and 
analysed by thin layer chromatography (TLC) and nuclear magnetic resonance (NMR) 
spectroscopy. Reacting this with the protected alcohol derivative of 1,3-cyclohexadione 
produced the protected fluorescein carbamate conjugate. Deprotection of the enol ether was 
achieved using 4 M HCl in 1,4-dioxane to give fluoreceinamine-5’-N-[2,4-dioxocyclohexyl) 
propyl] carbamate (DCP-FL1) (56). 
The synthesis of fluoresceinamine-5’-N-[3-((1-3-(2,4-dioxocyclohexyl)propyl)-1H-1,2,3-
triazol-4-yl)methyl]urea (DCP-FL2) involved the introduction of a urea linker 
propargylamine, which was added to fluoresceinamine-5’-N-(p-nitrophenyl)carbamate. The 
product, fluoresceinamine-5’-N-(3-propargyl)urea triethylamine salt, was precipitated and 
filtered off with the addition of triethylamine. In parallel, 3-ethoxy-6-(3-
azidopropyl)cyclohex-2-enone was synthesised from 3-ethoxy-6-(3-
hydroxylpropyl)cyclohex-2-enone by adding diisopropyl azodicarboxylate (DIAD), triphenyl 
phosphate and diphenylphosphorazide (DPPA) in tetrahydrofuran (THF) at 0 C̊. Utilizing 
‘click’ chemistry permitted the coupling of the azide compound of the alcohol with the 
propargyl urea to form fluoresceinamine-5’-N-[3-((1-3-(4-ethoxy-2-oxocyclohex-3-
enyl)propyl)-1H-1,2,3-triazol-4-yl)methyl]urea. Acid deprotection with 3 M HCl yielded the 
final product DCP-FL2 (56). 
The first biotinylated probe 3-(2,4-dioxocyclohexyl)propyl-5-((3aR,6S,6aS)-hexahydro-2-
oxo-1H-thieno[3,4-d]imidazole-6-yl)pentanoate (DCP-Bio1), was generated with the 
coupling of biotin to the alcohol 3-ethoxy-6-(3-hydroxypropyl)-cyclohex-2-enone. The 
coupling was done using dicyclohexylcarbodiimide (DCC) as the coupling agent. Acid 
deprotonation of 3-(4-ethoxy-2-oxocyclohex-3-enyl)propyl-5-((3aR, 6S, 6aS)-hexahydro-2-
oxo-1H-thieno[3, 4-d] imidazole-6-yl)pentanoate with HCl produced DCP-Bio1 in good yield 
(70%) 
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5-((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-6-yl)-N-((1-(3-(2,4-
dioxocyclohexyl)propyl)-1H-1,2,3-triazol-4-yl)methyl)pentanamide (DCP-Bio2), was 
synthesised with biotin and incorporating propargylamine similar to the synthesis of DCP-
FL2. 3-ethoxy-6-(3-azidopropyl)cyclohex-2-enone ( synthesis procedure described previously 
for the synthesis of DCP-FL2) and 5-((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-
d]imidazol-6-yl)-N-(prop-2-ynyl)pentanamide were reacted together using click chemistry 
utilised in the synthesis of the fluorescein triazole conjugate. The final step involved acid 
deprotection yielding DCP-Bio2 (56). 
 The final biotin linked probe 3-(2,4-dioxocyclohexyl)propyl-4-(5-((3aR,6S,6aS)-hexahydro-
2-oxo-1-H-thieno[3,4-d]imidazole-6-yl)pentanamide)butylcarbamate (DCP-Bio3) was 
synthesised incorporating a longer ‘linker’,1,4-diaminobutane. The first step of the synthesis 
was the mono N-Boc protection of 1,4-diaminobutane. This is followed by the DCC coupling 
of biotin and BOC deprotection to give the amine hydrochloric acid salt, N-(4-aminobutyl)-5-
((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-6-yl)pentanamide hydrochloric 
salt. 3-ethoxy-6-(3-hydroxylpropyl)cyclohex-2-enone and p-nitrophenyl chloroformate were 
reacted together to form 3-(4-ethoxy-2-oxocyclohex-3-enyl)propyl-4-nitrophenylcarbonate. 
This was coupled with the free amine of the hydrochloric acid salt to give the protected 
version of the biotin derivative 3-(4-ethoxy-2-oxocyclohex-3-enyl)propyl-4-(5-
((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-6-
yl)pentanamido)butylcarbamate. Deprotection of the compound resulted in the probe DCP-
Bio3. 
The synthesis of the rhodamine derivatives were explored because rhodamine B is known to 
be cell permeable (57) which would be advantageous for the detecting of intracellular 
sulphenic acids without cell lysis. The first step towards the synthesis of rhodamine B[4-[3-
(2,4-dioxocyclohexyl)propyl]carbamate]piperazine amide (DCP-Rho1) was the synthesis of 
rhodamine B piperazide amide. This was done with the addition of piperazine and rhodamine 
B in trimethylaluminum under reflux. Coupling the compound with 3-(4-ethoxy-2-
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oxocyclohex-3-enyl)propyl-4-nitrophenylcarbonate, which is described in the synthesis of 
DCP-Bio3 and deprotection proceeded to give the first rhodamine derivative DCP-Rho1. 
The synthesis of the second rhodamine derivative, rhodamine B-3-(2,4-
dioxocyclohexyl)propyl-4-oxo-4-(piperazin-1-yl)butylcarbamate (DCP-Rho2), was 
undertaken as described below. Rhodamine B piperazine amide was coupled using DCC to γ-
(Boc-amino)butyric acid, 4-(tert-Butoxycarbonylamino)butyric acid (N-Boc GABA) to yield 
the extended protective derivative rhodamine B tert-butyl-4-oxo-4-(piperazin-1-
yl)butylcarbamate. Deprotection of the N-Boc group with 4 M HCl and further coupling to 
the carbonate derivative 3-(4-ethoxy-2-oxocyclohex-3-enyl) propyl-4-nitrophenylcarbonate 
followed by enol ether deprotection yielded DCP-Rho2. 
To test the reactivity of the probes Poole et al used the C165S mutant of AhpC as the choice 
protein because of its rapid formation of the sulphenic acid intermediate at the active site (Cys 
46) upon oxidation by peroxides (55, 56, 57). The stabilized sulphenic acid forms of the 
proteins were then incubated with DMSO and the seven probes to yield the covalent protein 
adduct. These samples were analysed using electrospray ionisation mass spectroscopy. In 
each case the expected results and the observed results from the MS were very similar 
indicating the formation of adducts. The biotinylated probe DCP-Bio1was used to detect 
sulphenic acid formations of protein tyrosine phosphatases (PTPs) SHP-1 and SHP-2 in cell 
lysates from CD8+ T cells (58). It has also been used to identify sulphenic acid modifications 
of the serine/threonine protein kinase Akt2 (59). 
In 2008 Carroll et al (60) described a method that enabled live cell labelling of sulphenic acid 
modified proteins. A bifunctional probe N-(3-azidopropyl)-3,5-
dioxocyclohexanecarboxamide referred to as DAz-1 (Figure 1.8, 5) was synthesised. It 
includes the nucleophile 1,3-cyclohexanedione (Figure 1.8, 2), a dimedone analogue that 
reacts selectively with sulphenic acids to form adducts. In addition DAz-1 also contains an 
azide “chemical handle” that can be selectively detected with phosphine reagents via the 
Staudinger ligation (62) for identification, enrichment and visualisation. The advantages of 
this probe over existing probes was that due to its small size, it could be favourably up taken 
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by cells and facilitate protein labelling. Furthermore because of the azide group, once 
introduced into proteins it could be tagged by a variety of affinity and fluorescent reagents 
(60). The synthesis of DAz-1 is outlined below in Figure 1.8. 
 
 
Figure 1.8: Synthesis of DAz-1. 3,5-dihydroxybenzoic acid 1 was hydrogenated to give the 
diketone 2 and protected as a methyl ether using PTSA and methanol for 10 mintues at room 
temperature. 3-azidopropylamine was coupled to compound 3 using TBTU/DIEA in DMF to 
provide the amide 4. The synthesis was completed with the deprotection of the methoxy 
group with 2 M HCl. 
 
 
Ni-catalysed hydrogenation (a) of 3,5-dihydroxybenozoic acid 1, which is commercially 
available, gave the diketone 2 in 85% yield (61). To prevent undesired reactions at the ketone, 
it was protected as methyl ether 3 using p-toluene sulphonic acid (PTSA) and methanol for 10 
minutes at room temperature (b). The coupling of the amine, 3-azidopropylamine was carried 
out with O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium tetrafluoroborate (TBTU) and 
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N,N-diisopropylethylamine (DIEA) in dimethylformamide (DMF) (c) to provide the amide 4. 
The synthesis of DAz-1 was completed through deprotection of methyl vinyl ether with 2 M 
HCl in THF (d) (60). 
 
Experiments were carried out by Carroll and colleagues to test the ability of DAz-1 to bind 
specifically to protein sulphenic acids. Two model proteins were examined in vitro. Papain 
from Carica papaya which is the prototype cysteine endopeptidase has been studied 
comprehensively because of its homology with mammalian cysteine proteases. The oxidation 
of the active site Cys25 of papain induces a loss of enzymatic activity. Experiments were 
done to assess the modification at Cys25 by monitoring cleavage of the chromogenic 
substrate N α-benzoyl-L-arginine-4-nitroanilide hydrochloride (BAPNA). Untreated papain 
showed catalytic activity in the presence of BAPNA as the substrate. However when treated 
with a stoichiometric amount of hydrogen peroxide (H2O2) the protease activity was 
eliminated. Treatment of the oxidised papain sample with the reducing agent DTT led to the 
reactivation of enzymatic activity demonstrating that the Cys25 sulphenic acid was reduced to 
the thiol form. Having recognized that H2O2 and DTT can be used to modulate the activity of 
papain Cys25 the researchers then investigated the effect of DAz-1 on the assay. In the 
absence of hydrogen peroxide, the inclusion of DAz-1 had no effect on the enzymatic 
activity. However when the oxidised papain was treated with the probe the protease activity 
was abolished and this could not be reversed with the addition of DTT. These data suggested 
that a covalent modification of cysteine sulphenic acid and DAz-1 had occurred in papain. 
The selectivity of DAz-1 was also explored by western blot. Oxidised papain was incubated 
with the probe and subjected to labelling with phosphine-biotin (p-biotin) via the Staudinger 
ligation (62). The reactions were separated by electrophoresis and studied by streptavidin 
blotting. In the absence of oxidised papain no bands were detected by streptavidin blotting 
demonstrating the specificity of DAz-1 to detect sulphenic acid modified proteins (10). 
The specificity of DAz-1 for sulphenic acid was then investigated with a different protein, 
human serum albumin (HSA) (10). HSA contains one free cysteine, Cys 34, 17 disulphide 
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bridges and is the most abundant protein in plasma (63). It has been demonstrated by 
Carballal and colleagues that Cys 34 in HSA oxidises to form a stable sulphenic acid (64). In 
the experiments carried out by Carroll and the research group the thiol and sulphenic acid 
content was assessed using 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl). NBD-Cl is a 
non-fluorescent compound that upon the reaction with thiol groups or sulphenic acid groups 
(52) will emit distinctive signals. Reacting HSA with NBD-Cl yielded one major peak on the 
UV-Vis spectra at 347 nm and additional peak at 400 nm. This indicated that the NBD-Cl had 
formed adducts with both thiol and sulphenic acid groups. However, when DAz-1 was added 
to HSA prior to the addition of NBD-Cl the sulphenic peak at 347 nm disappeared leaving 
only the 400 nm thiol peak (10). The advantage of DAz-1 over existing probes is that it is a 
small molecule which is cell permeable therefore making it possible to detect sulphenic acids 
in intact cells. In this approach experiments were carried out on human T lymphoma cell line 
Jurkat. DAz-1 was incubated with Jurkat cells in increasing concentrations. After labelling the 
excess probe was washed off, cells lysed and the DAz-1 labelled proteins were detected after 
ligation with p-biotin. Through HRP-streptavidin western blotting it was shown that the 
intensity of DAz-1 labelling increased in a dose dependent manner thus demonstrating the 
cell permeability of DAz-1 (10). 
 
The synthesis of 4-(3-azidopropyl)cyclohexane-1,3-dione (DAz-2) was reported by Carroll et 
al in 2009 (1). This was an analogue of DAz-1 with a propyl azide linker installed directly at 
the C4 position of the 1,3-cyclohexadione scaffolds. (Figure 1.9) 
 
Figure 1.9: Chemical structure of DAz-2 
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Two synthetic routes are reported in the literature with a 10% yield of the final compound. 
Both routes begin with the protection of the reactive diketone of 1,3-cyclohexadione. The 
protected 3-ethoxy-cyclohex-2-enone was synthesised with I2 in ethanol at room temperature. 
A lithium diisopropyl amide (LDA) solution was used to activate 3-ethoxyclohex-2-enone for 
the alkylation with 3-iodo-tert-butyldimethylsilyloxypropane to give 6-(3-
tertbutyldimethylsilyloxypropane)-3-ethoxycyclohex-2-enone. This compound was then 
deprotected with tetrabutylammonium fluoride (TBAF) to give 6-(3-hydroxypropyl)-3-
ethoxycyclohex-2enone. Via mesylation, the azide chemical handle was installed and 
subsequent nucleophilic displacement of the mesyl alcohol by sodium azide in a two-step 
reaction. The resulting 6-(3-azidopropyl)-3-ethoxycyclohex-2-enone was deprotected in the 
final step using ceric(IV) ammonium nitrate to give the final product DAz-2. The alternative 
route was attempted to reduce the number of synthetic steps. An LDA solution was used to 
activate the protected 3-ethoxycyclohex-2-enone for alkylation with 3-iodopropylazide to 
yield 6-(3-azidopropyl)-3-ethoxycyclohex-2-enone. This was then deprotected to give DAz-2 
(1). 
The hypothesis that DAz-2 would be more effective to detect sulphenic acid than DAz-1 was 
investigated using their reactivity to GAPDH. GAPDH is a glycolytic enzyme with an active 
site cysteine (Cys149) that is readily oxidized (14, 65). For these experiments, untreated or 
H2O2 treated GAPDH was reacted with DAz-1 and DAz-2. The azide tagged proteins were 
conjugated to phosphine-biotin and analysed by HRP-streptavidin Western blot. In reactions 
without H2O2, faint labelling of GAPDH by the 2 probes was observed which was consistent 
with the high reactivity of Cys149. Control reactions carried out in the absence DAz-1 and 
DAz-2 showed no detectable protein labelling. Protein labelling of DAz-2 was notably more 
intense relative to DAz-1 (1). DAz-2 was also evaluated for sulphenic acid detection in living 
cells. The extent and selectivity of covalent modifications of sulphenic acid modified proteins 
were examined by performing Staudinger ligation in lysates from cells treated with azido-
probe. Cells probed with both DAz-1 and DAz-2 showed similar protein labelling patterns 
although DAz-2 treated cells showed a higher intensity. These data showed that DAz-2 was 
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more sensitive to sulphenic acid detection (1). Another study by Carroll et al led to the 
development of a new set of sulphenic acid detecting probes DYn-1 and DYn-2 (66). In these 
two probes the linker to the dimedone molecule contains an alkyl group instead of an azide 
group which offer higher sensitivity compared to the reverse combination in DAz-1 and DAz-
2. Another advantage of these over the existing probes were that they were synthesised in 
high yields and with less synthetic routes. When the two probes were tested for sulphenic acid 
labelling in a recombinant protein GPx3 it was revealed that DYn-2 detected more sulphenic 
acid modifications to DYn1. This could be due to steric hindrance during the click chemistry 
reactions (67). DYn-2 has been used to monitor sulphenic acid modifications during cell 
signalling. It was demonstrated that epidermal growth factor receptor (EGFR) goes through 
sulphenic acid modifications when epidermal growth factor (EGF) is added. Normally when 
EGF is bound to the extracellular domain of EGFR it leads to the activation of NADPH 
oxidase (Nox) that will generate hydrogen peroxide. While the intracellular domain of EGFR 
has six-cysteine residues only one cysteine (Cys797) is conserved. It was observed that it was 
this cysteine that was oxidised to sulphenic acid during endogenous production of hydrogen 
peroxide (68). 
The main strategies employed so far for the synthesis of probes relies on the reactivity of 
dimedone or dimedone based derivatives. They are either linked to fluorophores for 
visualisation or use biotin tags for affinity purification. One particular disadvantage of using 
dimedone is that the derivatization process requires multiple synthetic steps and the overall 
yield is low. In 2011 Poole et al report the synthesis of 1,3-cyclopentanedione derived probes 
(69). They examined 4-(ethylthio)cyclopentane-1,3-dione, which could be used for the 
synthesis of sulphenic acid detection probes. One major advantage of this was the opportunity 
for direct conjugation to thiol-containing tags through a Michael addition. Furthermore 
fluorophores or affinity tags such as biotin could be incorporated in easy steps with high 
yields. To test the reactivity and selectivity towards cysteine sulphenic acids the C165S 
mutant of AhpC was used as the model protein. The cysteine active site was mildly oxidised 
and incubated with 4-(ethylthio)cyclopentane-1,3-dione, dimedone and 1,3-
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cyclopentanedione respectively. These samples were then analysed by ESI-TOF MS. The 
results indicate that 1,3-cyclopentanedione reacts in a similar fashion to dimedone to detect 
sulphenic acids although kinetic studies have shown that this occurs about 20 times slower 
than the dimedone reaction (69). In summary, probes such as NBD-Cl that were first used to 
identify sulphenic acid modifications in proteins have the disadvantage of not being specific 
to sulphenic acids which could lead to false positive identifications. Although the probes 
synthesised by Poole and co-workers are cell permeable and have both affinity and 
fluorescence tags their synthesis is lengthy. While Daz-1 and Daz-2 are small molecules they 
have no affinity or fluorescent tags attached to them. Therefore additional molecules have to 
be synthesised and added to the experiments in order to be able to detect the modified sites.  
  
 
 
49 
1.5 Inflammation and the immune system: 
 
 
Inflammation is the simplest mechanism by which the body defends itself against any damage 
or bacterial infection. The inflammatory responses are clinically characterised by the basic 
symptoms such as heat, pain, redness, swelling and result in loss of function. These symptoms 
are common in everyday life and are the result of cytokines and other inflammatory mediators 
acting on specific receptors on circulating cells and endothelial cells in the local blood vessels 
(70, 71). The immune system is responsible for these inflammatory responses and can be 
separated into two systems known as innate and adaptive immunity. The cross talk between 
these two systems is essential for the development of an effective immune response (70). The 
innate immune system accounts for a rapid non-specific response to pathogens or to cells that 
are injured or stressed (72). It is comprised of natural killer (NK) cells, macrophages, 
neutrophils, eosinophils, basophils and dendritic cells (DC). When pathogens such as bacteria 
and other microorganisms invade the human body an innate response is triggered with 
phagocytic neutrophils being the first to respond. This leads to the activation of neutrophils at 
the inflammation site leading to the release of cytokines. Cytokines are small proteins that are 
secreted by cells that act as mediators between cells. These include tumour necrosis factor-α 
(TNF-α), interleukins 1L-1, IL-4, IL-6, IL-10, IL-12, IL-18, chemokines and interferon-γ 
(IFN-γ). Cytokines may act on the cells that secrete them, on nearby cells or even on distant 
cells by which they can mediate signalling processors to recruit cells to the site of infection 
(73, 74). 
The adaptive system compromises of T cells and B cells that are required for an effective 
immune response. Although it is slower to respond it is highly specific to the defined antigen 
and generation of immunological memory (72). Although T cells and B cells are the main 
cells involved in the adaptive system, DCs and macrophages from the innate system are 
needed to present antigens to naïve T cells. Cell-mediated immune responses occur due to T 
cells. When a specific antigen is presented by antigen presenting cells (APCs) to a T cell 
receptor (TCR) they become activated and differentiate in to effector T cells. B cells are 
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responsible for the generation of antibodies. They do so by bearing an immunoglobulin 
receptor on the cell surface that is antigen specific. They phagocytize the antigen and activate 
specific T cells that will then induce the B cells to expand and differentiate into antibody 
producing cells (75). These antibodies are very specific to the antigen that trigger their 
production and will eventually lead to the removal of antigen. Once the immune response is 
over most of the activated T cells and B cells will die (70). However, a number of these cells 
will differentiate into memory cells so that when the body is exposed to the same antigen 
again it will trigger a faster secondary immune response (73). 
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1.5.1 T cell maturation and sub populations: 
 
 
All blood cells including T cells arise from a type of cell called the hematopoietic stem cell 
(HSC). These cells are multipotent which mean that they can differentiate in various ways to 
generate different blood cells. Early on these HSCs differentiate to give rise to either a 
common lymphoid progenitor cell or a myeloid progenitor cell. The common lymphoid 
progenitor cells then give rise to T, B and natural killer cells and some of the dendritic cells. 
Developing T cells also known as thymocytes migrate from the bone marrow to the thymus 
where they undergo different maturation stages (Figure 1.10). In the early stages of 
thymocyte development they have not yet rearranged their T cell receptor (TCR) genes and 
don’t express proteins such as RAG-1 and RAG-2 that are required for rearrangement. As 
maturation progresses expression of cell surface molecules such as c-Kit (stem cell growth 
factor receptor), CD44 (adhesion molecule involved in homing) and CD25 (α-chain of IL-2 
receptor) occurs. When the cells stop expressing c-Kit, RAG-1 and RAG-2 gene expression is 
turned on thus beginning the rearrangement of the TCR genes. According to the TCR gene 
rearrangement two cell lineages namely : and : are produced (71). About 5% of T cells 
are  and are characterised by the expression of : TCR at the cell surface. The  cells 
express : TCR at the cells surface and after positive selections can either differentiate into 
CD4 or CD8 T cells (76). CD4 T cells also known as T helper (Th) cells can recognise 
antigens bound to major histocompatibility complex (MHC) class II (MHC-II) molecules 
whereas CD8 or cytotoxic T (Tc) cells recognise antigens which are bound to MHC class I 
(MHC-I) molecules. During the development of T cells about 98 % of thymocytes do not 
mature, either because they fail in making a productive TCR rearrangement or because they 
fail to survive thymic selection. If TCRs of T cells strongly interact with self-MHC then they 
are negatively selected and eliminated. Cells that recognise self-MHC molecules are 
positively selected and leave the thymus to circulate in the blood stream as resting T cells 
(71). T cells differ according to the markers expressed on the cell surface as well as their 
function. When a CD8 T cell comes into contact with an antigen via MHC-1 on APCs, they 
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turn into effector T cells. Their main function is to release cytotoxins such as granulysin, 
perforin and granzymes into infected cells. Once CD4 T cells are activated they can develop 
into a variety of cells that include Th1, Th2, Th17 and T regulatory (Treg) T cells. The 
development of these cells depends on the level and type of co-stimulation, the amount of 
antigen that is presented to them and the environment that surrounds them (77). Th1 cells 
secrete interferon- (IFN-) lymphotoxin- (LT-) and interleukin-2 (IL-2) and are important 
for the protection against intracellular pathogens such as macrophages that are infected. Th2 
cells induce the proliferation of B cells leading to an immune response against extracellular 
pathogens. They secrete B cell growth factors, interleukin-4 (IL-4), interleukin-5 (IL-5) and 
CD40 ligand (CD40 L) (70, 78, 79). Th17 cells produce IL-17, IL-21 and IL-22 and act 
against extracellular bacteria and fungi. Treg cells protect the immune system against self-
antigens and secrete transforming growth factor beta (TGF-), IL-10 and IL-35 (79). 
 
Figure 1.10: Development of T cells. T cell precursors arrive from the bone marrow via the 
blood stream into the thymus where they undergo development into mature CD8+, CD4+ or 
 T cells. Then they are exported to the peripheral tissues where they can undergo antigen-
induced activation into effector cells or memory cells. 
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1.5.2 T cell activation and TCR signalling: 
 
 
Once the T cells are mature they enter the blood stream as naïve T cells and circulate in the 
periphery until they become activated. When an antigen interacts with a resting T cell it 
initiates a cascade of biological events that induces a T cell to enter the cell cycle, proliferate 
and differentiate into memory or effector cells. The contact between T cells and APCs is very 
specific and when they present an antigen to the naïve T cells they become activated. It is the 
T cell receptor located on the T cell surface that recognises specific antigens that are bound to 
MHC molecules at the surface of APCs (80). Co-stimulatory molecules such as CD80 and 
CD86 and chemical mediators expressed by antigen presenting cells are also needed to 
activate the T cells. The T cell receptor (TCR) is a trans-membrane protein that consists of an 
extracellular ligand-binding unit (α and β chains) and an intracellular signalling unit (γ, δ, ε, 
and ζ chains or the CD3 complex) (81). All these components are important for signal 
transduction. The T cell receptor associates with the CD3 unit to form a TCR-CD3 complex. 
The CD3 is a complex of five polypeptide chains that form three dimers. It consists of a 
heterodimer of  and  chains, heterodimers of  and  chains and a homodimer of two  
chains or a heterodimer of  and  chains. The T cell receptor complex can therefore be 
conceived as a four-dimer complex. The cytoplasmic domains of the CD3 chains consist of 
the immunoreceptor tyrosine-based activation motif (ITAM). It has been shown that these 
sites interact with tyrosine kinases and that they play an important role in signal transduction 
(82). 
Although the recognition of antigen-MHC complexes is mediated mainly by the TCR-CD3 
complex, various other membrane molecules play and important role as accessories in antigen 
recognition and T cell activation. Once the MHC peptide has been engaged by the TCR it 
leads to clustering with co-receptors CD4 or CD8 where they bind to certain regions of the 
MHC molecule. This brings Lck, which is a protein tyrosine kinase associated with the 
cytoplasmic tails of the co-receptors into close proximity with the cytoplasmic region of the 
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TCR complex. The cytoplasmic tail of TCR contains immunoreceptor tyrosine based 
activation motifs (ITAMs), which are phosphorylated by the tyrosine kinase. This provides a 
docking site for zeta-chain-associated protein kinase 70 (ZAP-70) and it becomes activated. 
ZAP-70 in turn phosphorylates the membrane protein LAT (linker of activated T cells) and 
SLP-76 (SH-2 domain containing lymphocyte protein of 76kDa molecules). LAT acts as an 
anchor to signalling molecules such as GRB2 (growth factor receptor bound protein 2), 
GADS (GRB2 related adaptor protein), ADAP (adhesion and degranulation promoting 
adaptor protein), ITK (interleukin-2-inducible T cell kinase), PLC (phospholipase C1), 
NCK1 (non-catalytic region of tyrosine kinase adaptor protein 1) and VAV1 (guanine 
nucleotide exchange factor). Several signalling pathways such as Ca
2+
, MAPK (mitogen 
activated protein kinase) (Figure 1.11) become activated resulting in the transport of 
transcription factors that are essential for gene expression and the growth and differentiation 
of T cells into effector cells leading to the removal of pathogens (81, 83). 
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Figure 1.11: Schematic representation of TCR signalling. When an antigen is presented to 
the TCR via an APC and the MHC has been engaged, clustering with co-receptors CD4 or 
CD8 occurs. This brings Lck, which is a protein tyrosine kinase into close proximity with the 
cytoplasmic region of the TCR complex. The cytoplasmic tail of TCR contains 
immunoreceptor tyrosine based activation motifs (ITAMs), which are phosphorylated by the 
tyrosine kinase, leading to the activation of protein kinase 70 (ZAP-70). ZAP-70 in turn 
phosphorylates a membrane protein, LAT (linker of activated T cells) and SLP-76 (SH-2 
domain containing lymphocyte protein of 76 kDa molecules). LAT acts as an anchor to 
signalling molecules such as GRB2 (growth factor receptor bound protein 2), GADS (GRB2 
related adaptor protein), ADAP (adhesion and degranulation promoting adaptor protein), ITK 
(interleukin-2-inducible T cell kinase), PLC (phospholipase C1), NCK1 (non-catalytic 
region of tyrosine kinase adaptor protein 1) and VAV1 (guanine nucleotide exchange factor). 
Several signalling pathways such as Ca
2+
, MAPK (mitogen activated protein kinase) and NF-
κB (nuclear factor-κB) become activated resulting in the transport of transcription factors that 
are essential for gene expression and the growth and differentiation of T cells.  
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1.5.3 Oxidative stress in the immune system: 
 
 
In recent years the effect of ROS and oxidative stress on immune cells and their roles in 
diseases has gained much interest. T cells play an important role in the adaptive immune 
response and their function is influenced by changes in the redox environment. Therefore the 
release of ROS during inflammation by activated granulocytes and macrophages or by 
stimulated T cells is important for the balance of T cell activation/inactivation and the 
regulation of immune outcomes (84). Cells have developed defence mechanisms that help 
protect against oxidative damage thus maintaining redox homeostasis. When cells are under 
oxidative stress these molecules alter their expression and this has an effect on the cellular 
function of T cells. 
ROS are important for the activation and proliferation of T cells. A study by King and his 
research group have shown that when peripheral blood mononuclear cells (PBMCs) were 
reacted with the ROS generator 2,3-dimethoxy-1,4-naphthoquinone that Th1 phenotype was 
inhibited whereas the Th2 were promoted. This is indicative of the importance of a redox 
balance in the cells, which must be regulated for the maturation, and activation of T cells 
(85). The redox environment between the APC and T cell also plays a role in the activation of 
T cells. Upon activation T cells display increased cell surface thiols, which suggests that a 
reduced extracellular environment is needed for the activation of T cells (86). Enzymes such 
as superoxide dismutase (SOD) convert two peroxide anions into hydrogen peroxide and 
oxygen and catalase converts hydrogen peroxide into water and oxygen where it completes 
the detoxification process. SODs have three isoforms and are suggested as being important in 
preventing oxidative stress associated diseases (87, 88). SOD2 helps protect against 
superoxide anions, which are by products of respiration. A recent study using T cell specific 
SOD2 knockout mice has shown that when SOD2 is absent there is an increased level of 
superoxide production, which causes apoptosis and defects in T cell population resulting in 
immunodeficiency (89). Glutathione peroxidase (GPx) is another important group of 
antioxidants, which are responsible for reducing peroxides. They are capable of protecting 
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cells from damage against ROS to proteins, lipids and nucleic acids. (90). A study has 
recently shown that GPx1 deficient CD4+ T cells produced more ROS compared to normal T 
cells. It was also shown that GPx deficient cells are more susceptible to hydrogen peroxide 
induced apoptosis. When treated with anti IL-4 and anti IFN-γ antibody Th1 phenotype was 
evident and Th2 and Th17 were suppressed indicative that GPx1 is not only important in the 
redox balance of ROS but also in the regulation of Th1 cell proliferation and differentiation 
(91). 
There are also a number of non-enzymatic antioxidant molecules that play an important part 
in the regulation of the redox balance in the cell. Two major systems that control the thiol 
redox state are the thioredoxin (Trx) and the glutathione systems. Trx-1 is a cytosolic protein 
that is present in all the cells but is also secreted to the surface of the cell upon cell activation 
(92, 93). Trx-1 is a 12 kDa protein that has several redox active cysteine residues. They are 
involved in cytokine expression (94, 95, 96), regulation of transcription factors such as NF-
B and AP-1 (97) and act as an antioxidant and redox-regulating enzyme (98). A study by 
Shao et al (99) has shown that in patients with T cell acute lymphoblastic leukemia (T-ALL) 
higher lymphocyte count was associated with higher expression of Trx. In vitro studies have 
also shown that exogenous treatment with TRX increased proliferation of lymphocytes, which 
suggests that they are important in the proliferation of T cells (99). Glutathione (GSH) is one 
of the most powerful intra-cellular molecules that act as a defence against the negative effects 
of ROS. Glutathione is a thiol containing tri-peptide, which consists of L-glutamate, L-
cysteine and glycine (100). The free thiol of cysteine serves as a target for ROS and GSH is 
converted to its oxidised form GSH disulphide (GSSG). It can be reduced again to its initial 
form (GSH) by a specific enzyme, glutathione reductase and reduced NADPH (101). 
Maintaining the GSH/GSSG ratio is vital to the cell survival as the level of glutathione is 
responsible how efficiently the cell can recover from oxidative damage (102, 103, 104, 105, 
106, 107, 108, 109). Depletion of GSH levels in cells has been suggested to lead to the 
progression of certain diseases including HIV and arthritis (110, 111, 112).  
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In recent years the effect of ROS and oxidative stress on immune cells and their roles in 
diseases has gained much interest. T cells have an important role in the immune system and 
their function is influenced by changes in the redox balance. Various T cell subsets respond 
differently to oxidative stress and therefore can contribute to a variety of different immune 
responses (113). For T cells to become activated, a reduced environment is key and therefore 
the presence of an oxidative environment affects the activation of T cells, negatively (114). 
However, the range and kinetics of target protein oxidation in T cells which are able to act as 
molecular switches to activate/inactivate T cell function depending on the redox state of the 
cells remains unknown.  
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1.6 Aims and objectives: 
 
 
The aims of this thesis are to develop novel probes that can detect sulphenic acid formation 
and to apply it to detect sulphenic acid in T cells. Specific objectives are to; 
1) Optimise conditions of sulphenic acid formation in the purified protein human serum 
albumin (HSA) using the commercially available sulphenic acid detection probe 
DCP-Bio1.  
2) Establish a model for thiol oxidation using buthionine sulfoximine and activation of T 
cells. 
3) Identify specific protein sulphenic acids formed during glutathione (GSH)-depletion 
in human proliferating and resting CD4+
 
T cells. 
4) Synthesis of novel probes 
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Chapter 2.0 Materials and Methods 
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2.1 Materials: 
 
 
All chemicals were purchased from Sigma-Aldrich (Poole, UK) and all solvents from Fisher 
Scientific (Loughborough, UK) unless stated otherwise. The Jurkat E6.1 T cells were from 
the European collection of cell cultures (ECACC-HPA cultures, Porton, Down, UK). 
Rosewell Park Memorial Park medium (RPMI) 1640 with stable L-glutamine, Foetal Bovine 
Serum (FBS) and Alexa Fluor 488C5 Maleimide were purchased from Life Technologies 
(Paisley, UK). Penicillin/Streptomycin 100x (containing 10,000 U penicillin and 10 mg/mL 
streptomycin) was purchased from PAA Laboratories (Pasching, Austria). Lymphoprep was 
purchased from Axis-Shield (Dundee, Scotland). Dynabead untouched human CD4 kit was 
purchased by Invitrogen (Paisley, UK). The recombinant human IL-2 ELISA development kit 
was purchased from Peprotech (London, UK). Protein Kaleidoscope markers were purchased 
from Bio-Rad (Hemel Hempstead, UK). Hydrobond-P transfer membrane and enhanced 
chemiluminescence (ECL) reagent were purchased from GE Healthcare (Piscataway, NJ, 
USA). Cell culture plastics and plastic ware and poly-L-lysine slides where from Thermo 
Scientific (Loughborough, UK). Needles and syringes were obtained from BD (Oxford, UK) 
and Vacuette blood collection tubes were from Greiner Bio-one (Gloucester, UK). Optilise 
was purchased from Beckman Coulter (High Wycombe, UK). DCP-Bio1 was purchased from 
Kerafast (Boston, USA). Mouse monoclonal (MEM-241) against CD4 conjugated to 
phycoerythrin (PE) (ab18282), mouse IgG1 isotype control conjugated to PE (ab81200) were 
purchased from Abcam (Cambridge, UK).  
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2.2 Methods: 
 
 
2.2.1 Jurkat E6.1 T Cell culture: 
 
 
Jurkat T cells are an immortalised line of the human T lymphocyte cells. The E6.1 T cell line 
is a sub clone derived from the original Jurkat T cell line taken from the peripheral blood of a 
patient with T cell leukaemia. Jurkat E6.1 T cells were from the European collection of cell 
cultures (ECACC-HPA cultures, Porton, Down, UK). Jurkat T cells were cultured in 
Rosewell Park Memorial Institute (RPMI) 1640 medium with L-glutamine (Gibco®, Life 
Technologies) supplemented with 10% heat inactivated foetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S). Actively growing T cells were maintained between 2x10
5 
- 
5x10
5 
cells per mL and passaged every three days. The cell cultures were maintained at 37 ºC 
in a 5% CO2 /95% air-humidified atmosphere. 
 
2.2.2 Trypan blue cell counting and cell viability: 
 
 
Cells were collected by centrifugation and resuspended in RPMI media. The cell suspension 
was mixed with an equal volume of trypan blue solution and counted in a haemocytometer for 
determination of viable and non-viable cells. 
Viability% = number of viable cells/number of total cells x 100 
Total cells (number of viable and non-viable cells) 
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2.2.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE): 
 
 
2.2.3.1 Reagents: 
 
 
Reagent Description 
1. Buffer 1 for the resolving gel Tris-base (36.3 g) and SDS (0.8 g) were dissolved 
in 150 mL of water and the pH adjusted to 8.4. 
The solution was made up to 200 mL. 
2.  Buffer 2 for the stacking gel Tris-base (6.05 g) and SDS (0.4 g) were dissolved 
in 80 mL water. The pH was adjusted to 6.8 and 
the solution made up to 100 mL 
3. Ammonium persulphate (10 
% w/v) 
1.0 g APS was dissolved in 10 mL of water and 
was aliquoted to 200 µL and frozen at -20 ˚C. 
4. Running buffer Tris-base (3 g), glycine (14.4 g) and SDS (1 g) 
were dissolved in 1 L of water. 
5. Transfer buffer Tris-base (4.5 g), glycine (21.6 g) was dissolved 
in 300 mL of methanol and 1200 mL of water 
6. Acrylamide solution Acrylamide/bis-Acrylamide 30% solution 
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7. TEMED N,N,N`,N`-tetramethylethyleneamine 
8. Tris buffered saline (TBS) 
buffer 
NaCl (12 g), Tris-HCl (6 g) were dissolved in 900 
mL water. pH was adjusted to 7.5 and the solution 
was made up to 1 L. 
9. TTBS buffer Tween20 (0.5 g) in 1 L of TBS buffer. 
 
Table 2.1: Buffers and reagents used for SDS-PAGE 
 
2.2.3.2 Gel Electrophoresis: 
 
 
Resolving and stacking gels were prepared using the hand cast Bio-Rad Mini Protean III 
system (Bio Rad). The reagent concentrations for a 10% resolving and 3% stacking gel are 
described in Table 2.2 below. Gels were left for 45 minutes to set at room temperature. 
Samples were mixed with 1:1 laemmli buffer (Sigma) or non-reducing buffer, boiled for 5 
minutes at 95 ˚C. Varing sample volumes depending on the experiment were loaded into each 
well and electrophoresed at 115 V for 1 hour 45 minutes. 
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2.2.3.3 Reagents: 
 
 
Reagent Resolving (10%) Stacking (3%) 
Water 5 mL 4.87 mL 
Buffer 1 3 mL - 
Buffer 2 - 1.87 mL 
Acrylamide 4 mL 750 µL 
10% APS 100 µL 100 µL 
TEMED 10 µL 10 µL 
 
Table 2.2: Reagents required for the polyacrylamide gels 
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2.2.3.4. Western blot: 
 
 
Proteins were separated by SDS-PAGE and were transferred on to polyvinylidene difluoride 
(PVDF) membrane (GE Healthcare, Amersham Hybond TM) that was soaked in 100% 
methanol for 5 minutes and transfer buffer (Tris-base (4.5 g), glycine (21.6 g) was dissolved 
in 300 mL of methanol and 120 mL of water) for 5 minutes prior to use as shown in Figure 
2.1. 
 
Figure 2.1: Schematic representation of protein transfer to PVDF membrane 
 
The proteins were then transferred at 240 mA for 65 minutes in transfer buffer. After transfer 
the PVDF membrane was blocked with 3% BSA (bovine serum albumin) in Tris buffered 
saline Tween-20 (TBST) overnight at room temperature. The membrane was washed with 
TBST (6 x 15 minutes) then incubated with 1:20,000 HRP streptavidin (Sigma) for 2 hours at 
room temperature. The membrane was washed with TBST (6 x 5 minutes) and developed 
with Amersham ECL
TM 
prime western blotting detection reagent (GE Healthcare). The 
membrane was visualised on the G box chemi XT4 (Syngene) 
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2.2.4 The bicinchoninic acid (BCA) assay: 
 
 
The BCA assay was performed to determine the total protein concentrations of proteins and 
cell lysates after different treatments. The BCA method was adapted from Smith et al (115). 
Unknown protein concentrations were determined from a standard curve prepared fresh with 
each experiment. The protein standards were prepared by diluting stock solution of 1 mg/mL 
BSA in distilled water as described in Table 2.3 
Protein concentration 
(mg/mL) 
BSA (µL) Water (µL) Final volume (µL) 
0.0 0 10 10 
0.2 2 8 10 
0.4 4 6 10 
0.6 6 4 10 
0.8 8 2 10 
1.0 10 0 10 
 
Table 2.3: Combination of chemicals needed to prepare a standard curve to determine 
protein concentrations. 
 
 
A standard curve was generated by plating BSA standards in triplicate wells of a 96 well plate 
with a final volume of 10 µL. Samples (10 µL) were also pipetted in triplicates onto the same 
plate. BCA reagent was prepared by adding bicinchoninic acid to copper II sulphate (50:1 
v/v). 200 µL of BCA reagent was pipetted into each well and the plate was incubated at 37 ºC 
for 30 minutes and the absorbance was read at 570 nm on a micro plate reader (Biotek, UK). 
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2.2.5 Glutathione (GSH) assay: 
 
 
2.2.5.1 Reagents: 
 
 
Reagent Description 
Stock buffer 125 mM sodium phosphate, 6.3 mM EDTA 
adjusted to pH 7.5. 
Daily buffer 3 mg of NADPH (reduced tetrasodium salt) 
in 10 mL of stock buffer. 
DTNB solution 0.024g of 5,5’–dithiobis(2-nitrobenzoic acid) 
(DTNB) in 10 mL of stock buffer. 
GSH solution 0.15 g of glutathione (GSH) in 5 mL of 
distilled water. 
SSA 1 g of sulphosalicylic acid (SSA) in 1 mL of 
distilled water. 
GSR  8 µL (2U/mL) Glutathione reductase (GSR) 
in 1 mL of stock buffer. 
 
Table 2.4: List of reagents required for the GSH assay 
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The total GSH levels were determined by a DTNB-GSR recycling procedure. Samples for the 
standard curve were prepared as described in Table 2.5 below. 
Concentration (µM) GSH (µL) SSA (µL) Water (µL) 
0 0 33.3 966 
20 0.2 33.3 966 
40 0.4 33.3 966 
60 0.6 33.3 966 
80 0.8 33.3 966 
  
Table 2.5: Combination of reagents required for the standard curve to determine total 
GSH Level. 
 
 
To a 96 well plate 25 µL of the standards and samples were added in triplicates followed by 
150 µL of daily buffer and 50 µL of DTNB solution. The plate was incubated at 37 ºC for 5 
minutes. Finally 25 µL of GSR was added to each well and the plate was read at 405 nm at 0, 
1, 2, 5 and 10 minutes on a spectrophotometric plate reader (Bio TeK). 
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2.2.6 Flow cytometry: 
 
 
Flow cytometry was performed on a Cytomics 
TM
 FC500 flow cytometer with CXP software 
(Beckman-coulter, Miami, USA). It is equipped with 5 fluorescent channels, FL1 (525 nm), 
FL2 (575 nm) FL3 (620 nm) FL4 (660-690 nm) and FL5 (740-770 nm). It uses two lasers 
either the air-cooled argon ion laser at 488 nm or the red solid-state laser at 630 nm as 
excitation beams. It can measure and analyse multiple characteristics of single particles such 
as cells simultaneously. The cells that can be detected range from 0.5-40 µm in diameter. 
When a stained cell suspension is injected into the cytometer it is hydro-dynamically focused 
using sheath fluid to create a tiny stream of samples. The cells then pass the laser light one at 
a time. The different detectors capture the light scattered from the cells as they pass through 
the beam. Forward scatter (FS) is used as a relative measure of the particle size and side 
scatter (SC) represents relative granularity and internal complexity of the particles. 
Fluorescence detectors are used to detect the fluorescence emitted from the positively stained 
cells. The resulting scattering and fluorescent is collected and detected as electrical signals 
that can be processed and analysed by the computer. Specific antigens on the surface of the 
cells can be detected by labelling them with antibodies that are fluorescently tagged with 
fluorophores such as fluorescein isothiocyanate (FITC) or phycoerythrin (PE). Flow 
cytometry was used to compare and analyse CD4+ T cell purity and surface thiol levels as 
described later on in chapter 4. 
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Chapter 3.0 Detection of sulphenic acid in 
human serum albumin (HSA) 
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3.1 Preface:  
 
 
This chapter describes optimisation of a method to detect sulphenic acid in human serum 
albumin (HSA) using the biotinylated probe, 3-(2,4-dioxocyclohexyl)propyl5-((3aR,6S, 
6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-6-yl)pentanoate (DCP-Bio1). SDS-PAGE 
and western blotting techniques and mass spectrometry were used to detect the sulphenic 
acid modifications. 
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3.2 Introduction: 
 
3.2.1 Thiol oxidation: 
 
 
Proteins are preferential targets of oxidation and cysteine, because of its thiol group, is 
particularly susceptible to oxidation (116). When low molecular weight or protein thiols are 
oxidised typically disulphide bonds (RSSR) are formed. Disulphide bonds support 
extracellular proteins to fold correctly and to maintain structural stability. However, 
intracellular proteins usually contain mainly reduced cysteine due to the reducing 
environment inside the cellular compartment. Among the various other oxidation states that 
thiols can have, sulphenic acids (RSOH) are a key intermediate in thiol oxidation. Sulphenic 
acid has been identified to serve catalytic or regulatory functions in a number of redox-
susceptible proteins (117).  
 
3.2.2 Human serum albumin:  
 
 
HSA is the most abundant protein in plasma and is a monomeric three-domain protein, 
which constitutes to about 60% of total plasma proteins (118). It contains 585 amino acids 
including 18 tyrosine, one tryptophan, six methionines, 17 disulphide bridges and one free 
reactive cysteine, Cys34 (64).  Albumin is a 66 kDa globular protein, which is mainly 
synthesised in hepatocytes and accounts for about 10% of liver protein synthesis (119). It 
has a half-life of about 19 days and it is mostly degraded in muscle, skin, liver and kidney. 
Albumin that has been modified due to oxidative stress will be preferentially recognised 
over native protein by several receptors resulting in rapid internalization and degradation 
(120, 121). HSA due to its high number of negative charges at physiological pH plays an 
essential role in the maintenance of colloid osmotic pressure. It also binds and transports 
long chain fatty acids that are circulating in the plasma. In addition to fatty acids it can also 
bind to hormones and drugs as well as cations such as copper, zinc and gold (118). Albumin 
also functions as an antioxidant in the vascular compartment because of its ability to 
scavenge reactive oxygen species (ROS) and reactive nitrogen species (RNS) that are being 
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produced by various metabolic processes (122). This protective role is attributed to the free 
thiol of HSA, Cys34 that accounts for about 80% of free thiols in the plasma (64). Radi and 
co-workers have shown that reactive oxygen species such as hydrogen peroxide, superoxide 
and hydroxyl radicals, which are derived from the enzyme xanthine oxidase, are primarily 
scavenged by HSA-SH in the plasma and not by lipids or other biomolecules (123). Unlike 
other proteins that have thiols that are more reactive, such as peroxiredoxins and tyrosine 
phosphatases (124, 125, 126) the thiol HSA is not particularly reactive. It has a pKaSH of 8.3-
8.6, which is similar to those of cysteine (8.36) and glutathione (8.75) (127). Although the 
thiol is oxidised at slow rates, due to its high concentration in the plasma it still acts as a 
major scavenger. Recent work has shown that thiols reacting with ROS/RNS not only serve 
as scavengers but also serve as modulators in signalling mechanisms by changing protein 
function (128). In the plasma, HSA contains thiols that are in its reduced form and this 
accounts to about 70% of the total albumin, which is known as the mercaptalbumin. A main 
fraction of the non-mercaptalbumin contains mixed disulphides between the albumin thiol 
and other low molecular weight thiols. It forms mixed disulphides with cysteines, 
cysteinylglycine, homocysteine, γ-glutamylcysteine or glutathione. The remaining non-
mercaptalbumin is further oxidised to non-reducible thiol reagents such as sulphinic and 
sulphonic acids (129, 130, 131). However, the balance between reduced and oxidised HSA 
can shift with intense exercise or during aging. An age dependent decrease in the amount of 
thiol per HSA molecule was observed, with is consistent with age-related oxidative damage 
(132, 133, 134). It has been reported that the oxidation of HSA-SH with hydrogen peroxide 
and peroxynitrite does not lead to the formation of disulphide bonded HSA dimers (135, 64). 
This could be due to the fact that the single free thiol is located in a crevice causing steric 
restrictions to hinder dimerisation. Therefore it is suggested that HSA-SH is oxidised to 
higher oxidation states such as sulphenic acid or further oxidised to sulphinic or sulphonic 
acids (116). 
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3.2.3 Sulphenic acid in human serum albumin: 
 
 
The stabilisation of sulphenic acids in proteins is dependent on the local environment. The 
absence of other thiol groups close to the site of sulphenic acid formation is important as 
well as adequate hydrogen bond formation between molecules and limited solvent 
accessibility (116). Until recently it has been difficult to identify sulphenic acids because 
they are highly unstable and do not possess any unique absorbance or fluorescence 
properties that can be used for identification. The first evidence that sulphenic acid was 
formed in albumin came from its reaction with sodium arsenite. This reagent can reduce 
sulphenic acids back to its thiol form whereas disulphides would not be reduced (135). 
Other studies to detect sulphenic acid formation in albumin have used the electrophilic 
reagent 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl). The drawback of using this 
reagent is that it can also react with tyrosyl and amine groups especially at alkaline pH 
(136). Proof that albumin samples oxidised with hydrogen peroxide formed sulphenic acid 
was provided by mass spectrometry; the nucleophilic reagent 5,5-dimethyl-1,3-
cyclohexanedione (dimedone) which was first discovered by Alison et al in 1974, has been 
used to show that sulphenic acid was formed at Cys34 of HSA (14). 
The aim of this chapter is to develop a method to detect sulphenic acids in HSA, by 
optimising conditions in which sulphenic acid formation occurs and visualising them using 
the biotinylated probe, DCP-Bio1. 
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3.3 Materials and methods: 
 
 
3.3.1 HSA sample preparation for dot blot and western blotting and mass 
spectrometry: 
 
 
HSA (1.0 mM) (Sigma, UK) was incubated with 10 mM 2-mercaptoethanol at 4 °C, 
overnight. The protein samples were then cleaned up through a PD-10 desalting column 
(GE Healthcare, UK) to remove excess reducing agent and the final HSA concentrations 
were measured using a BCA assay. The concentration was adjusted to 0.5 mM HSA for 
subsequent experiments. 
 
3.3.2 Glutathione preparation for mass spectrometry: 
 
 
Glutathione (1.0 mM) samples (1 mL) were used as control or treated with 1 mM DCP-Bio1 
and 2 mM hydrogen peroxide for 30 minutes on ice or treated with 1 mM DCP-Bio1 and 10 
mM hydrogen peroxide for 30 minutes on ice. The samples were then cleaned up using a 
PD-10 column to get rid of excess DCP-Bio1. The final samples were prepared by adding 
formic acid to a final concentration of 0.1% to enhance ionisation and subjected to mass 
analysis by direct infusion at 1 µL/min using a Finnigan LXQ linear ion trap mass 
spectrometer (Finnigan, Thermo Scientific, UK) equipped with a nano-electrospray 
ionisation (ESI) source operating in positive ionisation (PI) mode. The acceleration voltage 
was set to 2 KV. Data was collected as the average total scans and the scan range was set 
from 100-1000 m/z to search for glutathione and modifications. The data system was the 
Xcalibur® software version 2.0 SR2 (Thermo Scientific, UK). 
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3.3.3 Protein Enzyme Linked Sulphenyl Probe Assay (ELSPA): 
 
3.3.3.1 Buffers: 
 
 
Reagent  Description 
PBS (Phosphate buffer saline) NaCl (8.0 g), KCl (0.2 g) Na2HPO4 
(1.15 g), KH2PO4 (0.2 g) were 
dissolved in 1 L of water. 
Sodium carbonate coating buffer  Na2CO3 (1.59 g), NaHCO3 (2.93 g) 
were dissolved in 900 mL of distilled 
water the pH was adjusted to 9.2 and 
the solution was made up to 1 L to a 
final concentration of 50 mM. 
Washing buffer To 1 L of PBS, Tween-20 was added 
to a final concentration of 0.05% v/v. 
Blocking buffer Tween-20 1% v/v in 1 L of PBS. 
Citrate phosphate buffer Citric acid (21.0 g) Na2HPO4 (35.6 g) 
were dissolved in 900 mL of distilled 
water, the pH adjusted to 5.0 and 
solution was made up to 1 L with a 
final concentration of 0.15 M 
 
Table 3.1: Reagents required for the ELSPA 
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HSA was dissolved in carbonate buffer to 20 µg/mL and added to a Nunc maxisorb 96 well 
plate in triplicate (50 µL) and incubated for 1 hour at 37 °C. The plate was then washed with 
0.05% (v/v) Tween-20 containing PBS three times and blocked with 1% (v/v) Tween-20 in 
PBS overnight at 4 °C. The plate was washed again three times with washing buffer to 
remove excess blocking buffer and the different treatments in which the probe was added 
were performed. The plate was washed six times with washing buffer and incubated with 50 
µL of streptavidin-HRP (1:10,000 in 1% BSA in PBS) for 1 hour at 37 °C. The plate was 
washed 3 times with washing buffer, then developed with 50 µL OPD substrate (10 mL 
citrate phosphate buffer, 20 mg of o-phenylenediamine tablet with 10 µL 8.8 M hydrogen 
peroxide) and incubated at 37 °C for 15 minutes in the dark. Adding 2 M H2SO4 stopped the 
reaction and the absorbance was read at 490 nm on the spectrometric plate reader (BioTek).  
 
3.3.4 Dot blot for sulphenic acid on HSA: 
 
 
HSA (0.5 mM) was either untreated or was treated with 1.0 mM hydrogen peroxide, 1.0 mM 
hydrogen peroxide and 1 mM DCP-Bio1 for 30 minutes on ice. The excess probe was 
removed using a PD-10 column and samples were kept on ice until they were ready for use. 
Meanwhile a PVDF membrane was soaked in methanol for 10 minutes and washed for 5 
minutes in TTBS. 2 µL of the samples were dotted on to a small spot and left to dry. The 
membrane was then blocked overnight with 3% BSA in TTBS and washed 6 times at 15 
minute intervals with 20 ml of TTBS. The blot was then incubated with streptavidin-HRP 
(1:20,000) in TTBS for 2 hours at room temperature. It was washed 6 times with 20 mL 
TTBS at 5 minute intervals and visualised with ECL reagent using a G-box Chemi XT4 
transilluminator. 
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3.3.5 SDS-PAGE and western blotting for sulphenic acid on HSA: 
 
 
HSA (0.5 mM) samples were prepared as described in 3.3.1 and either treated with varying 
concentrations of DCP-Bio1 or hydrogen peroxide or both. Samples were heated for 5 
minutes at 95 °C in Laemmli buffer. Equal amounts (10 µg) of each sample were resolved 
on to a 10% polyacrylamide gel (SDS-PAGE) (see general methods 2.2.3) in running buffer 
and transferred onto a PVDF membrane in transfer buffer. The membrane was then blocked 
with 3% BSA in TTBS overnight and washed 6 times in 20 mL TTBS at 15 minute 
intervals. After washing the membrane was incubated with streptavidin-HRP (1:20,000) in 
TTBS for 2 hours at room temperature, washed again for 30 minutes at 5 minutes intervals 
with TTBS and visualised with ECL using a G-box transilluminator. 
 
3.3.6 Coomassie staining: 
 
 
SDS-PAGE gels were stained with coomassie blue staining solution [0.05% (w/v) 
coomassie brilliant blue R-250 was dissolved in 50% (v/v) methanol, 10% (v/v) acetic acid 
and 40% distilled water] for 1 hour on a rotator. Gels were then destained using destaining 
solution (5% methanol, 7% acetic acid and 88% distilled water) at least three times for one 
hour each to remove excess background stain. 
 
3.3.7 HSA preparation for mass spectrometry: 
 
 
HSA samples (0.5 mM) were used as a control or treated with 0.5 mM H2O2 with 0.5 mM 
DCP-Bio1 for 30 minutes on ice. The sample containing DCP-Bio1 was enriched using 
streptavidin-coupled Dynabeads (Life Technologies, UK) (100 µL) for 30 minutes. The 
magnetic bead-bound protein was boiled with Laemmli buffer (20 µL) and heated for 5 
minutes at 95 C and loaded on a 10% SDS-PAGE gel.  
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3.3.8 In-gel protein digestion for mass spectrometry: 
 
 
In order to investigate protein sulphenic acid modifications, 20 L albumin treated with 
peroxide and DCP Bio1 were separated by polyacrylamide gel electrophoresis and the major 
bands from the gels were digested. Bands were stained with coomassie staining as described 
previously. Using a clean razor blade, protein bands were carefully cut eliminating as much 
of the polyacrylamide as possible. The gel pieces were placed in clean 1.5 mL micro 
centrifuge tubes that were prewashed with 500 L of 100 mM ammonium bicarbonate 
(NH4HCO3) for one hour on the shaker. After discarding the wash, the gel pieces were 
washed again with 500 L of 50% acetonitrile (ACN) / 100 mM NH4HCO3 for one hour. 
Once the wash has been discarded 150 L of 100 mM NH4CO3 and 10 L of 45 mM 
dithiothreitol (DTT) was added to the sample and incubated for 30 minutes at 60 C to 
reduce the protein. The sample was left to cool to room temperature followed by alkylation 
with 10 L of 100 mM IAM for 30 minutes in the dark. After discarding the solvents the gel 
pieces were washed again with 500 L of 50% ACN/100 mM NH4HCO3 for one hour. The 
gel slices were then dehydrated for 10 minutes at room temperature in 50 L 100% ACN. At 
this point the slices were much smaller than their original size and were white or opaque in 
colour. The gel slices were then dried in a Speed Vac concentrator for 15 minutes at room 
temperature to remove all the solvent. The gel slices were pre-incubated in 20 L of the 
trypsin gold solution (Trypsin gold was resuspended at 1 g/L in 50 mM acetic acid, then 
diluted in 40 mM NH4HCO3/10% ACN to 20 g/mL) at room temperature not exceeding 30 
C, for one hour. The gel slices rehydrated during this time. Another 20 L of trypsin was 
added and incubated for another hour at room temperature if required. Enough digestion 
buffer (40 mM NH4HCO3/10% ACN) was added to cover the gel slices completely and the 
tightly capped micro centrifuge tubes were incubated at 37 C overnight. The gel slices were 
then diluted with 150 L of MilliQ water for 10 minutes with frequent vortex mixing. The 
liquid was removed and transferred to new microcentrifuge tubes. Gel slice digests were 
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extracted twice with 50 L of 50% ACN/5% TFA with mixing for 60 minutes each time at 
room temperature. All the extracts including the wash with MilliQ water were pooled 
together. Extracts were dried in a Speed Vac concentrator at room temperature for 2-4 hours 
not exceeding 30 C. The precipitate was dissolved in 100 L of 0.1% formic acid. Samples 
were analysed by mass spectrometry using a Thermo LTQ-Orbitrap Elite coupled to a 
Dionex Ultimate 3000 (RLSC). The samples were separated over a 56 minute gradient, 3.2-
44% mobile phase (MP) B over 30 minutes (MP A = 0.1% formic acid in H2O, MP B = 
0.1% formic acid in ACN), then 90% MP B for 10 minutes before 16 minutes re-
equilibrating at 3.2% B. The flow rate was set to 350 nL/min. The mass spectrometer 
operates in a data dependent mode where it performs a full MS scan at resolution 60,000 
followed by CID of the 7 most abundant multiply charged ions. These are then entered into 
an exclusion list to ensure the ions are not analysed multiple times. The full scan followed 
by top seven then repeats. Proteome Discoverer version 1.4 was used to analyse the results 
and the data was searched against a human database (Uniprot) and the results were filtered 
to give a 1% false discovery rate.  
 
3.3.9 Peptide sequencing using mass spectrometry: 
 
 
Mass spectrometry is a technique that is used to sequence peptides after proteins have been 
tryptic digested. LC-MS involves the separation of peptides according to their 
hydrophobicity after which they can be ionised using one of several methods. Electrospray 
ionisation (ESI) is a popular technique where an electrospray is created by putting a high 
voltage on a flow of liquid, which is then directed to an opening in the vacuum system of the 
mass spectrometer where droplets are formed. When the high temperatures and voltage 
evaporates the droplets of solvent the ions are ejected from the droplets and accelerated into 
the mass analyser. It has an advantage over other techniques such as matrix-assisted laser 
desorption ionisation (MALDI) because of low flow rate of peptides to increase sensitivity. 
There are three main types on analyser: time of flight (TOF) where ions are accelerated 
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towards the analyser according to size with lighter ions arriving at the detector first.  The 
second type is a quadrupole mass analyser where a radio frequency (RF) voltage is applied 
to 4 rods after which a direct current (DC) voltage is superimposed. This causes an 
oscillating electrical current in the analyser and the ions are filtered out according to their 
mass to charge (m/z). The third type is an ion trap where ions are separated according to 
their m/z resonance frequency. The Thermo LTQ Orbitrap Elite (Thermo Scientific) uses a 
linear-ion-trap quadrupole (LTQ) coupled to a mass analyser and is capable of tandem mass 
spectrometry (137, 138). 
In tandem mass spectrometry a full scan is completed on a peak by the orbitrap from the 
liquid chromatograph to identify the parent ion. This is known as a full ms scan. A zoom 
scan is then done on this peak to identify the charge on the ion in order to determine the 
mass of the ion. The ion is then selected and fragmented further using collision induced 
fragmentation (CID). This results in spectra of b and y ions, which are fragments where the 
amide bonds have split during the collision. This is knows as an ms/ms scan and the 
fragmentation into b and y ions are shown below (Figure 3.1) (137, 138) 
 
 
 
Figure 3.1: Schematic representation of b and y ions. During CID the amide bonds are 
split.  
 
 The sequence of the peptide can be determined from these ions. If a peptide had a sequence 
of A1B1C1D1 where each letter represents an amino acid the b ions would be calculated from 
the N terminus and b1 ion would have a molecular weight equivalent to A1. The weight of 
the b2 ion would be A1+B1 and so on. The y ions are calculated in the same way but start 
from the C terminus (137, 138). 
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3.4 Results: 
 
 
3.4.1 Detection of glutathione (GSH) modifications by mass spectrometry: 
 
 
In order to identify oxidative modifications of GSH (structure below), samples were treated with 
hydrogen peroxide as described in the materials and methods section above (3.3.2). The samples 
were subjected to mass analysis by direct infusion at 1 µL/min using a Thermo LXQ tandem mass 
spectrometer. Three peaks were observed from GSH (m/z = 308.17, 614.87, 921.13) and hydrogen 
peroxide and DCP-bio1 (m/z = 308.20, 614.91, 921.13) treatment (Figure 3.2). There was no 
evidence of a DCP-bio1 conjugate with sulphenic acid on glutathione which has a predicted mass of 
703.5 m/z in +ve ion mode when GSH is conjugated to DCP-bio1. 
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Figure 3.2: Disulphide bond formation in glutathione is increased by hydrogen peroxide.  
A) 2 mM glutathione  
B) 2 mM glutathione treated with 2 mM H2O2 and 1 mM DCP-Bio1 for 30 minutes on ice  
C) 2 mM glutathione treated with 10 mM H2O2 and 1 mM DCP-Bio1 for 30 minutes on ice.  
Samples were injected at 1 µL/min and analysed using a Thermo LXQ tandem mass 
spectrometer. Data is representative of 2 independent experiments. 
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3.4.2 Optimisation of hydrogen peroxide concentrations for sulphenic acid formation 
determined by ELSPA: 
 
 
To identify optimised conditions for formation of sulphenic acids under oxidising conditions 
an ELSPA was developed. HSA was dissolved in carbonate buffer to 20 µg/mL and added to 
a Nunc maxisorb 96 well plate in triplicate (50 µL) and incubated for 1 hour at 37 °C. After 
washing the plates the wells were either left untreated or treated with increasing amounts of 
hydrogen peroxide for 4 minutes washed 3 times and incubated with 0.1 mM DCP-Bio1 for 
30 minutes on ice. There was an increase in absorbance until the addition of 1 mM hydrogen 
peroxide but further increase to 3 mM hydrogen peroxide resulted in less DCP-Bio1 bound 
than after 1 mM hydrogen peroxide treatment (Figure 3.3). 
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Figure 3.3: Increasing hydrogen peroxide concentration increases sulphenic acid 
modifications in HSA. HSA was treated with increasing concentrations of hydrogen 
peroxide while keeping the DCP-Bio1 concentration constant. The plates are washed 6 times 
with washing buffer to remove excess reagent and incubated with 50 µL of streptavidin-
HRP (1:10,000 in 1% BSA in PBS) for 1 hour at 37 °C. The plate was aspirated and washed 
3 times with washing buffer and developed with 50 µL OPD substrate (10 mL citrate 
phosphate buffer, 20 mg of o-phenylenediamine tablet with 10 µL 8.8 M hydrogen 
peroxide) and incubated at 37 °C for 15 minutes in the dark. The reaction was stopped by 
adding 2 M H2SO4 and the absorbance was read at 490 nm on the spectrometric plate reader 
(BioTek). The experiment is representative from 2 independent experiments performed in 
triplicate.  
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To determine the effects of hydrogen peroxide further experiments were performed using 
two concentrations of DCP-Bio1 (0.1 mM and 1 mM) which yielded similar results. When 
HSA was incubated with just hydrogen peroxide or the probe on its own, there was no 
increase in the absorbance. However, when the protein was incubated with 1 mM hydrogen 
peroxide and 0.1 mM DCP-Bio1 as well as 1 mM DCP-Bio1 there was an increase in 
absorbance at 490 nm indicative of sulphenic acid formation in human serum albumin. 
When the HSA was oxidised with 3 mM hydrogen peroxide the absorbance was lower than 
with 1 mM hydrogen peroxide.(Figure 3.4). 
 
 
Figure 3.4: Effect of DCP-Bio1 concentration on detection of sulphenic acid formation 
in HSA with hydrogen peroxide. Detection with A) 0.1 mM DCP-Bio1, and B) with 1.0 
mM DCP-Bio-1. Excess reagent was removed and incubated with 50 µL of streptavidin-
HRP (1:10,000 in 1% BSA in PBS) for 1 hour at 37 °C. Prior to developing with 50 µL 
OPD substrate (10 mL citrate phosphate buffer, 20 mg of O-phenylenediamine tablet with 
10 µL 8.8 M hydrogen peroxide) and incubated at 37 °C for 15 minutes in the dark. The 
reaction was stopped by adding 2 M H2SO4 and the absorbance was read at 490 nm on the 
spectrometric plate reader (BioTek).The figure shows the results from one experiment 
performed in triplicate. 
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The effects of the order and timings of DCP-Bio1, H2O2 and catalase addition and the 
number of washing steps on sulphenic acid detection were examined. In the first experiment 
(Figure 3.5, bars1-3) HSA was dissolved in carbonate buffer to 20 µg/mL, added to a Nunc 
maxisorb 96 well plate in triplicate (50 µL) and incubated for 1 hour at 37 °C. After 
washing, the plates were incubated with hydrogen peroxide for 4 minutes followed by the 
addition of the probe for 30 minutes on ice without further washing. In the second 
experiment (Figure 3.5, bars 4-6) the wells were treated as above with the addition of 
catalase for 1 minute before adding the probe, again without any washing steps. Experiment 
7-9 (Figure 3.5) was carried out by adding the probe and hydrogen peroxide to HSA on the 
plate at the same time and incubating for 30 minutes on ice. The final experiment (Figure 
3.5, 10-12) was done by adding hydrogen peroxide to HSA for 4 minutes, washing the plate 
3 times and adding DCP-Bio1 for 30 minutes on ice. There is an increase in the absorbance 
after addition of hydrogen peroxide in all of the experiments with the highest absorbance in 
experiment 6 where catalase is present. 
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Figure 3.5: Treatment conditions affect the detection of sulphenic acids. HSA was either  
treated with 1.0 mM hydrogen peroxide for 4 minutes and 0.1 mM DCP-Bio1 for 30 
minutes on ice without a wash step between the addition of reagents (1-3), treated with 
hydrogen peroxide for 4 minutes followed by the addition of catalase for 1 minute and 
addition of DCP-Bio1 without the wash step (4-6), addition of hydrogen peroxide and DCP-
Bio1 at the same time and incubating for 30 minutes on ice (7-9) and addition of hydrogen 
peroxide for 4 minutes washing the plate 3 times followed by the addition of DCP-Bio1 for 
30 minutes on ice. The plates are washed 6 times with washing buffer to remove excess 
reagent and incubated with 50 µL of streptavidin-HRP (1:10,000 in 1% BSA in PBS) for 1 
hour at 37 °C. The plate was aspirated and washed 3 times with washing buffer and 
developed with 50 µL OPD substrate (10 mL citrate phosphate buffer, 20 mg of o-
phenylenediamine tablet with 10 µL 8.8 M hydrogen peroxide) and incubated at 37 °C for 
15 minutes in the dark. The reaction was stopped by adding 2 M H2SO4 and the absorbance 
was read at 490 nm on the spectrometric plate reader (BioTek). The experiment is 
representative from one experiment performed in triplicate.  
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3.4.3 Visualisation of sulphenic acid formation on HSA by dot bot: 
 
 
To determine if it is possible to visualise sulphenic acid modifications by western blotting a 
preliminary dot blot was performed using DCP-Bio1 that can detect sulphenic acid 
modifications. 0.5 mM HSA was untreated, treated with 1 mM hydrogen peroxide or 1 mM 
hydrogen peroxide and 1 mM DCP-Bio1 for 30 minutes on ice. The dot blot was performed 
as described in materials and methods (3.3.4) and visualised with ECL reagent on the G-box 
transilluminator. Figure 3.6 shows a streptavidin peroxidase signal indicative of DCP-Bio1 
binding to sulphenic acid in dot 3. Further experiments were done using SDS-PAGE and 
western blotting to optimise conditions for sulphenic acid formation. 
     
Figure 3.6: Sulphenic acid formation can be detected on dot blot. Protein spots were; 
1-0.5 mM HSA  
2-0.5 mM HSA+1.0 mM H2O2  
3-0.5 mM HSA+1.0 mM H2O2 + 1.0 mM DCP-Bio1.  
PVDF membrane was soaked in methanol for 10 minutes and washed for 5 minutes in 
TTBS. 2 µL of the samples were spotted on to a small spot and left to dry. The membrane 
was then blocked overnight with 3% BSA in TTBS and washed 6 times at 15 minute 
intervals with 20 mL of TTBS. The blot was incubated with streptavidin-HRP (1:20,000) in 
TTBS for 2 hours at room temperature. It was washed 6 times with 20 mL TTBS at 5 minute 
intervals and visualised with ECL reagent. The blot is a representative of two independent 
experiments. 
 
 
 
 
 
 
 
  
1 2 3 
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3.4.4 Effect of different concentrations of DCP-Bio1 on sulphenic acid formation in 
HSA: 
 
 
As shown in Figure 3.7A, when incubating HSA with increasing concentrations of DCP-
Bio1 (0.1 mM, 0.2 mM, 0.4 mM, 0.5 mM, 0.6 mM, 0.8 mM, 1.0 mM) the intensity of the 
bands increase until lane 7 (0.5 mM HSA + 1 mM H2O2 + 0.5 mM DCP-Bio1) after which 
the intensity of the bands remained the same. On the basis of these results 0.5 mM DCP-
Bio1 was used for subsequent experiments. 
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Figure 3.7: HSA sulphenic acid modifications with different concentrations of DCP-
Bio1. The samples were resolved by 10% SDS-PAGE for western blot analysis with 
streptavidin-HRP against DCP-Bio1 detection as described in materials and methods. The 
blot is representative of 2 independent experiments. A) Western blot B) Coomassie-
stained gel for equal loading of the protein. 
 
 
A 
B 
 
 
93 
3.4.5 HSA treatment with different concentrations of hydrogen peroxide: 
 
 
HSA (0.5 mM) was either untreated or treated with increasing concentrations of hydrogen 
peroxide (0.5 mM, 1.0 mM, 1.5 mM, 2.0 mM, 2.5 mM, 3.0 mM, 3.5 mM) keeping the DCP-
Bio1 concentrations constant at 0.5 mM. Figure 3.8A shows that the intensity of the bands 
has increased with 0.5 mM H2O2 compared to control. Band labelling was evident after 
treatment with concentrations of greater than 1 mM H2O2 but was lower than observed with 
0.5 mM H2O2 treated HSA. Therefore further experiments were done with hydrogen 
peroxide concentrations ranging from 0.1 mM-0.8 mM. Figure 3.8B indicates that after 
treating HSA with 0.5 mM hydrogen peroxide and 0.5 mM DCP-Bio1 (lane 6) the band 
intensity does not increase. Therefore for subsequent experiments 0.5 mM hydrogen 
peroxide was used. 
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A
 
 
 
 
Figure 3.8: Increasing hydrogen peroxide concentrations increases sulphenic acid 
modifications in HSA. 0.5 mM HSA was either untreated or treated with different 
concentrations of hydrogen peroxide and 0.5 mM DCP-Bio1 and incubated on ice for 30 
minutes. The samples were loaded onto 10% polyacrylamide gel and transferred onto a 
PVDF membrane as described before.   
B 
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3.4.6 The effect of iodoacetamide on sulphenic acid formation in HSA: 
 
 
To confirm the specificity of the probe, thiols in HSA were blocked to determine whether 
this would stop the recognition of sulphenic acid on HSA by DCP Bio1. HSA was prepared 
as described in materials and methods (3.3.1) and then either left untreated (Figure 3.9, lane 
2) treated with 0.5 mM hydrogen peroxide (Figure 3.9, lane 3), HSA treated with 0.5 mM 
DCP-Bio1 (Figure 3.9, lane 4), HSA treated with 0.5 mM hydrogen peroxide and 0.5 mM 
DCP-Bio1 (Figure 3.9, lane 5), HSA treated with 10 mM iodoacetamide (Figure 3.9, lane 
6), HSA treated with 0.5 mM hydrogen peroxide and 0.5 mM DCP-Bio1 on ice for 30 
minutes and treated with 10 mM IAM on ice for 10 minutes to block thiols (Figure 3.9,lane 
7) or treated with 10 mM IAM for 10 minutes on ice followed by 0.5 mM hydrogen 
peroxide and 0.5 mM DCP-Bio1on ice for 30 minutes (Figure 3.9, lane 8). There are no 
bands visible for lane 2 or 3 as they both do not have the probe present. There is a prominent 
band in lane 4 indicative of sulphenic acid formation despite there being no addition of 
hydrogen peroxide. When IAM is added prior to the treatment of hydrogen peroxide and 
DCP-Bio1 there is no band visible, which suggests that there is no detection of sulphenic 
acid by DCP-Bio1 (Figure 3.9, lane 8). However when IAM is added after treating HSA 
with hydrogen peroxide, DCP-Bio1 binding is still observed, albeit to a lower level, which is 
visible in lane 7. 
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Figure 3.9: Sulphenic acid formation is prevented by the addition of iodoacetamide. A. 
Western Blot and B. coomassie stain for equal loading. Samples were prepared as described 
above and resolved on a 10% polyacrylamide gel and transferred on to a PVDF membrane. 
The membrane was probed with avidin-HRP (1:20,000) and developed with ECL reagent. 
The blot is a representative of 2 independent experiments. 
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3.4.7 Detection of sulphenic acid modifications of HSA by mass spectrometry: 
 
 
To identify oxidative modifications of HSA samples were treated with hydrogen peroxide 
and DCP-Bio1 as described in the materials and methods section above (3.3.7) followed by 
in gel tryptic digestion (3.3.8). The samples were subjected to mass analysis and two peaks 
observed (m/z = 657.29, 770.38) indicate the formation of adduct at the cysteine with DCP-
Bio1. (Figure 3.10) 
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Figure 3.10: The formation of sulphenic acid detected by mass spectrometry. A) peptide 
sequence of HSA, B) peptide sequence with modified cysteine, C) fragment matches of 
modified sequence, D) ms/ms showing b and y ion peaks, E) DCP-Bio1 adduct formation 
with a thiol. 
DCP-Bio1 adduct formation
1 MKWVTFISLL FLFSSAYSRG VFRRDAHKSE VAHRFKDLGE ENFKALVLIA
51 FAQYLQQCPF EDHVKLVNEV TEFAKTCVAD ESAENCDKSL HTLFGDKLCT
101 VATLRETYGE MADCCAKQEP ERNECFLQHK DDNPNLPRLV RPEVDVMCTA
151 FHDNEETFLK KYLYEIARRH PYFYAPELLF FAKRYKAAFT ECCQAADKAA
201 CLLPKLDELR DEGKASSAKQ RLKCASLQKF GERAFKAWAV ARLSQRFPKA
251 EFAEVSKLVT DLTKVHTECC HGDLLECADD RADLAKYICE NQDSISSKLK
301 ECCEKPLLEK SHCIAEVEND EMPADLPSLA ADFVESKDVC KNYAEAKDVF
351 LGMFLYEYAR RHPDYSVVLL LRLAKTYETT LEKCCAAADP HECYAKVFDE
401 FKPLVEEPQN LIKQNCELFE QLGEYKFQNA LLVRYTKKVP QVSTPTLVEV
451 SRNLGKVGSK CCKHPEAKRM PCAEDYLSVV LNQLCLHEK TPVSDRVTKC
501 CTESLVNRRP CFSALEVDET YVPKEFNAET FTFHADICTL SEKERQIKKQ
551 TALVELVKHK PKATKEQLKA VMDDFAAFVE KCCKADDKET CFAEEGKKLV
601 AASQAALGL
A
- K   C-DCPBio1    A        S       L       Q       K  -
b1 b2 b3 b4 b5
y4 y3 y2 y1y5
B
C
D
E
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3.5 Discussion: 
 
 
This chapter has described optimisation of a method for sulphenic acid formation in human 
serum albumin and of two methods for its detection using the biotinylated probe DCP-Bio1. 
Mass spectrometry experiments on glutathione showed that cysteine favours disulphide 
bond formation (m/z 614.87) in the presence of hydrogen peroxide and that sulphenic acid 
was not formed under the conditions shown here. This was also observed when performing 
dot blots using glutathione with DCP-Bio1, (data not shown) using similar conditions 
described for HSA in 3.4.3. Glutathione is a small thiol-containing molecule that is 
important in the regulation of cellular reducing environment. In the presence of oxidants 
such as hydrogen peroxide it will form glutathione disulphide (GSSG) with glutathione 
peroxidase as a substrate (139) 
 The results from the modified ELSPA with HSA could imply that there was an increase in 
sulphenic acid formation until the hydrogen peroxide concentration was increased to 1 mM 
and that the addition of more oxidant causes sulphenic acid to oxidise to its higher oxidation 
states such as sulphinic and sulphonic acids, which were not detectable by DCP-Bio1. When 
the concentration of the DCP-Bio1 was increased to 1 mM a similar result was observed. 
Results from the ELSPA also show that simultaneous addition of DCP-Bio1 with H2O2 
resulted in more sulphenic acid detection; the absorbance was higher than that of the 
experiment where a wash step was introduced. This protocol was adopted for future HSA 
oxidation experiments. Addition of catalase to stop the oxidation of HSA gave the highest 
absorbance value. Although a lower absorbance was expected, as fewer sulphenic acids 
would be formed, this could be due to the fact that catalase also contains cysteines some of 
which could have been oxidised to form sulphenic acids. 
Before performing SDS-PAGE and western blotting a simple dot blot experiment was 
performed on HSA to determine whether sulphenic acid modifications would be detectable. 
When 0.5 mM HSA was treated with hydrogen peroxide and 1.0 mM DCP-Bio1 a spot was 
observed which is indicative of sulphenic acid formation. Next, experiments were performed 
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to investigate the concentration of DCP-Bio1 needed to capture all the modified sulphenic 
acids in 0.5 mM HSA. With increasing concentrations of the probe the band intensity 
increased until 0.5 mM of the probe was added after which the intensity remained the same. 
This could be an indication that all the sulphenic acid modified HSA has been detected by 
the DCP-Bio1. To determine the concentrations of hydrogen peroxide needed to modify 
cysteine residues to sulphenic acids using 0.5 mM DCP-Bio1, increasing amounts of 
hydrogen peroxide were added to 0.5 mM HSA keeping all other conditions the same. The 
band intensity decreased when the concentrations were increased further than 0.5 mM H2O2. 
These observations imply that between 0.5 mM-1 mM hydrogen peroxide was needed to 
oxidise sulphenic acids of HSA and at higher concentrations it will over oxidise. 0.5 mM 
hydrogen peroxide was needed to oxidise all of the thiols to sulphenic acids as the band 
intensity did not increase after adding higher concentrations of H2O2. When increasing 
concentrations of hydrogen peroxide was used to oxidise HSA the intensity of the bands on 
the western blots increased until hydrogen peroxide and HSA were at a 1:1 ratio. Over-
oxidation of HSA led to a decrease in absorption in the ELSPA as well as a decrease in band 
intensity on the western blots. Previous studies done by Carballal and co-workers suggest 
that the reaction between hydrogen peroxide and HSA proceeds with a 1:1 stoichiometry 
(64). They performed experiments using 0.5 mM HSA and adding hydrogen peroxide at 
increasing concentrations and quantifying the thiols after the reaction was completed. The 
advantage of the method used here over NBD-Cl used previously is that DCP-Bio1 is 
specific towards sulphenic acids and also the fact that because of its biotin tag it can be 
visualised by western blotting. Using different concentrations of the probe led to the 
conclusion that in order to capture all the sulphenic acids formed 0.5 mM DCP-Bio1 had to 
be used with 0.5 mM HSA in an equimolar ratio. Therefore it can be concluded that HSA 
sulphenic acid is formed and DCP-Bio1 reacts to a 1:1 ratio. To determine the effects of 
alkylating agents such as IAM on the formation of sulphenic acid experiments were done 
adding excess of IAM before the treatment of HSA with hydrogen peroxide or DCP-Bio1. 
The absence of a band is indicative that the thiol has been blocked by IAM preventing it 
 
 
101 
from being oxidised to the sulphenic acid. Noting the liability of HSA thiol groups to 
oxidation, although there was no H2O2 present a DCP-Bio1 bound band was observed which 
could be due to oxidation of HSA by air. It is also interesting to note that the sulphenic acid 
and probe adduct formation is stable even in the presence of reducing agents such as 2- 
mercaptoethanol which is present in the Laemmli buffer used to load samples on to the gels.  
Work by Allison has demonstrated that the covalent bond between dimedone and sulphenic 
acid cannot be broken by reducing agents (140). As DCP-Bio1 is a biotinylated dimedone-
like molecule, it is not surprising that the same trend is observed. 
Previously, others have trapped the sulphenic acid with the nucleophilic reagent dimedone 
and after mass spectral analyses have confirmed that the site of modification is Cys34, 
which is the redox active thiol of human serum albumin (118). Although sulphenic acids are 
considered to be unstable and intermediates to higher oxidation states such as sulphinic and 
sulphonic acids, the microenvironment plays an important role in the stabilisation of 
sulphenic acids. Nevertheless, research by Carballal et al suggests that HSA-SOH is 
remarkably stable. The three-dimensional structure of HSA provided by X-ray diffraction 
confirms that the Cys34 is situated in a hydrophobic crevice, which is partially protected 
against solvents. The fact that there are no other thiols adjacent to Cys34 and side chains of 
Pro35 and Val77 help in preserving the oxidised HSA (110). Finally, the imidazole ring 
from His39, the hydroxyl group of Tyr84 and the carboxylate group of Asp38 could also 
help in the stabilisation of sulphenic acid at Cys34 with hydrogen bond and electrostatic 
interactions (141, 142, 143). 
Mass spectrometry also suggests that sulphenic acid modifications occur at the cysteines of 
albumin. Although the expected modification is at the Cys34 the observed modification here 
was at cysteine 200. This cysteine usually takes part in intramolecular disulphide formation. 
A possible explanation for finding this modification could be that when the albumin is 
reduced with 2-ME and desalted using a spin column, some of the reducing agent remained 
in the sample while the H2O2 was added leading to some of the disulphide bonds not 
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reforming but instead becoming available, oxidised to sulphenic acids by peroxide and then 
reacting with DCP-Bio1. 
In conclusion HSA reacts with hydrogen peroxide and DCP-Bio1 in a 1:1:1 ratio indicating 
that sulphenic acid formation occurs at one cysteine. If high concentrations of hydrogen 
peroxide are present, sulphenic acids may over oxidise and not be detectable by the probe. 
The sulphenic acid of human serum albumin could be a central intermediate in thiol 
oxidation pathways and further work needs to be done to understand properties and 
reactivity of biological sulphenic acid.  
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Chapter 4.0 Protein sulphenic acid formation in 
Jurkat T cells and human CD4+ T cells 
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4.1 Preface: 
 
 
The purpose of this chapter was to investigate protein sulphenic acid modifications in Jurkat 
T cells and human CD4+ T cells under oxidative and activating conditions. Previous studies 
have demonstrated that intra- and extra-cellular antioxidant concentration can play a key role 
in T cell thiol content. To investigate this buthionine sulfoximine (BSO) has been used to 
manipulate the endogenous antioxidant glutathione (GSH) in human CD4+
 
T cells and 
surface protein sulphenic acid and thiol levels (using flow cytometry and DTNB assay) have 
been examined. T cells were treated with BSO and activated by lectins such as the lectin 
phytohaemagglutinin-L (PHA-L). Any effect on sulphenic acid formation of proteins was 
investigated using the commercially available probe, DCP-Bio1 that specifically interacts 
with sulphenic acids. Techniques such as SDS-PAGE, western blotting and confocal 
microscopy were used to identify T cell protein modification. 
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4.2 Introduction: 
 
 
If the balance between the production of ROS and the removal is disrupted, cells are said to 
be under oxidative stress, which can lead to irreversible changes in bio molecules (144). For 
cells to function properly a redox balance needs to be maintained within the cellular 
environment (145). The redox balance in cells is maintained through three major redox 
couples; NAD
+
-NADH; NADP
+
-NADPH and GSH-GSSG (150). GSH, which is a cysteine 
containing tripeptide, is the most abundant non-protein thiol. GSH and its oxidised dimer, 
GSSG play an important role in the maintenance of the redox state and the thiol groups in 
cells. GSH reacts with some ROS such as hydrogen peroxide and is converted to its oxidised 
GSSG. It is ultimately reduced back to GSH by GSH reductase and NADPH to maintain 
cellular GSH levels. The ratio of GSH/GSSG is very important to cell survival and is a 
sensitive indicator to oxidative stress (146). GSH synthesis is dependent on the enzyme 
gamma-glutamyl cysteinyl ligase (GCL) and cysteine availability. A decrease in protein 
thiols, due to oxidation leads to an Nrf-2 mediated transcriptional increase in the synthesis of 
GSH to restore the redox balance (147). 
The main role of T cells is to recognise foreign matter and promote efficient removal of them 
and therefore they play a key role in the effective adaptive immune response (107). The 
functions of T cells are greatly influenced by alterations in the redox balance. Lymphocytes 
require a reducing environment for optimal activation and proliferation which relies on the 
expression and secretion of IL-2 to affect T cell surface CD25 in an autocrine manner (148, 
149). It has been shown that an increase of cell surface thiols increases T cell activation and 
proliferation in vitro and in vivo. Therefore the presence of ROS can have an inhibitory effect 
on T cell activity (149). However if APCs are present that produce GSH, ROS can help 
mediate T cell activation, thus maintaining the redox balance (144). Membrane proteins that 
reside on the cell surface of T cells contain many cysteine (Cys) residues that can be oxidised 
if there is an increase of ROS production, if there is a lack of free thiols on proteins or 
peptides such as albumin, GSH and thioredoxin, or if there is insufficient enzyme activity to 
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reduce the oxidised GSSG or thioredoxin back to the reduced forms (108). Therefore changes 
in the redox balance of extracellular proteins can result in modifications not only in proteins 
that act as redox sensors but also in receptors and can affect cell activation by ligands 
(150,151). Therefore, a decrease in the function of NADPH oxidase will lead to a decrease in 
the production of ROS. This results in changes in the redox balance of immune cells and 
could lead to defective immune regulation (152). 
Although ROS can modify proteins and other macromolecules irreversibly, reversible 
modifications of cysteine play important roles in events such as cell signalling. Phosphatases 
such as PTEN (phosphatase and tensin homologue deleted on chromosome 10) and SHP-2 
(Scr homology 2 domain-containing phosphatase) and transcription factors such as AP-1 and 
NF-κB undergo reversible cysteine oxidation that regulates their function (153, 154, 155, 
156). Therefore it is important to understand the role of sulphenic acid modification in T 
cells, and how these protein modifications change under oxidative stress and activation. 
The aims of this chapter are as follows: 
1.  To optimise conditions to detect protein sulphenic acid modifications in Jurkat T 
cells  
2. To investigate the effect of BSO on GSH levels, surface thiols and sulphenic acid 
modifications of human CD4+
 
T cells. 
3. To explore activation of T cells using phytohaemagglutinin-L (PHA-L) at different 
concentrations.  
4. To examine the effect of PHA-L on sulphenic acid formation in primary CD4+ T 
cells. 
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4.3 Materials and Methods: 
 
 
4.3.1 Isolation of peripheral blood mononuclear cells (PBMC): 
 
 
Venous blood (20 mL) from consenting volunteers was collected into Vacuette blood 
collection tubes (Greiner Bio-one) containing EDTA.  The blood was then transferred to a 50 
mL centrifuge tube and 30 mL of PBS containing 0.1% BSA was added. The above solution 
(25 mL) was layered carefully over 11 mL of Lymphoprep (Beckman Coulter). The blood 
was separated by centrifugation at 160 x g for 20 minutes at 20 ºC.  A typical separation is 
shown in Figure 4.1. The top layer of plasma (~10 mL) was removed and discarded and the 
samples were centrifuged at 381 x g for 20 minutes at 20 ºC. The PBMCs were removed from 
two tubes using a sterile pasteur pipette and transferred to a 50 mL centrifuge tube. PBS 
containing 0.1% BSA was added to create a cell suspension with a final volume of until 50 
mL and centrifuged at 500 x g for 10 minutes at 20 ˚C to wash the cells.  The supernatant was 
discarded and the pellet was resuspended in 10 mL PBS containing 0.1% BSA and transferred 
into a 15 mL centrifuge tube for a final wash. The cells were diluted ten times for cell 
counting using a haemocytometer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Schematic representation of centrifuged whole blood in lymphoprep® 
density gradient with Red blood cells (RBC), peripheral blood mononuclear cells 
(PBMC) 
  
Density gradient medium 
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4 .3.2 Negative isolation of human CD4+
 
T cells: 
 
 
4.3.2.1 Reagents: 
 
 
Reagent Description Volume per 1x10
7
 
PBMC 
1. Isolation buffer Ca
2+ 
Mg
2+
 free PBS 
supplemented with 0.1% BSA 
and 2 mM EDTA 
100 µL 
2. Antibody mix 
(Human CD4+ T 
Cells) 
 
 
20 µL 
3. FBS  20 µL 
4. Depletion Dynabeads  100 µL 
  
Table 4.1: Reagents and quantities used for isolation of CD4+
 
T cells  
 
 
Isolated PBMCs were resuspended at 1x10
7 
cells in isolation buffer (100 µL). FBS (20 µL) 
and antibody mix (20 µL) (Dynabeads untouched human CD4 T cells kit, Invitrogen) was 
added and incubated for 20 minutes at 4 ˚C.  The cells were washed by adding isolation buffer 
(2 mL), mixed and then centrifuged at 300 x g for 8 minutes at 4 ºC. The supernatant was 
discarded and the cells were resuspended in isolation buffer (100 µL). Meanwhile MyOne 
Dynabeads (Dynabeads untouched human CD4 T cells, Invitrogen; 100 µL) were washed by 
resuspending in 1mL of isolation buffer. The supernatant was discarded after placing the 
sample in a magnet. The washed beads were resuspended in isolation buffer (100 µL) and 
added to the cells and incubated for 15 minutes at room temperature with gentle tilting and 
rotation. Isolation buffer (2 mL) was added and the bead bound cells were resuspended by 
thoroughly pipetting 10 times using a pipette with a narrow tip opening. 
 After placing the micro centrifuge tubes in the magnet for 2 minutes the supernatant 
containing the untouched human CD4+
 
T cells were isolated. The bead-bound cells were 
resuspended in isolation buffer (2 mL) and the supernatant was again collected and combined 
with the previously isolated untouched T cells and counted on the haemocytometer prior to 
further experiments.  
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4.3.3 Flow cytometric assay for cell surface CD4+ analysis: 
 
 
Human CD4+
 
T cells were washed twice with PBS (500 µL) and resuspended to 1x10
6 
cells/mL in RPMI-1640 media supplemented with 10% FBS and 1% penicillin/streptomycin 
for 30 minutes on ice. Phycoerythrin (PE) labelled anti-CD4 monoclonal antibody (1 µL, 
Abcam) or negative isotype control (2 µL, Abcam) were added to 100 µL of cell suspension 
and incubated on ice in the dark for 30 minutes. The samples were analysed on the Cytomics 
TM FC500 flow cytometer (Beckman-Coulter, Miami, USA). Cells were gated based on the 
forward scatter (FS)/side scatter (SS) and applying FL2 positive gate. The data was collected 
for 10000 events against forward scatter (FS). 
 
4.3.4 Modulation of cellular CD4+ T cell thiol levels: 
 
 
CD4+ T cells (1x10
6
 cells/mL) were treated with 25 µM buthionine sulphoximine (BSO) for 
24 hours to investigate whether decreasing GSH levels intracellularly has any effect on 
surface thiol levels and sulphenic acid modifications.  
 
4.3.5 Preparation of cells for flow cytometry to detect surface thiols: 
 
 
0.5x10
6
 BSO-treated and control cells were collected into independent 1.5 mL 
microcentrifuge tubes and were centrifuged for 2 minutes at 400 x g in the microcentrifuge 
(Eppendorf Centrifuge 5415D). The supernatants were removed and the cell pellet was 
washed twice with PBS (500 µL) by centrifugation at 400 x g for 2 minutes. The cells were 
resuspended in PBS (500 µL). Maleimide (1 mM, 9 µL) and maleimide Alexafluor-488C5 (1 
mM, 1 µL) was added to each tube and incubated at 37 ˚C for 30 minutes in the dark. The 
samples were centrifuged at 400 x g for 2 minutes and washed three times with PBS (500 µL) 
each. The pellet was resuspended in PBS (500 µL) and the samples were analysed on the 
Cytomics TM FC500 flow cytometer ((Beckman-coulter, Miami, USA). Cells were gated 
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based on the FS/SS using FL1 and results and data was collected for 5000 events against 
forward scatter (FS). 
 
4.3.6 Effect of BSO on surface thiols using 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB) 
assay: 
 
 
DTNB is a water-soluble non-cell permeable compound that is used to quantify sulphydryl 
groups. DTNB reacts with a free sulphydryl group to yield a mixed disulphide and 2-nitro-5-
benzoic acid (TNB
-
), which is a measurable yellow coloured product (Figure 4.2). 
 
Figure 4.2: The reaction between a thiol and 5,5’-dithiobis(2-nitrobenzoic) acid. In the 
presence of a free sulphydryl group the DTNB reacts to yield the yellow TNB
- 
 
 
DTNB is used to determine the cell surface thiol levels. The method was adapted from the 
method described by Laragione et al (157). CD4+
 
T cells (1x10
6 
cells/
 
mL) were either treated 
with or without 25 µM buthionine sulfoximine (BSO) for 24 hours. The cells were washed 
twice in PBS (1 mL), centrifuged at 1200 x g for 5 minutes in the microcentrifuge (Eppendorf 
centrifuge 5415D) and resuspended in 1 mL of PBS. The cells (1.5 x10
5 
cells) were then 
incubated in a 96 well plate with DTNB (200 µM) for 20 minutes in the dark at room 
temperature. All the samples were centrifuged at 1200 x g for 5 minutes and the supernatants 
were collected after the incubation time and the absorbance read at 405 nm using a 
spectrophotometric plate reader (BioTek). The results were calculated from a standard curve 
using freshly prepared N-acetyl cysteine (NAC) where concentrations of the calibration curve 
ranged from 0-100 µM. 
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4.3.7 Cell lysate preparation for GSH assay: 
 
 
Cells (2x10
6
 cells/mL) were collected in 1.5 mL micro centrifuge tubes and centrifuged at 
6600 x g (Eppendorf Centrifuge 5415D) for 1.5 minutes. The supernatants were removed and 
PBS (0.5 mL) was added to resuspend the pellet. The tubes were centrifuged at 6600 x g for 
1.5 minutes and the PBS was removed making sure that the pellet was completely dry. SSA 
(3.33 µL) was then added to the micro centrifuge tubes to precipitate the proteins and 
immediately centrifuged at 13000 x g for 1.5 minutes. Stock buffer (96.6 µL) was added and 
the tubes were vortexed and centrifuged as above. The supernatants were transferred into new 
micro centrifuge tubes and samples were analysed for GSH as described in chapter 2 and total 
protein content (BCA assay) or frozen at -80 ºC. 
 
 
4.3.8 Activation of T cells by PHA-L and PHA-P: 
 
 
CD4+ T cells (1x10
6
 cells/mL) were either untreated or treated with 1 µg/mL PHA-L, 5 
µg/mL PHA-L, 1 µg/mL PHA-P and 5 µg/mL PHA-P for 24 hours in at 37 ˚C in a 5% 
CO2/95% air humidified atmosphere. The cells were collected to 1.5 mL microcentrifuge 
tubes and centrifuged 400 x g for 2 minutes. The supernatants were collected and analysed for 
interleukin-2 (IL-2) secretion. The cells were resuspended in 1 mL of Optilyse® C lysing 
solution (Beckman Coulter, France) to be used for flow cytometry experiments. 
 
4.3.9 Quantification of interleukin-2 (IL-2): 
 
 
The supernatants that were collected from activated and control T cells were analysed by a 
standard enzyme linked immunosorbent assay (ELISA). The IL-2 detection and quantification 
was performed according to manufacturer’s instructions (Peprotech, UK) with some 
modifications. A monoclonal goat anti-IL-2 capture antibody was diluted with PBS for a final 
concentration of 2 µg/mL and coated onto a NUNC 96 well plate overnight at room 
temperature. The plate was washed 4 times with 300 µL of wash buffer per well and blocked 
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for 1 hour with 1% (w/v) BSA in PBS (300 µL). Triplicates of IL-2 standards (0.0-4.0 ng/mL) 
and supernatants from treated and untreated cells were added to the plate and incubated for 2 
hours at room temperature. A biotinylated polyclonal anti IL-2 antibody was diluted in diluent 
(0.05% Tween-20, 0.1% (w/v) BSA in PBS) to a final concentration of 0.25 µg/mL and added 
to the plate for 2 hours at room temperature. Avidin horseradish peroxidase (HRP) conjugate 
(1:2000) was then added and incubated for 30 minutes at room temperature. The amount of 
bound avidin was measured used o-phenylenediamine dihydrochloride (OPD), which was 
added to each well (100 µL) and incubated for 15 minutes in the dark. The reaction was 
stopped using 2 M sulphuric acid (H2SO4) and the absorbance was read at 490 nm using a 
spectrophotometric plate reader (Biotek, USA). 
 
4.3.10 Flow cytometry for the detection of T cell activation: 
 
 
Activated and control cells (1x10
6
 cells/mL) were collected into 1.5 mL microcentrifuge tubes 
and were centrifuged for 2 minutes at 400 x g in the microcentrifuge (Eppendorf Centrifuge 
5415D). The supernatants were removed and the cell pellet was washed twice with PBS (500 
µL) by centrifugation at 400 x g for 2 minutes. Cells were resuspended in RPMI-1640 media 
and left on ice for 30 minutes for blocking. Cells (2.5x10
5
) were then either treated with 
allophycocyanin (APC) conjugated mouse monoclonal antibody to IL-2 receptor alpha 
(CD25; 1.25 µL), or APC-conjugated isotype control (1.25 µL) in the dark and were kept on 
ice for 30 minutes. The samples were analysed on the Cytomics TM FC500 flow cytometer 
(Beckman-Coulter, Miami, USA). Cells were gated based on the FS/SS using FL4 and results 
and data was collected for 10000 events against forward scatter (FS). 
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4.3.11 Protein sulphenic acid extraction in Jurkat T cells and human CD4+ T cells: 
 
 
Jurkat T cells or CD4+ T cells (1x10
6
 cells/mL) were either left untreated or treated with 25 
M BSO, 5 g/mL PHA-L or a combination of both for 24 hours. The cells were washed 
three times with ice cold PBS (1 mL) and centrifuged at 1200 x g for 5 minutes in the 
microcentrifuge (Eppendorf centrifuge 5415D) each time. The cells were resuspended in PBS 
(90 L) and 10 mM DCP-Bio1 (10 L) (Kerafast, USA) the biotinylated probe that detects 
acid modifications, was added and the cells were incubated for 30 minutes on ice. The 
principles for the separation and major steps are illustrated in Figure 4.3. 
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Figure 4.3: Schematic representation of the approach for isolation of sulphenic acid 
modified proteins. After incubating with 10 mM iodoacetamide (IAM) for 10 minutes on 
ice, the samples were washed three times with ice cold PBS (1 mL) and centrifuged at 1200 x 
g for 5 minutes to remove excess DCP-Bio1 and IAM. The cells were resuspended in ice cold 
MNE lysis buffer (100 L, 150 mM NaCl, 2 mM EDTA, 25 mM MES, 1 mM Na3VO4, 1% 
Triton X-100 and 0.1% protease inhibitor cocktail) for 30 minutes on ice and sheared with a 
21G needle (BD, UK) to lyse the cells. Meanwhile, streptavidin magnetic beads (200 L) 
were washed 3 times in PBS (1mL) and the supernatants were removed with the use of 
magnet. The beads were then resuspended in PBS (200 L) and added to the cell lysates and 
incubated for 30 minutes at room temperature with gentle tilting and rotation. The proteins 
that have sulphenic acid modifications are bound to the streptavidin magnetic bead through 
biotin-streptavidin covalent binding. The magnetic bead bound proteins were then captured 
and resuspended in Laemmli sample buffer (40 L), heated for five minutes at 95 °C to elute 
the modified proteins off the bead. Samples were analysed by SDS-PAGE and western 
blotting. 
 
  
T cell
DCP-Bio1 Cell lysis
Streptavidin magnetic bead
SDS-PAGE
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4.3.12 Method development for protein sulphenic acid extraction using Jurkat T cell 
line: 
 
 
4.3.12.1 Determination of DCP-Bio1 concentration:  
 
 
To determine the concentration of probe needed for the capture of sulpenic acid-modified 
proteins Jurkat T cells (1x10
6
 cells/mL) were harvested. The cells were washed three times 
with ice cold PBS (1 mL) and centrifuged at 1200 x g for 5 minutes in the microcentrifuge 
(Eppendorf centrifuge 5415D) each time. The cells were resuspended in four different 
conditions; PBS (99 L) and 10 mM DCP-Bio1 (1 L) 1; PBS (95 L) and 10 mM DCP-
Bio1 (5 L) 2; PBS (90 L) and 10 mM DCP-Bio1 (10 L) 3; or PBS (80 L) and 10 mM 
DCP-Bio1 (20 L) 4 to give final concentrations of DCP-Bio1 of 0.1 mM, 0.5 mM, 1.0 mM 
and 2.0 mM respectively. The cells were incubated for 30 minutes on ice and washed three 
times with ice cold PBS (1 mL) and centrifuged at 1200 x g for 5 minutes to remove excess 
DCP-Bio1. The cells were lysed and streptavidin magnetic beads (200 L) were and added to 
the cell lysates and incubated for 30 minutes at room temperature with gentle tilting and 
rotation. The proteins that have sulphenic acid modifications are bound via DCP-Bio1 to the 
streptavidin magnetic bead through biotin-streptavidin covalent binding. The magnetic bead- 
bound proteins were then captured and resuspended in Laemmli sample buffer (40 L), 
heated for five minutes at 95°C to elute the modified proteins off the bead. Samples were 
analysed by SDS-PAGE and western blotting as shown on Figure 4.4. At low concentration 
of the probe, a band is visible at 65 kDa. When the concentration is at 1 mM of DCP-Bio1 
two bands are visible which can be seen when the DCP-Bio1 concentration is increased 
further. Since at 1 mM DCP-Bio1 concentration bands were observed with high intensity, this 
concentration was used for subsequent experiments. 
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Figure 4.4: Determination of DCP-Bio1 concentration required for sulphenic acid 
detection in Jurkat T cells. Jurkat T cells (1x10
6
 cells/mL) were harvested, washed three 
times with ice cold PBS (1 mL) and resuspended in PBS as described in methods 4.3.12.1 to 
achieve final concentrations of DCP-Bio1 of 0.1 mM (1), 0.5 mM (2), 1.0 mM (3) and 2.0 
mM (4) respectively. The probe was incubated on ice for 30 minutes and washed 3 times with 
PBS (1 mL) to remove excess reagent. The cells were lysed and streptavidin magnetic beads 
(200 L) were added to the cell lysate and incubated for 30 minutes. The magnetic bound 
proteins were captured and loaded onto a 10% polyacrylamide gels and analysed by western 
blotting using HRP-conjugated streptavidin for biotinylated probe detection. 
 
 
117 
4.3.13 T cell sample preparation for mass spectrometry: 
 
 
In order to identify the proteins which have sulphenic modifications, spots removed from 
PVDF membranes were used for mass spectrometric analysis using a method adapted from 
Klarskov et al (158). After stripping the membrane by leaving it in stripping buffer for 15 
minutes the membranes were washed with TTBS at 15-minute intervals 6 times. Protein 
bands were excised from the PVDF membrane after staining with Ponceau red for 10 minutes 
to visualise the bands. Bands of the same molecular weight were cut into small pieces, pooled 
together and washed with TTBS 3 times every 15 minutes to remove the staining. The bands 
were then reduced in 10 µL of 100 mM NH4HCO3 containing 5 mg/mL DTT for 45 minutes 
at 37 ˚C. After the sample had cooled to room temperature alkylation was performed in the 
dark in 20 µL of 200 mM NH4HCO3 containing 25 µg/µL of IAM for 30 minutes. After 
discarding the solvents the membrane pieces were washed 4 times with 400 µL 50 mM 
NH4HCO3 containing 10% ACN each at 15 minute intervals on the shaker. Digestion was 
performed at 37 ˚C for 3.5 hours in 8 µL of 50 mM NH4HCO3 containing 20 ng/µL of trypsin 
with 50% DMF. The samples were centrifuged every half an hour to prevent the membranes 
from drying out. The samples were then sonicated for 2 minutes and 30 µL 5% formic acid 
was added to them. The samples were concentrated with Millipore
®
ZipTip C18 (Sigma, UK) 
according to the manufacturer’s instructions. Extracts were dried in a Speed Vac concentrator 
at room temperature for 2-4 hours and the precipitate was dissolved in 100 µL 0.1% formic 
acid. Samples were analysed by mass spectrometry using a Thermo LTQ-Orbitrap Elite 
coupled to a Dionex Ultimate 3000 (RLSC). The samples were separated over a 56 minute 
gradient, 3.2-44% mobile phase (MP) B over 30 minutes (A = 0.1% formic acid in H2O, B = 
0.1% formic acid in ACN), then 90% MP B for 10 minutes before 16 minutes re-equilibrating 
at 3.2% B. The flow rate was set to 350 nL/min. The mass spectrometer operates in a data- 
dependent mode where it performs a full MS scan at resolution 60,000 followed by CID of 
the 7 most abundant multiply charged ions. These are then entered into an exclusion list to 
ensure the ions are not analysed multiple times. The full scan followed by top seven then 
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repeats. Proteome Discoverer version 1.4 was used to analyze the results and the data was 
searched against a human database (Uniprot) and the results were filtered to give a 1% false 
discovery rate. Haemoglobin and keratin identifications were discounted as contaminants. 
Successful identification of other proteins was based on the protein band being of expected 
mass, having at least two distinct peptides and >10% coverage. 
 
4.3.14 Confocal microscopy: 
 
Isolated CD4+ T cells (1x10
6 
cells/mL) were washed three times with PBS (1 mL) and 
allowed to adhere to poly-L-lysine coated microscope slides (Thermo Scientific, UK) for 20 
minutes. Cells were fixed with 70% ice-cold methanol for 5 minutes and washed three times 
with PBS (1 mL). The fixed cells were them either treated with 1 mM DCP-Bio1 for 30 
minutes on ice, 1 mM maleimide (9 µL) and 1 mM maleimide Alexafluor-488C5 (1 µL) for 
30 minutes at 37 °C in the dark or a combination of all the reagents. The slides were then 
blocked with 1% (w/v) PBS for 30 minutes at 4 °C and rinsed three times with PBS. On the 
slides where DCP-Bio1 was present, streptavidin-PE (Sigma, UK) was used in 1:100 dilution 
in PBS and incubated for 30 minutes at 4 °C in the dark. Cells were rinsed three times with 
PBS mounted with 4’,6-diamidino-2-phenylindole (DAPI) containing mounting media and 
visualised using Leica Confocal microscopy (Leica, UK). 
4.3.15 Data analysis: 
 
Unless specified all data is presented as the mean ± standard error of the mean (SEM) of at 
least 3 independent experiments performed in triplicates. Statistical analysis was done using a 
paired student’s t-test when comparing the differences between two group means. When 
comparing means of columns from more than two samples the one-way analysis of variance 
(one way ANOVA) followed by Dunnett’s multiple comparison tests was used. A P≤ 0.05 
was considered to be significant and a 95% confidence interval was used for the difference 
between all selected pairs of means in the t-test. Statistical analysis was performed using the 
Graphpad Prism version 5.0 software. 
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4.4 Results: 
 
 
4.4.1 Isolation of BPMC s and CD4+ T cells from 20 mL of blood: 
 
 
To investigate the number of PBMCs and CD4+ T cells isolated, 20 mL of blood was taken 
and isolated as described in the methods 4.3.1 and 4.3.2.  From 20 mL of blood, 22x10
6
±1.53 
PBMCs (mean ±SEM, n=3) were recovered while 5.4x10
6
±0.31 CD4+ T cells (mean ± SEM) 
were negatively isolated (Figure 4.5). 
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Figure 4.5: PBMC and CD4+ T cells recovered from 20 mL of blood. Blood (20 mL) was 
mixed with 30 mL of 0.1% BSA in PBS and layered onto 11 mL of lymphoprep. The blood 
was separated by centrifugation at 160 x g for 20 minutes followed by 381 g for 20 minutes. 
The PBMCs were recovered as described in methods 4.3.1. From the isolated PBMCs, CD4+ 
T cells were negatively isolated using the Dynabeads untouched CD4 T cells kit as described 
in methods 4.3.2.Cells (20 µL) were transferred into a micro centrifuge tube with an equal 
volume of trypan blue and transferred onto a haemocytometer for cell counting. Mean values 
are shown with standard error of mean for three independent experiments. Statistical analysis 
was done using two tailed paired students t test. 
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4.4.2 Purity of negatively isolated human CD4+ T cells using flow cytometry: 
 
 
To determine the purity of the negatively isolated CD4+
 
T cells, cells were either stained with 
phycoerythrin (PE)-labelled anti-CD4 monoclonal antibody on ice, in the dark or labelled 
with PE-labelled isotype control antibody. The purity of the CD4+
 
T cell gated population 
was 95% (Figure 4.6). 
 
Figure 4.6: Purity of negatively isolated CD4+
 
T cells. CD4+ T cells were isolated as 
described previously and stained with PE-labelled anti-CD4 or PE-labelled isotype control 
antibody and analysed by flow cytometry. CD4+ positive cells were gated and data was 
collected for 10000 events. (A) Forward and side scatter (FS and SS respectively) of the 
whole T cell population. (B) Overlay plot of isotype control antibody and anti-CD4-PE 
stained T cell population.  
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4.4.3 The effect of GSH synthetase inhibitor, buthionine sulphoximine (BSO) on CD4+ T 
cell viability:  
 
 
To investigate if depletion of the intracellular GSH level by BSO affects cell viability, the 
human CD4+ T cells were treated with 25 µM BSO, which is an inhibitor of GSH synthesis, 
for 24 hours. Cells were counted before and after the 24-hour treatment and measured using 
trypan blue exclusion method (Figure 4.7). The cell viability of the BSO treated cells 
(95.6±0.30; mean±SEM) was the same as the untreated cells (97.5±0.88) after 24 hours.  
c
o
n
tr
o
l
2
5 
M
 B
S
O
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
C
e
ll
 v
ia
b
il
it
y
(%
)
 
Figure 4.7: Buthionine sulphoximine (BSO) treatment of CD4+
 
T cells does not affect 
cell viability. Cells (20 µL) were transferred into a micro centrifuge tube with an equal 
amount of trypan blue. The contents were mixed gently and transferred onto a 
haemocytometer for cell counting. Mean values are shown with standard error of mean for 3 
independent experiments. 
 
  
 
 
122 
4.4.4 Effect of buthionine sulphoximine on CD4+
 
T cell total GSH level: 
 
 
To confirm that treatment of CD4+ T cells with BSO has an effect on the intracellular GSH 
levels, cells (1x10
6
 cells/mL) were incubated for 24 hours with 25 µM BSO. After 24 hours 
the GSH and BCA assays were performed to determine the intracellular GSH levels. The 
GSH levels have decreased significantly (P=0.042) after 24 hours of BSO treatment 
8.80±0.87 nmol GSH/total protein (mean±SEM), compared to the control samples 10.07±1.03 
nmol GSH/total protein were detected (Figure 4.8). 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Pre-incubation with buthionine sulphoximine (BSO) affects the total 
glutathione (GSH) levels in CD4+ T cells. CD4+
 
T cells (1x10
6
 cells/mL) were treated with 
BSO (25 µM) for 24 hours then harvested and analysed for total GSH as described in the 
methods. Significant differences were calculated with one tailed, paired student’s t-test. The 
results are for 3 independent experiments done in triplicates. 
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4.4.5 Effect of BSO on surface thiols of CD4+T cells:  
 
 
In order to investigate the cell surface thiol levels under normal and oxidatively stressed 
conditions, such as GSH depletion, CD4+ T cells were treated with 25 µM BSO for 24 hours. 
Surface thiols were measured using DTNB assay and flow cytometry and the results are 
displayed in Figure 4.9. Cells treated with BSO for 24 hours show a significant decrease in 
surface thiols levels (2.36±0.38 µM; mean±SEM) compared to untreated cells (3.23±0.47 
µM) when measured by the DTNB assay (P=0.01). Flow cytometry data show similar results 
with treated cells (83.6±2.22 X-mean) showing a significant decrease in maleimide 
Alexafluor-488C5 binding (P=0.004) compared to control sample (111.0±3.05 X-mean) 
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Figure 4.9: Buthionine sulphoximine (BSO) pre-incubation with CD4+ T cells reduces 
surface thiol levels. 1x10
6
 cells/mL were treated with 25 µM BSO for 24 hours. A) 0.5 x10
6
 
cells either treated or untreated were washed twice with PBS to remove media and excess 
BSO. Cells were resuspended in PBS and thiols were labelled with 1 mM maleimide 
Alexafluor-488C5 then analysed by flow cytometry. Mean peak staining intensity for thiols is 
displayed with standard error of the mean from 3 independent experiments. Statistical 
analysis was done using two tailed paired students t test.B) Cells were washed twice with 
PBS and resuspended in PBS. CD4+ T cells (1.5x10
5
) were added to 96 well plates and 
DTNB was added to a final concentration of 200 µM for 20 minutes in the dark at room 
temperature. Supernatants were collected and absorbance read at 405 nm and the free thiols 
calculated. Data represent three independent experiments of three replicates. Significant 
differences were calculated using two tailed, paired student’s t test. C) Forward and side 
scatter (FS amd SS respectively) of the whole T cell population and histogram of T cell 
population without BSO treatment 
 
  
C 
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4.4.6 Effect of PHA-L and PHA-P on cell viability: 
 
 
Phytohemagglutinin (PHA) is a lectin derived from Phaseolus vulgaris. It consists of two 
related proteins, leukoagglutanin (PHA-L), which has a high mitogen activity to T 
lymphocytes and erythroagglutanin (PHA-E), which has low mitogenic activity but high 
erythroagglutanin activity. PHA-P is the protein form of lectin prior to the purification to 
PHA-L and PHA-E. To study their effects on T cell activation 1 µg/mL PHA-L, 5 µg/mL 
PHA-L, 1 µg/mL PHA-P and 5 µg/mL PHA-P were studied over 24 hours. T cell viability 
was assessed by the trypan blue exclusion method. Figure 4.10 shows that when increasing 
the concentration of PHA-L there is a decrease in cell viability from 88.2±7.8% (mean±SEM) 
for 1µg/mL PHA-L to 72.1±23.9% with 5µg/mL PHA-L. The decrease in cell viability is 
similar when using 1µg/mL PHA-P (84.7±11.23%) and 5 µg/mL PHA-P (76.6±19.2%) (P 
0.05) at 5 µg/ml for both lectins compared to untreated controls. 
 
Figure 4.10: PHA-L and PHA-P treatment decreases cell viability. Cells (1x10
6
 cells/mL) 
were treated with lectins for 24 hours then an aliquot was transferred into a micro centrifuge 
tube with an equal amount of trypan blue. The contents were mixed gently and transferred 
onto a haemocytometer for cell counting. Mean values are shown with standard error of mean 
for 3 independent experiments. Significant differences were calculated ( P 0.05) with one-
way ANOVA analysis followed by Dunnett’s multiple comparison tests. 
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4.4.7 Effect of PHA-L and PHA-P on CD4 + T cell activation: 
 
 
To investigate the effect of 1 µg/mL PHA-L, 5 µg/mL PHA-L, 1 µg/mL PHA-P and 5 µg/mL 
PHA-P on the activation of T cells after 24 hours of treatment, flow cytometry was used to 
determine the amount of cells expressing CD25 at the cell surface. Results show a PHA-
concentration dependent increase in the amount of activated cells for both PHA-L and PHA-
P. In untreated T cells, 24.0% were positive for CD25 and after 5 µg/mL PHA-L treatment, 
64.5% of cells were CD25 positive (Figure 4.11). 
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Figure 4.11: T cell activation markers are increased by increasing concentrations of 
PHA-L and PHA-P. Isolated CD4+ T cells (1x10
6 
cells/mL) were activated with 1µg/mL 
PHA-L, 5 µg/mL PHA-L, 1 µg/mL PHA-P and 5 µg/mL PHA-P for 24 hours or left 
untreated. Samples were collected to 1.5 mL microcentrifuge tubes, washed in PBS then 
resuspended in RPMI-1640 media for blocking. Cells (2.5x10
5
) were then either treated with 
allophycocyanin (APC)-conjugated mouse monoclonal antibody to IL-2 receptor alpha 
(CD25; 1.25 µL), or APC-conjugated isotype control antibody (1.25 µL) in the dark and were 
kept on ice for 30 minutes. The samples were analysed on the Cytomics TM FC500 flow 
cytometer (Beckman-Coulter, USA). Cells were gated based on the forward scatter (FS)/side 
scatter (SS) using FL4 and results and data was collected for 10000 events against FS. The 
results shown are from one experiment. 
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4.4.8 Effect of PHA-P and PHA-L on T cells using IL-2 ELISA: 
 
 
The CD4+
 
T cell response to activation with 1 µg/mL PHA-L, 5 µg/mL PHA-L, 1 µg/mL 
PHA-P and 5 µg/mL PHA-P after 24 hour treatment was assessed by measuring the levels of 
the interleukin-2 (IL-2) secreted into the supernatant. IL-2 is a cytokine that is mainly 
produced by activated CD4+ T cells in response to TCR and CD28 signalling (42). Figure 
4.12 shows that there is an increase in IL-2 secretion when PHA-L concentration was 
increased to 5 µg/mL (0.29 ng/mL). 
 
Figure 4.12: PHA-L increases IL-2 secretion. Isolated CD4+
 
T cells (1x10
6 
cells/mL) 
were activated with 1µg/mL PHA-L, 5 µg/mL PHA-L, 1 µg/mL PHA-P and 5 µg/mL 
PHA-P for 24 hours or left untreated. Samples were collected to 1.5 mL microcentrifge 
tubes and centrifuged at 400 x g for 2 minutes. The supernatants were collected and 
analysed for IL-2 using a human IL-2 ELISA as described in the methods. Data is from 
one experiment. 
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4.4.9 Protein sulphenic acid modifications in Jurkat E6.1 T cells: 
 
 
To investigate protein sulphenic acid modifications in T cells, a cultured Jurkat E6.1 T cell 
line was used. The biotinylated dimedone based probe, 3-(2,4-dioxocyclohexyl)propyl5-
((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-6-yl)pentanoate (DCP-Bio1, 
Kerafast) was used to capture sulphenic acid modified proteins. Jurkat T cells (1x10
6
 
cells/mL) were washed three times with ice cold PBS and treated with 1 mM DCP-Bio1 for 
30 minutes on ice. The free thiols were blocked with 10 mM IAM for 10 minutes. Cells were 
incubated in MNE lysis buffer for 30 minutes on ice. Excess was reagent was washed off and 
the cells were lysed and proteins separated by SDS-PAGE. The gels were then transferred on 
to a PVDF membrane and probed with HRP-conjugated streptavidin. Gels were run under 
reducing and non-reducing conditions and showed similar band patterns (Figure 4.14). Lane 
4 where cells have been treated with DCP-Bio1 and IAM show two prominent bands at 
around 65 kDa and 45 kDa respectively. Lane 2 (total cell lysate) and lane 3 where cells were 
first treated with 10 mM IAM to block free thiols and then treated with DCP-Bio1 show 
weaker bands at around 65 kDa. 
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Figure 4.13: Schematic presentation of isolation of sulphenic acid modified proteins. 
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Figure 4.14: Protein sulphenic acid modifications in Jurkat E6.1 T cells. Jurkat T cells 
(1x10
6 
cells/mL) were washed three times ice cold PBS (1 mL) and treated as follows prior to 
SDS-PAGE and western blotting with HRP-streptavidin. 
1-Protein marker 
2-Untreated T cells 
3-Cells treated with 10 mM IAM for 10 minutes followed by 1 mM DCP-Bio1 for 30 minutes 
on ice 
4-Cells treated with 1 mM DCP-Bio1 for 30 minutes on ice followed by 10 mM IAM, 
5- Supernatant of 2 after protein removal by streptavidin magnetic beads,  
6- Supernatant of 3 after protein removal by streptavidin magnetic beads.  
The gel is representative of 3 independent experiments. 
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4.4.10 CD4+ T cell protein sulphenic acid modifications: 
 
 
To investigate protein sulphenic acid modifications in primary cells, CD4+
 
T cells were 
isolated from blood. T cells (1x10
6 
cells/mL) were either left untreated (Figure 4.15, lane 2), 
treated with 10 mM IAM for 10 minutes followed by 1 mM DCP-Bio1 for 30 minutes on ice 
(Figure 4.15, lane 3) or treated with 1mM DCP-Bio1 for 30 minutes on ice followed by 10 
mM IAM treatment for 10 minutes (Figure 4.15, lane 4). The cells were washed with ice cold 
PBS three times to get rid of any excess chemicals and incubated with MNE lysis buffer for 
30 minutes on ice and lysed with a 21 G needle. Samples were run on a 10% SDS-PAGE to 
separate the proteins. After transfer to a PVDF membrane, they were probed with HRP-
conjugated streptavidin. When treated with DCP-Bio1 prior to IAM treatment 3 bands are 
visible around 65 kDa, 45 kDa and 25 kDa (Figure 4.15). The band at 65 kDa is also visible 
in both total cell lysate (lane 2) and treatment with IAM followed by treatment with DCP-
Bio1 (lane 3). 
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Figure 4.15: Protein sulphenic acid modifications in resting CD4+T cells. CD4+
 
T cells 
(1x10
6 
cells/mL) were washed three times with ice cold PBS. Cells were either untreated (2), 
treated with 10 mM IAM for 10 minutes followed by 1 mM DCP-Bio1 for 30 minutes on ice 
(3) or treated with DCP-Bio1 for 30 minutes on ice followed by 10 mM IAM for 10 minutes 
(4). Cells were lysed and loaded onto 10% polyacrylamide gels and analysed by western 
blotting using HRP conjugated streptavidin for biotinylated probe detection. The blot is 
representative of 3 independent experiments. 
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4.4.11 BSO treated CD4+ T cell protein sulphenic acid modifications: 
 
 
To explore the formation of protein sulphenic acid modifications under oxidatively stressed 
conditions, CD4+
 
T cells (1x10
6
 cells/mL) were treated with 25 M BSO for 24 hours. The 
cells were either left untreated, treated with 10 mM IAM for 10 minutes followed by 1 mM 
DCP-Bio1 treatment for 30 minutes on ice or vice versa. An increased number of bands at 65 
kDa, 50 kDa, 45 kDa, 40 kDa and 25 kDa, are visible in Figure 4.16 compared to resting 
cells shown in Figure 4.15. Lane 3 where the cells have been treated with excess IAM 
followed by 1 mM DCP-Bio1 show similar banding patterns although bands are less 
prominent.  
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Figure 4.16: Sulphenic acid modifications in buthionine sulphoximine (BSO) treated T 
cells. CD4+
 
T cells (1x10
6
 cells/mL) were washed three times with ice cold PBS. Cells were 
either untreated (1), treated with DCP-Bio1 for 30 minutes on ice followed by 10 mM IAM 
for 10 minutes (2) or treated with 10 mM iodoacetamide (IAM) for 10 minutes followed by 1 
mM DCP-Bio1 for 30 minutes on ice (3) Cells were lysed and loaded onto 10% 
polyacrylamide gels and analysed by western blotting using HRP conjugated streptavidin for 
biotinylated probe detection.  
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4.4.12 BSO and PHA-L treated CD4+ T cell protein sulphenic acid modifications: 
 
 
To investigate the effects of oxidative stress and T cell activation of the formation of protein 
sulphenic acid modifications, T cells (1x10
6
 cells/mL) were treated with 25 M BSO and 5 
g/mL PHA-L for 24 hours. Western blot results show 4 bands at 65 kDa, 50 kDa, 45 kDa 
and 40 kDa (Figure 4.17, lane 2) where cells have been treated with 1 mM DCP-Bio1 
followed by 10 mM IAM. Similar less intense bands are observed in lane 3 where cells were 
first treated with IAM followed by DCP-Bio1 treatment. Although there is an increase in the 
number of bands compared with untreated T cells (Figure 4.15) there is one band missing (25 
kDa) compared to the BSO-treated T cells (Figure 4.16). 
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Figure 4.17: Protein sulphenic acid modifications with BSO and PHA-L treated T cells. 
CD4+ T cells (1x10
6
 cells/mL) were washed three times with ice cold PBS. Cells were either 
untreated (1), treated with DCP-Bio1 for 30 minutes on ice followed by 10 mM IAM for 10 
minutes (2) or treated with 10 mM iodoacetamide (IAM) for 10 minutes followed by 1 mM 
DCP-Bio1 for 30 minutes on ice (3). Cells were lysed and biotinylated proteins were captured 
with streptavidin magnetic beads. The proteins were eluted with sample buffer and proteins 
and supernatants of sample 2 (lane 4) and sample 3 (lane 5) were loaded onto 10% 
polyacrylamide gels and analysed by western blotting using HRP conjugated streptavidin for 
biotinylated probe detection. 
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4.4.13 PHA-L treated CD4+
 
T cell protein sulphenic acid modifications: 
 
 
To investigate the effects of T cell activation on the formation of sulphenic acid 
modifications, CD4+
 
T cells (1x10
6 
cells/mL) were treated with 5 g/mL PHA-L for 24 hours. 
After activation, cells that were treated with DCP-Bio1 for 30 minutes, followed by excess 
IAM, show bands at 65 kDa and 25 kDa (Figure 4.18, lane 3). Lane 2 where cells were 
treated with 10 mM IAM followed by 1 mM DCP-Bio1 treatment also show a similar, but 
less intense, banding pattern. There is a decrease in the number of bands present in Figure 
4.18 compared with untreated, BSO treated and BSO and PHA-L treated T cells.  
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Figure 4.18: Protein sulphenic acid modifications after 5 g/mL PHA-L for 24 hours. 
CD4+
 
T cells (1x10
6 
cells/mL) were treated with 5g/mL PHA-L for 24 hours. The cells were 
washed 3 times with ice cold PBS to remove excess reagent and either untreated (1), treated 
with 10 mM iodoacetamide (IAM) for 10 minutes followed by 1 mM DCP-Bio1 for 30 
minutes on ice (2) or treated with 1 mM DCP-Bio1 for 30 minutes followed by incubation of 
10 mM ioadoacetamide for 10 minutes (3). Cells were lysed in MNE lysis buffer and proteins 
separated on a 10% polyacrylamide gel. Proteins were transferred on to a PVDF membrane 
and probed with HRP-conjugated streptavidin for visualisation.  
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4.4.14 Mass spectrometry identification of protein bands containing sulphenic acid 
modifications: 
 
In order to identify proteins that contained sulphenic acid modifications, bands were cut out 
from PVDF membranes as described in the methods section above (4.3.13). The samples 
were subjected to mass analysis and the proteins that met inclusion criteria for each band 
excluding keratin and haemoglobin are listed in Table 4.2-6 below. 
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Accession Protein Function Unique 
peptides 
MW 
(KDa) 
Coverage 
P02768 Serum albumin Maintaining osmotic pressure. Transportation of 
molecules 
3 69.3 11.66 
P30043 Flavin reductase (NADPH) 
Catalyses the NADPH-dependent reduction of a 
variety of flavins.  Can also reduce the complexed 
Fe(3+) iron to Fe(2+) in the presence of FMN and 
NADPH 
1 22.1 14.56 
P81605 Dermcidin Antimicrobial, limits skin infection 1 11.3 22.73 
 
 
Table 4.2: Results of protein identifications for the 25 kDa band. The Accession is the unique identifier used for the sequence. The coverage indicates the 
percentage of the protein sequence that has been covered by the identified protein. The number of unique peptides displays the number of peptides matching 
the protein identified. The proteins highlighted in red are closest matched to the MW of the band identified. 
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Accession Protein Function Unique 
Peptides 
MW (KDa) Coverage 
P81605 Dermcidin Antimicrobial. Limits skin infection 4 11.3 35.45 
P04406 Glyceraldehyde-3-
phosphate dehydrogenase 
Plays a role in glycolysis and nuclear function 6 36.0 24.78 
P60709 Actin, cytoplasmic 1 Internalisation of TCR and activation of calcium 
signalling 
5 41.7 18.40 
Q9NZT1 Calmodulin like protein 5 Plays a role in calcium binding 2 15.9 21.23 
Q06830 Peroxiredoxin-1 Involved in redox regulation of the cell and 
reduces peroxides through the thioredoxin system 
3 22.1 16.58 
P07355 Annexin A2 Calcium and phospholipid binding protein 3 38.6 12.09 
P05089 Arginase-1 Synthesis of polyamines such as putrescine, 
spermidine and spermine 
3 34.7 10.56 
 
 
Table 4.3: Results of protein identifications for 40 kDa band. The Accession is the unique identifier used for the sequence. The coverage indicates the 
percentage of the protein sequence that has been covered by the identified protein. The number of unique peptides displays the number of peptides matching 
the protein identified. The proteins highlighted in red are closest matched to the MW of the band identified. 
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Accession Protein Function Unique 
peptides 
MW(KDa) Coverage 
P30043 Flavin reductase (NADPH) Catalyses the NADPH dependent reduction of a 
variety of flavins. Can also reduce the complexed 
Fe(3+) to Fe(2+) in the presence of FMN and 
NADPH 
1 22.1 14.45 
P02768 Serum albumin Maintains osmotic pressure.Transportation of 
molecules 
3 69.3 10.18 
 
Table 4.4: Results of protein identifications for 45 kDa band. The Accession is the unique identifier used for the sequence. The coverage indicates the 
percentage of the protein sequence that has been covered by the identified protein. The number of unique peptides displays the number of peptides matching 
the protein identified.   
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Accession Protein Function Unique 
peptides 
MW(KDa) Coverage 
P81605 Dermcidin Antimicrobial. Limits skin infection 3 11.3 35.45 
P05109 Protein s100-A8 Functions as a calcium and zinc binding protein 
and has a prominentrole in the regulation of 
immune response  
2 10.8 19.35 
P47929 Galectin-7 A Pro-apoptotic protein that functions 
intracellularly upstream of JNK activation and 
cytochrome release 
2 15.1 18.38 
P02656 Apolipoprotein C-III Plays a role in trigylceride homeostasis 1 10.8 16.16 
P30043 Flavin reductase (NADPH) Catalyses the NADPH dependent reduction of a 
variety of flavins. Can also reduce complexed Fe 
(3+) iron to Fe(2+) in the presence of FMN and 
NADPH 
1 22.1 14.56 
P02768 Serum albumin Regulates osmotic pressure and plays a role in the 
transport of molecules 
3 69.3 13.46 
P31151 Protein S100-A7 May function in calcium and zinc binding 1 11.5 10.89 
 
 
Table 4.5: Results of protein identifications for 50 kDa band. The Accession is the unique identifier used for the sequence. The coverage indicates the 
percentage of the protein sequence that has been covered by the identified protein. The number of unique peptides displays the number of peptides matching 
the protein identified.  
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Accession Protein Function Unique 
peptides 
MW(KDa) Coverage 
J3QL26 Serine/threonine-protein 
phosphatase 4 regulatory 
subunit 1 
May be involved with regulation of cell division 
in renal glomeruli 
1 15.5 21.48 
P02768 Serum albumin Functions as a transporter molecule and in 
maintaining osmotic pressure 
4 69.3 16.91 
P02656 Apolipoprotein C-III Plays a role in triglyceride homeostasis 1 10.8 16.16 
P30043 Flavin reductase (NADPH) Catalyses the NADPH dependent reduction of a 
variety of flavins. Can also reduce complexed 
Fe(3+) iron to Fe(2+) in the presence of FMN and 
NADPH 
1 22.1 14.56 
 
 Table 4.6: Results of protein identifications for 65 kDa band. The Accession is the unique identifier used for the sequence. The coverage indicates the 
percentage of the protein sequence that has been covered by the identified protein. The number of unique peptides displays the number of peptides matching 
the protein identified. The proteins highlighted in red are closest matched to the MW of the band identified. 
. 
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4.4.15 Cell imaging: 
 
 
To investigate the labelling of thiols as well as to examine if DCP-Bio1 labelling of protein 
sulphenic acids was extracellular, intracellular or both, CD4+
 
T cells (1x10
6
 cells/mL) were 
either stained with maleimide/maleimide Alexafluor488C5, DCP-Bio1 followed by 
streptavidin-PE or a combination of all of the reagents above. The nucleus was stained with 
DAPI (4’,6-diamino-2-phenylindole) and visualised by confocal microscopy (Leica, UK). 
Figure 4.19 shows the nucleus of the T cells stained in blue, DCP-Bio1 (red) appears to be 
cell permeable and is able to detect protein sulphenic acid modifications on the membrane as 
well as in the cytosol of T cells. T Cells stained with maleimide/maleimide Alexafluor 488C5 
(green) show extensive surface thiols (Figure 4.19B). When cells are stained for sulphenic 
acids and surface thiols, yellow patches are observed in the nucleus, which are areas where 
both sulphenic acids and thiols are present. In some cells blebbing could also be observed 
(Figure 4.19D). 
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Figure 4.19: Detection of protein thiols and sulphenic acids in CD4+
 
T cells. CD4+ T 
cells (1x10
6
 cells/mL) were adhered onto poly-L-lysine microscopy slides for 20 minutes at 
room temperature (Thermo Scientific, UK). Cells were fixed with 70% ice-cold methanol for 
5 minutes and washed three times with PBS (1 mL). The fixed cells were then either A) 
treated with 1 mM DCP-Bio1 for 30 minutes on ice, B) 1 mM maleimide (9 µL) and 1 mM 
maleimide Alexafluor-488C5 (1µL) for 30 minutes at 37 °C in the dark C) a combination of 
all the reagents. D) presence of blebs when both DCP-Bio1 and maleimide are present. The 
slides were then blocked with 1% (w/v) PBS for 30 minutes at 4 °C and rinsed three times 
with PBS. On the slides where DCP-Bio1 was present streptavidin-PE (Sigma, UK) was used 
in 1:100 dilution in PBS and incubated for 30 minutes at 4 °C in the dark. Cells were rinsed 
three times with PBS, nucleus stained with DAPI and visualised using Leica Confocal 
microscopy (Leica, UK).  
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4.5 Discussion: 
 
 
This chapter has described the identification of sulphenic acids on proteins in primary human 
T cells for the first time and has shown that activation and oxidative stress can affect the 
presence of sulphenic acids discretely and independently. A method was optimised in which 
sulphenic acid modified proteins could be captured using the biotin tagged probe DCP-Bio1. 
Incubation of the probe at increasing concentrations showed that 1mM DCP-Bio1 was 
optimised for western blot experiments, as the band intensity did not increase further after the 
addition of 1 mM DCP-Bio1. Iodoacetamide (IAM), which is an alkylating agent, was used to 
block thiols to reduce non-physiological cysteine oxidation that could occur during lysis of 
cells. Although it is important to block thiols using alkylating agents such as IAM or N-
ethylmaleimide (NEM) Reisz et al (159) have demonstrated that these reagents themselves 
could react with sulphenic acids thus competing with the probes that are used to detect the 
modifications. This could be a possible explanation as to why there are faint bands visible 
when adding IAM before treatment of DCP-Bio1 in T cells. 
Under normal conditions cells maintain a reducing intracellular environment. A major factor 
influencing the redox status in the cytosol is the concentration of the cysteine containing 
tripeptide, GSH (160). BSO has been widely used to deplete GSH in T cells. BSO is preferred 
as a GSH depleting agent in cell culture and in primary cells since it does not appear to have 
any toxic effects (161). This was confirmed when cell viability was assessed after treatment 
of CD4+ T cells with BSO for 24 hours. CD4+ T cells exposed to BSO for 24 hours showed 
lower level of cellular GSH compared to untreated cells. Unreported experiments using lower 
concentrations of BSO (12.5M) did not show a decrease in the total GSH levels. This 
decrease in GSH suggested that the cell was in a more oxidised environment. This would lead 
to more thiols being oxidised not only inside the cell but also potentially on the cell surface. 
Previous work from our lab has shown that BSO elicited a change in surface T cell Trx (108) 
Intracellular oxidative stress did affect the amount of surface thiols on the cell surface, after 
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being depleted of GSH by treatment of BSO for 24 hours, as shown by both DTNB assay and 
flow cytometry. 
Thiol containing proteins undergo oxidation when cells are under oxidative stress. Among the 
various oxidation states of cysteine, cysteine sulphenic acid modifications are important as it 
is a reversible modification and has been implicated as a molecular switch to activate or 
deactivate protein function (42). Therefore the effects of GSH depletion on the formation of 
cysteine sulphenic acids was investigated and compared to T cells under normal conditions. 
To investigate sulphenic acid formation in T cells a method was developed using the biotin 
tagged dimedone based probe, DCP-Bio1.This probe specifically reacts with sulphenic acids 
either by a Michael addition or a nucleophilic substitution reaction (7). Once the probe was 
bound to the modified proteins, they were pulled out of the total cell lysate using streptavidin 
bound magnetic beads. When the proteins were eluted off the beads they were easily detected. 
The modified proteins will carry the biotin tag, which allows their detection via western blot 
methods and cellular localisation by fluorescence microscopy.  
Following western blotting of T cell lysates, an increase in the number of sulphenated protein 
bands were present when cells are treated with BSO. A non-specific band was detected in all 
cell lysates following labelling with streptavidin peroxidase. Others have also reported this 
observation and it is suggested to be an endogenously biotinylated protein (1). Its mass was 
greater than any other band that could be specifically detected using DCP-Bio1 hence it is 
unlikely to interfere with other experiments that were designed to identify specifically 
sulphenated proteins. This suggests that when GSH levels were lower in the cells and the 
redox state of the T cell were disrupted, more proteins undergo cysteine oxidation and form 
stable sulphenic acids that can be captured and isolated. 
In order to visualise the location of sulphenic acid formation, microscopy of the DCP-Bio1 
and maleimide-labelled T cells was undertaken. It was anticipated that the membranes only 
would be labelled by maleimide Alexafluor due to its hydrophilicity but the data gathered 
here suggest that DCP-Bio1 may label intra and extra-cellular proteins. Although larger, 
DCP-Bio1 is a much more hydrophobic structure and at a molecular mass of 396.5 is 
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predicted to be membrane permeable. Microscopy confirmed that maleimide-Alexafluor 
labelled the cell membranes only. However, in the presence of DCP bio1, the membrane 
labelling was lost and instead co-localised staining of the nucleus was observed. In some 
images, there was apparent labelling of blebs with DCP bio1. These findings suggest that 
under the conditions used here, DCP bio1 is exerting some toxicity and this may limit its use 
in real time studies of sulphenic acid formation. 
Reactive oxygen species are generated in response to mitogen-induced activation of naïve T 
cells (58). Therefore the hypothesis was that when T cells were activated the formation of 
protein sulphenic acid modifications would increase. To investigate the effects of activation, 
cells were treated with lectins, PHA-L or P. Increasing the concentrations of PHA-L and 
PHA-P reduced the percentage of viable cells. The cell viability and levels of CD25 
expressed at the cell surface was measured after 24-hour treatment. CD25 expression is a key 
marker of T cell activation (70). When naïve CD4+
 
T cells become activated through the 
presentation of antigen by APCs, IL-2 secretion and IL-2R expression is stimulated. The 
interaction between IL-2 and IL-2R induces cell growth and differentiation (162). IL-2 
secretion was measured by using IL-2 ELISA and CD25 expression was measured by flow 
cytometry. In both cases data showed that there was an increase in IL-2 secretion and CD25 
expression with activation of T cells using 5 µg/mL PHA-L. Therefore for further 
experiments where cells were activated to detect protein sulphenic acid modifications, this 
concentration was used. When T cells were activated to look at sulphenic acid modifications, 
although an increase in the number of protein bands was expected, only two bands could be 
observed. However, when cells were activated under oxidative stress, the number of bands 
increased. Subsequent experiments by mass spectrometry analysis have identified several 
interesting proteins for the band at ~40 kDa. Peroxiredoxin-1 belongs to the 2-cys 
peroxiredoxins, which are responsible in the reduction of peroxides such as H2O2 through 
cysteine sulphenic acid formation at the active site and subsequently forming disulphide 
bonds with a second resolving cysteine (163). Experiments conducted by Morais et al (164) 
have demonstrated that pH changes can determine the formation of dimers or decamers of 
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peroxiredoxin-1. They have demonstrated that at physiological pH peroxiredoxins remain as 
dimers but with small changes to pH (8.0) the decamer is formed (164). The formation of a 
dimer which as a molecular mass of ~44 kDa fits well with the data and with the fact that 
under oxidative stress conditions sulphenic acids are formed. Another possibility for this 
protein is Arginase 1. Iyamu et al (165) have recently reported that oxidation of thiols leads to 
increased arginase activity in the cells and increases the levels of arginase 1 being produced. 
Aurothiomalate (ATM) a gold analogue forms a thiol gold adduct with cysteine thiols and 
prevents the thiols being oxidised. As expected, the enzyme activity decreased thereby 
proving the importance of cysteine oxidation (165). Since this protein band appears when T 
cells are treated with BSO whereby a more oxidised environment is present it is plausible that 
this could be the protein of interest. Furthermore studies by Ckless et al (166) have 
demonstrated that reduction of arginase activity leads to an increase in nitric oxide 
concentrations in cells, which results in a decrease in NFκB activity. Therefore arginase 1 
dependent nitric oxide regulation could have an influence in inflammatory diseases that are 
regulated by the transcription factor NFκB (166). Actin is a main component of the 
cytoskeleton, which is involved, in many cellular functions including cell adhesion, growth 
and cytokinesis (167). Cell adhesion is important in various biological processes including 
inflammation and wound healing. In -actin six cysteine residues are present but only one of 
them the Cys374 is exposed on the molecular surface, which makes it susceptible to 
oxidation. Recent studies by Sobierajska et al (168) have demonstrated that protein disulphide 
isomerase (PDI), which is a member of the thiol disulphide oxidoreductase family, interacts 
with -actin to form disulphide bonds during cell adhesion to mediate cytoskeletal 
rearrangement (168). Perhaps the oxidation of actin Cys374 to form disulphide bonds occur 
via sulphenic acid formation as this was one of the proteins identified ~40 kDa protein band. 
The peptide sequences of these proteins do not cover any cysteine residues and therefore it is 
not possible to detect the DCP-Bio1 modification in any of the proteins. Perhaps different 
ionisation methods need to be employed in order to detect more modified peptides. Although 
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several proteins hits were obtained for bands 45 kDa and 50 kDa none of the proteins 
identified matched the molecular mass of the proteins and therefore were disregarded. A 
possibility for the proteins at ~65 kDa could be human serum albumin which has a mass 
around ~66 kDa and has been shown in chapter 3 to have a sulphenic acid that can be 
detected by DCP-Bio1. 
T cell inactivation has been suggested to be due to oxidation of surface thiols. In models of 
rheumatoid arthritis (RA) a specific defect in ROS production led to more aggressive disease 
(109). Phillips et al (106) have shown that RA patients, who have hyperactive T cells, have 
lower ROS production. The model developed here, using BSO to deplete intracellular GSH, 
has simulated conditions of older adults without RA, who have lower intracellular GSH and 
refractory T cells. By identifying the proteins that are sulphenated in conditions of low GSH, 
in the future it will be possible to explore whether these proteins are differentially affected by 
RA and ageing.  
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Chapter 5.0 Synthesis of novel compounds for 
the detection of cysteine sulphenic acids 
 
 
 
 
  
 
 
153 
5.1 Preface:  
 
 
This chapter describes the synthesis of two novel probes that have the potential to be targets 
for the detection of sulphenic acid modifications. 
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5.2 Introduction: 
 
 
Sulphenic acids are highly unstable molecules that are difficult to isolate from biological 
systems. Therefore scientists have spent a significant amount of time synthesising sulphenic 
acids that could be used as a model system to better understand these moieties in a biological 
system (7). The first stable sulphenic acid, which was an anthraquinone-1-sulphenic acid, was 
reported by Fries in 1912. The formation of a hydrogen bond with the neighbouring carbonyl 
group gives this structure its stability (169). This and the synthesis of two other compounds, 
1-methyluracil-4-sulphenic acid (170) and 1,3,6-trimethyllumazine-7-sulphenic acid (171) 
which show similar stability due to hydrogen bonding lead to the conclusion that sulphenic 
acids in biological systems could be stabilised if hydrogen bonds could be formed (171). To 
explore the influence of steric hindrance in the stabilisation of sulphenic acids Yoshimura et 
al (172) synthesised a molecule, trans-decalin-9-sulphenic acid containing a trans-9-decalyl 
group with four axial protons. This molecule proved to be stable at room temperature for 
about 30 minutes before it was either converted to its disulphide or further oxidised to the 
sulphonic acid. When two molecules with the sulphenic groups come into close proximity the 
four axial protons causes a steric hindrance, which is attributed to the stability of the molecule 
(172). Another important contribution in finding out what contributes to the stability of 
sulphenic acids in a protein was done by Goto and co-workers in 1997 (173). They 
synthesised a bowl shaped cyclophane framework abbreviated as Bmt (4-tert-butyl-2,6-
bis[(2,2”,6,6”-tetramethyl-m-terphenyl-2’-yl)methyl]phenyl ) bearing a thiol which under 
mild oxidation could be oxidised to the corresponding sulphenic acid. The sulphenic acid 
proved to be stable towards self-condensation even after weeks of exposure to air because of 
its location inside the cavity. When reactions were carried out with reducing agents such as 
DTT it was reduced back to the thiol form. This Bmt framework mimics the environment of 
crevices often present in protein with sulphenic acid modifications. It has been suggested that 
the position of the cysteine on proteins are very important in the stable formation of sulphenic 
acids (173). Therefore these molecules give important information on why only some 
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sulphenic acids can be captured in a biological system. Apart from hydrogen bonding and 
limited solvent access as well as an apolar protein environment the absence of adjacent thiols 
is the major factor in the formation of sulphenic acids. This has been demonstrated by work 
done by Miller and co-workers using the enzyme glutathione reductase (GR) (174). The 
reduced form of GR has two cysteine thiols; Cys58 and Cys63. When Cys58 was reacted with 
small molecules like GSH formed mixed disulphides and became inactive. When this inactive 
form was oxidised further, sulphenic acid modification was detected at Cys63, which were 
not present when the active form was oxidised. Therefore elimination of the neighbouring 
cysteine stabilised the formation of Cys-SOH (174). 
Although there was growing interest to understand the biological significance sulphenic acid 
formation, the initial evidence was indirect because there were no direct detection techniques. 
One of the most common methods used was stoichiometry and proving that the oxidation of 
some protein thiols was consistent with formation of sulphenic acids and not disulphide 
bonds. As an example, work done by Fraenkel-Conrat (175) indicated that in the tobacco 
mosaic virus (TMV) under certain conditions, when treated with iodine reacted to form 
sulphenyl iodine groups, which was based on the stoichiometry of the reaction (175). Over 
the years several elegant methods have been introduced to detect sulphenic acid formation 
directly in proteins as well as in cells in physiological conditions. While probes like DCP-
Bio1 which is a biotinylated probe has been used in the identification of sulphenic acids in a 
number of proteins like GAPDH, papain and even in cell lysates the drawback of these probes 
are that because of their bulky nature they could have limitations on cell permeability and that 
they can cause steric hindrance and obstruct protein target labelling. To address these issues 
Carroll et al synthesised small molecules while still retaining the dimedone “warhead” added 
an azide or alkyne functional group to make dimedone analogues DAz-1, DAz-2, DYn-1 and 
DYn-2(1, 10, 66). The same group in 2009 developed a method using antibodies to detect 
protein sulphenic acid modifications. A synthetic hapten, which consists of the dimedone 
moiety on a cysteamine backbone with a five-carbon linker to keyhole limpet hemocyanin 
(KLH) was synthesized and was used to extract rabbit α-hapten-Ig gamma (IgG) (176). 
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Although much progress has been made over the recent years in the development of tools to 
detect SOH there is still scope for novel probes. As an example when DCP-Bio1 was used to 
identify SOH in primary T cells a possible toxic effect was observed. With this in mind the 
aim of this chapter was to synthesise a novel fluorescent probe that would be smaller than the 
existing probes to make them cell permeable and also reduce bulk steric hindrance and be 
able to monitor sulphenic acid formation in real time. The synthesis of the novel magnetic 
probe could be used to pull modified proteins directly from a cell lysate and then be cleaved 
off to detect the protein using methods such as mass spectrometry. 
 
5.2.1 Strategy for the synthesis of fluorescent probe: 
 
The aim of this work was to synthesise a new fluorescent probe for the detection of sulphenic 
acids. The general structure of the probe is described in Figure 5.1. Based on this general 
structure, compound 1 has been proposed as a potential probe. 
 
Figure 5.1: General structure of the fluorescent probe. 
The diketocyclohexane ring was chosen as a warhead, as it is a dimedone like molecule and 
can act as a nucleophile to attack the sulphur atom of the cysteine sulphenic acid. The 
anthracene group will be used as a fluorophore. Both moieties will be connected through a 
glycine linker, which is relatively short, but will still bring flexibility to the molecule to 
enhance targeting of sulphenic acids.  
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5.3 Materials and methods: 
 
 
5.3.1 Materials:  
 
 
Unless otherwise noted all reactions were performed in oven dried glassware. Chemicals 
unless stated, were obtained from Sigma (Sigma-Aldrich, UK) or Fisher (Fisher Scientific, 
UK) without further purification. Magnabind amine linked magnetic beads were from 
Invitrogen (Invitrogen, Sweden). All work was carried out as Aston University in the 
medicinal chemistry laboratory, NMR and instrumentation suits. All experiments were 
COSHH assessed using the standard practices in the medicinal chemistry laboratory. Thin 
layer chromatography (TLC) was carried out using Millipore 60 F254 silica gel sheets. TLC 
plates were visualised using a combination of UV, ninhydrin, vanillin and potassium 
permanganate staining. Flash chromatography was performed using silica gel (40-63 µm pore 
size) from Millipore. Dry column chromatography was performed using Kieselgel 60G 
(Merck,Germany).NMR spectra were obtained using a Bruker AC250 (250MHz for 
1
H; 62.9 
MHz for 
13
C) spectrometer.
1
H and 
13
C NMR chemical shifts are reported as parts per million 
(ppm) relative to TMS (0.00 ppm) with its solvent peak used as an internal reference. Infra-
red (IR) spectra were obtained with samples made of KBr discs on a Mattson 3000 FT 
spectrometer or Thermo Scientific Nicolet is5 with iD5 ATR attachment as a solid sample. 
Melting points were obtained using a Reichert-Jung Thermo Galen hot stage microscope. 
Fluorescence spectrometry was done on Spectramax GeminiXS using softmax proV5 
software for analysis. Mass spectrometry was performed on a Waters 2795 LC/MS using 
Mass lynx software. 
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5.3.2 Methods: 
 
5.3.2.1 Synthesis of 3,5-diketohexahydrobenzoic acid: 
 
 
 
 
 
 
 
 
 
 Using a method adapted by Hildahl et al (61) 3,5-dihydroxybenzoic acid (15.4 g, 0.1 mol), 
sodium hydroxide (8.8 g, 0.22 mol) and Raney nickel (0.1 g) was mixed with water (45 mL) 
and added to the hydrogenator. The hydrogenation was carried out overnight at 50 °C, 42 bars 
with continuous stirring. The solution was cooled in an ice bath; the Raney nickel filtered off 
and acidified using concentrated hydrochloric acid (30 mL). The solution was kept at 4 °C 
overnight to give white crystals which were vacuum dried to give white crystals with a yield 
of 9.6 g (61.4%) 
Rf (Methanol: ethyl acetate: acetic acid 1:1:0.1): 0.44 
Melting point: 178.2-179.0 °C (reference (61) 178.0-178.7 °C) 
IR (KBr): 844, 1133, 1266, 1197, 1312, 1600, 1687, 1947, 3200 cm
-1 
Mass spectrum (TOF MS ES+) (M+Na
+
) m/z: = 179.01 expected: 179.12 
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5.3.2.2 Synthesis of 3-methoxy-5-oxocyclohex-3-ene-1-carboxylic acid: 
 
 
 
3,5-diketohexahydrobenzoic acid (0.2 g, 1.34 mmol), p-toluenesulphonic acid (PTSA) (0.013 
g, 0.067 mmol) was added to methanol (10 mL) in a round bottom flask purged with argon 
and stirred at room temperature for 10 minutes. The reaction mixture was concentrated on the 
rotary evaporator. The white solid was purified by silica gel chromatography eluting with 9:1 
ethyl acetate: methanol to give a white solid in a yield of 0.207 g (91%). 
Rf (Ethyl acetate: methanol 1:1) : 0.55 
Melting point: 196.3-199.6 °C 
1H NMR DMSO (250 MHz) δ: 2.45 (d, 2H) ppm, 2.64-2.61 (m, 2H), 2.99-3.07 (m, 1H), 3.68 
(s, 3H), 5.36 (s, 1H) ppm 
13C NMR DMSO (63 MHz) δ: 30.73 (C2), 37.53 (C1), 38.38 (C6), 55.84 (CH3), 101.42 (C4), 
174.18 (C=OCH3), 176.32 (C=OOH), 195.89 (C=O) ppm  
 IR: 3206.91, 2916.92, 2507.53, 1931.81, 1684.47, 1556.53, 1415.80 cm
-1
 
Mass spectrum (TOF MSES+) (M+Na
+
) m/z: 193.03 expected: C8H9O4Na: 193.16 
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5.3.2.3 Synthesis of N-(anthracen-2-yl)-2-chloroacetamide: 
 
 
Chloroacetyl chloride (0.41 mL, 5.2 mmol) was added drop wise to a solution of 2-
aminoanthracene (0.1 g, 0.52 mmol) in 5 mL DCM and TEA (0.72 mL, 5.2 mmol). The 
reaction was refluxed at for 2 hours and monitored by TLC. Upon completion the solvents 
were evaporated and the solid was washed with water and the light brown precipitate was 
vacuum filtered and dried under vacuum to give a light brown powder in a final yield of 1.30 
g (93%). 
Rf (Methanol: ethyl acetate 1:1) : 0.88 
Melting point: 233.4-235.6 °C 
1H NMR DMSO (250 MHz) δ: 10.5 (s, 1H, NH), 8.5 (m, 3H, CH), 8.0 (m, 3H, CH), 7.5 (m, 
1H, CH), 7.4 (m, 2H, CH), 4.3 (s, 2H, CH2) ppm 
13C NMR DMSO (63MHz) δ: 165.0 (C=O), 135.41 (C2), 133.68 (C9CC1), 131.69 (C8CC9), 
131.37 (C10CC5), 130.53 (C4), 129.04 (C8), 128.59 (C5), 128.05 (C4CC10), 127.70 (C7), 
125.89 (C6), 125.71 (C10), 125.22 (C9), 125.10 (C3), 120.67 (C1), 43.64 (CH2Cl) ppm   
IR: 3262.78, 3044.31, 2367.66, 1921.61, 1657.62, 1569.63 cm
-1
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5.3.2.4 Synthesis of 2-amino-N-(anthracen-2-yl) acetamide:  
 
 
 
 
N-(anthracen-1-yl)-2-chloroacetamide (0.25 g, 0.92 mmol) and urotropine (0.26 g, 1.84 
mmol) was dissolved in THF (10 mL) and water (0.1 mL) and refluxed overnight. The 
precipitate was filtered off vacuum dried and dissolved in methanol (20 mL) and HCl (2 M, 1 
mL) and refluxed for 2 hours while monitoring by TLC. The solvent was evaporated and the 
precipitate was re-dissolved in acetone (10 mL) and stirred at room temperature for 10 
minutes. The precipitate was vacuum filtered to give a yellow product with a yield of 0.087 g 
(38%). 
Rf (Petrolium ether: ethyl acetate 1:1): 0.2 
Melting point: 231.6-235.5 °C 
1
H NMR DMSO (250 MHz) δ: 10.72 (s, 1H, NH), 8.54 (m, 3H, CH), 8.22 (NH2), 8.05 (m, 
3H, CH), 7.60 (m, 1H, CH), 7.52 (m, 2H, CH), 3.90 (s, 2H, CH2) ppm 
13
C NMR DMSO (63 MHz) δ : 165.16 (C=O), 135.31 (C2), 131.69 (C9CC1), 131.38 
(C8CC9), 130.51 (C10CC5), 129.09 (C4), 128.56 (C8), 128.05 (C5), 127.66 (C4CC10), 
125.94 (C7), 125.73 (C6), 125.15 (C10), 125.11 (C9), 120.51 (C3), 114.16 (C1), 41.10 
(CH2NH2) ppm 
IR: 3378.84, 2629.93, 2358.15, 1708.90, 1669.64, 1630.39 cm
-1
 
Mass spectrum (TOF MS ES+) m/z: 251.16 expected C16H14N2O 250.29  
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5.3.2.5 Synthesis of tert-butyl [2-(anthracen-2-ylamino)-2-oxoethyl]carbamate: 
 
 
 
 
 
To a cold solution (ice bath) of N-Boc-glycine (168 mg, 0.96 mmol) in dry THF (8.0 mL), 
triethylamine (148 µL, 1.06 mmol) and ethyl chloroformate (91 µL, 0.96 mmol) were added 
dropwise. The mixture was stirred for 30 minutes in the ice bath before adding a solution of 
2-aminoanthracene (185 mg, 0.96 mmol) in 12 mL of dry THF. The reaction mixture was 
stirred at room temperature overnight and monitored with TLC. The compound was extracted 
3 times with ethyl acetate (20 mL) and washed with saturated sodium bicarbonate (3 x 30 
mL) and 0.1 M hydrochloric acid (3 x 30 mL). The solvent was evaporated and purified with 
dry column chromatography to give the final product in a yield of 0.302 g (90%) as a light 
yellow powder. 
Rf (Petrolium ether: ethyl acetate1: 1): 0.50 
Melting point = 186.3 -187.8 ˚C 
1
H NMR DMSO (250 MHz) δ: 10.12 (s, 1H, NH), 8.53 (m, 3H, CH), 8.06 (m, 3H, CH), 
7.64 (m, 1H, CH), 7.47 (m, 2H, CH), 3.82 (d, 2H, CH2), 1.44 (s, 9H, CH3) ppm  
13
C NMR DMSO (63 MHz) δ : 168.64 (C=O), 156.04 (OC=O), 135.89 (C2), 131.68 
(C9CC1), 131.58 (C8CC9), 130.36 (C10CC5), 128.84 (C4), 128.46 (C8), 128.03 (C5), 
127.66 (C4CC10), 125.81 (C7), 125.59 (C6), 124.91(C10), 120.85 (C9), 119.02 (C3), 113.79 
(C1), 78.15 (C(CH3)3), 43.88 (CH2), 28.2 (3C, C(CH3)3) ppm  
IR: 3312.40, 3273.15, 2974.19, 2358.15, 1690.78, 1657.56, 1361.62 cm
-1
 
 Mass spectrum (TOF MS ES-) m/z: 349.1314 Expected C21H22N2O3: 350.42 
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5.3.2.6 Synthesis of 2-amino-N-(anthracen-2-yl) acetamide by removal of Boc protection: 
 
 
 
 
tert-Butyl [2-(anthracen-2-ylamino)-2-oxoethyl]carbamate (0.3 g, 0.85 mmol) was dissolved 
in 35 mL of DCM at room temperature and and trifluoroacetic acid (TFA) (8.5 mL) was 
added to it. The reaction was left to stir for 10 minutes and monitored by TLC. The solvents 
were evaporated under reduced pressure and the residue was dissolved in ethanol 2 times and 
evaporated to remove any TFA residue to afford the title compound in 85% yield (0.18 g) as a 
yellow powder. 
Rf (Petrolium ether: ethyl acetate 1:1): 0.20 
Melting point: 231.6-235.5 °C 
1
H NMR DMSO (250 MHz) δ: 10.72 (s, 1H, NH), 8.54 (m, 3H, CH), 8.22 (NH2), 8.05 (m, 
3H, CH), 7.60 (m, 1H, CH), 7.52 (m, 2H, CH), 3.90 (s, 2H, CH2) ppm 
13
C NMR DMSO (63MHz) δ : 165.16 (C=O), 135.31 (C2), 131.69 (C9CC1), 131.38 
(C8CC9), 130.51 (C10CC5), 129.09 (C4), 128.56 (C8), 128.05 (C5), 127.66 (C4CC10), 
125.94 (C7), 125.73 (C6), 125.15(C10), 125.11 (C9), 120.51 (C3), 114.16 (C1), 41.10 
(CH2NH2) ppm 
IR: 3378.84, 2629.93, 2358.15, 1708.90, 1669.64, 1630.39 cm
-1 
Mass spectrum (TOF MS ES+) m/z: 251.16 expected C16H14N2O 250.29  
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5.3.2.7 Synthesis of N-[(2-anthracen-2-ylamino)-2-oxoethyl]-3-methoxy-5-oxocyclohex-3-
ene-1-carboxamide: 
 
 
 
 
To a cold solution (ice bath) of 3-methoxy-5-oxocyclohex-3-ene-1-carboxylic acid (168 mg, 
0.96 mmol) in dry DMF (8.0 mL), triethylamine (148 µL, 1.06 mmol) and ethyl 
chloroformate (91 µL, 0.96 mmol) were added drop wise over 5 minutes. The mixture was 
stirred for 30 minutes in the ice bath before adding a solution of 2-amino-N-(anthracen-2-
yl)acetamide (240 mg, 0.96 mmol) in 12 mL of dry DMF and TEA (148 µL, 1.06 mmol). The 
reaction mixture was stirred at room temperature overnight and monitored by TLC. The 
solvent was evaporated and purified with dry column chromatography eluting with ethyl 
acetate: methanol 9:1 to give the final product in 43% (0.165 g) yield as a pale yellow 
powder. 
Rf (Ethyl acetate: methanol 1:1): 0.88 
Melting point: 245.4-247.8 ˚C 
1
H NMR DMSO (250 MHz) δ: 10.25 (s, 1H,NH), 8.51 (m, 3H,CH), 8.05 (m, 3H,CH), 7.60 
(m, 1H,CH), 7.52 (m, 2H,CH), 5.36 (s, 1H), 4.01 (s, 2H,CH2,), 3.72 (s, 3H,CH3), 3.03-
3.12(m, 1H), 2.74 (s, 1H), 2.67(s, 1H), 2.44 (d, 2H) ppm 
13
C NMR DMSO (63 MHz) δ: 196.29(C16), 176.56 (C13), 172.63 (C11), 168.01 (C18), 
135.79 (C2), 131.67 (C9CC1), 131.56 (C8CC9), 130.39 (C10CC5), 128.85 (C4), 128.48 
(C8), 128.09 (C5), 128.03 (C4CC10), 127.65 (C7), 125.83 (C6), 125.61 (C10), 124.94 (C9), 
120.87 (C3), 113.92 (C1), 101.48 (C17), 55.98 (C20), 42.79 (C12), 31.00 (C19) ppm  
IR: 3274.92, 2944.18, 2364.62, 2161.32, 2161.32, 1697.07, 1630.31 cm
-1
 
Mass spectrum (TOF MS ES+) (M+CN
-
) m/z: 429.39 expected: C25H22N3O4: 429.45  
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5.3.2.8 Synthesis of N-[2-(anthracen-2-ylamino)-2-oxoethyl]-3,5-
dioxocyclohexanecarboxamide: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-[(2-anthracen-2-ylamino)-2-oxoethyl]-3-methoxy-5-oxocyclohex-3-ene-1-carboxamide 
(0.03 g, 0.074 mmol) was dissolved  in DMF (5 mL) and 1 M HCl (2 mL) was added to it and 
stirred at room temperature for 1 hour. The reaction was monitored by TLC and the solvent 
was evaporated to get the crude product of light brown powder in 23% (0.006 g) yield. 
Rf (Methanol: ethyl acetate 1:1): 0.55  
1
H NMR DMSO (250 MHz) δ: 10.43 (s, 1H,NH), 8.50 (m, 3H,CH), 8.07 (m, 3H,CH), 7.65 
(m, 1H,CH), 7.52 (m, 2H,CH), 5.29 (s, 1H), 4.02 (s, 2H,CH2,), 2.98-3.07 (m, 1H), 2.62(s, 
1H), 2.42 (d, 2H) ppm  
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5.3.2.9 Fluorescecne spectrometric analysis of N-[2-(anthracen-2-ylamino)-2-oxoethyl]-
3,5-dioxocyclohexanecarboxamide 
 
 
N-[2-(Anthracen-2-ylamino)-2-oxoethyl]-3,5-dioxocyclohexanecarboxamide (0.0005 g) was 
dissolved in 1 mL of DMSO and 200 µL was transferred on to Costar™ 96-Well Black 
plates ( Fisher Scientific, UK) in triplicates along with 200 µL of DMSO in triplicates as the 
blank. The samples were run on the Spectramax GeminiXS, setting the instrument to read 
fluorescence. In the first instance the excitation wavelength was fixed at 300 nm and an 
emission sweep was done between 300-750 nm with no cut-offs and a wavelength increment 
of 5 nm. The maximum emission was determined as 520 nm. In the next instance this was set 
as the emission wavelength and the excitation wavelength was varied from 300-750 nm. 
Figure 5.2 (top) shows the excitation spectrum of DMSO and Figure 5.2 (bottom) shows the 
excitation spectrum of the compound, which has an excitation of 385 nm. 
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Figure 5.2: Fluorescence excitation spectra of N-[2-(anthracen-2-ylamino)-2-oxoethyl]-
3,5-dioxocyclohexanecarboxamide in DMSO and DMSO. 
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5.3.2.10 Synthesis of reagent tagged magnetic probe: 
 
Amine linked magnetic beads (0.2 mL) were washed with 2-[N-morpholino]ethane sulphonic 
acid (MES) (0.1 M, pH 4.5, 1 mL) three times. 3-methoxy-5-oxocyclohex-3-ene-1-carboxylic 
acid (0.1 g) was dissolved in 10 mL of MES. Separately a solution was prepared by 
dissolving 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (0.1 g) and N-hydroxy 
succinimide (NHS) (0.15 g) in 10 mL of deionised water. 5 mL of this solution was added to 
the previous solution and incubated for 2 hours at room temperature with tilt rotation to get 
the final compound. 
Since the compound has a magnetic bead, analysis with NMR or mass spectrometry was not 
possible. Therefore an infrared spectrum was taken and compared to the starting material, 
which is discussed in detail in results and discussion. 
 
 
IR: 2925.97, 2850.11, 1502.87, 1433.08, 1381.50 cm
-1
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5.4 Results and discussion: 
 
 
5.4.1 Retrosynthetic approach for fluorescent probe to detect sulphenic acid: 
 
The desired final fluorescent probe has been deconstructed according to the following 
retrosynthetic approach (Figure 5.3). Compound 1 can be obtained by coupling 3,5-
diketohexahydrobenzoic acid (Figure 5.3, 2) with the free amine (Figure 5.3, 3). The latter 
can be obtained by acylation of the commercially available 2-aminoanthracene. 
 
 
 
Figure 5.3: Schematic representation of retrosynthetic approach for sulphenic acid 
fluorescent probe (1). 
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5.4.2 First synthesis of synthon 3 
 
 
Two different strategies have been adopted for the synthesis of synthon 3. Firstly, the 
bifunctional chloroacetyl chloride was used to convert 2-aminoanthracene to the 
corresponding chloroacetamide 4 (Figure 5.4). Primary and secondary amines are known to 
react with chloroacetyl chloride to form amides (177, 178). Between the chlorides in the 
molecule the acyl chloride is known to be more reactive towards nucleophiles. It is also 
important to have a base such as triethyl amine (TEA) present as the reaction produces HCl, 
which will be neutralised by the presence of a base and will drive the reaction to completion 
(177). Coupling of 2-aminoanthracene with chloroacetyl chloride in DCM in the presence of 
TEA at room temperature led to the acylated compound 4 in a 93% yield. 
2-Aminoanthracene and 9-Aminoacridine were chosen as two fluorescent molecules for the 
starting materials. While the synthesis was successful for 2-aminoanthracene the reaction 
failed to occur with 9-aminoacridine. Although experiments were carried out using different 
reaction conditions there was no success. One possibility for this could be because 9–
aminoacridine has a nitrogen it its ring structure by which the lone pair on the NH2 gets 
delocalised in the ring making it less reactive than 2-aminoanthracene. Therefore for further 
experiments only 2-aminoanthracene was used.  
Subsequent reaction of compound 4 with urotropine (also known as hexamethylenetetramine) 
in THF, followed with hydrolysis using 2 M HCl in methanol gave the desired free amine 3 
(Figure 5.4) with a 38% yield. 
 
 
Figure 5.4: Reaction conditions for the synthesis of 2-amino-N-(anthracen-2-yl) 
acetamide 
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The production of primary amines from alkyl chlorides using urotropine is known as the 
Délepine reaction and is a very convenient way to produce primary amines selectively (179). 
Ammonia could also be used to synthesise amines from alkyl chlorides. However, if ammonia 
is used instead, the formation of the corresponding secondary and tertiary amines as side 
products is very likely, unless ammonia is used in excess, which might not be tolerated 
depending on the substrate. The reaction mechanism for the amine formation with urotropine 
is outlined below in Figure 5.5. 
 
 
Figure 5.5: Reaction mechanism for the formation of an amine 
 
The formation of the hexamethylenetetramine salt proceeds via and SN2 reaction. While the 
staring materials are soluble in the organic solvent the salt crystallizes out. This compound is 
then treated to acid hydrolysis where the salt decomposes to yield the amine hydrochloride, 
ammonium chloride and formaldehyde (179). This reaction was quite difficult to optimise and 
the yield of the product was relatively low. Although different solvents were used and the 
reaction was left for longer periods with urotropine in excess, the yield did not improve. One 
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reason could be that because the starting material as well as urtropine is bulky in nature steric 
hindrance caused the relatively low reactivity between the compounds. However, in this case, 
the yield for the formation of the primary amine was moderate (38 %) and not always 
reproducible. Therefore an alternative route was explored for the synthesis of synthon 3. 
 
5.4.3 Second strategy for the synthesis of synthon 3 
 
2-aminoanthracene was reacted with an N-protected glycine derivative. It is important to use 
glycine where the NH2 group has been protected in order to prevent side reactions. Boc-
Glycine was thus reacted with ethyl chloroformate in THF at 0 °C to form the mixed 
anhydride, which was then reacted with 2-aminoanthracene to yield the desired acetylated 
compound 5 (Figure 5.7) in a 90% yield after dry column chromatography. The reaction 
mechanism for the mixed anhydride formation is outlined below in Figure 5.6 (178). 
 
 
Figure 5.6: Reaction mechanism for mixed anhydride formation  
 
The carboxylic acid was deprotonated by the base TEA, and the slightly nucleophilic oxygen 
reacts on ethyl chloroformate to produce the mixed anhydride. When the amine is added to 
the reaction mixture, it could then react on both carbons a and b. However, carbon a is much 
more electrophilic than carbon b due to the presence of only one mesomer donor oxygen and 
therefore the amine will preferentially react with a to give the desired product. Boc 
deprotection using TFA in DCM finally the gave free amine 3 in a 85% yield (Figure 5.7). It 
has to be noted that this second synthetic route allowed the synthesis of synthon 3 in a much 
shorter reaction time and with highly improved yield compared to the first one. However 
 
 
173 
optimising the reaction conditions were lengthy and purification steps were needed to remove 
unreacted starting material and side products. 
 
Figure 5.7: Reaction conditions for the synthesis of 2-amino-N-(anthracen-2-yl) 
acetamide via synthetic route 2 
 
The reaction for the removal of the Boc group was very rapid. Initial experiments where the 
reaction was left for 1 hour at room temperature revealed 2 spots on the TLC, which were 
both, visualised when stained with ninhydrin. An NMR of this crude product led to the 
conclusion that both amide bonds had been cleaved off which left a mixture of 2-
aminoanthracene and 2-amino-N-(anthracen-2-yl) acetamide. Therefore the reaction was 
closely monitored with TLC. As soon as the acid was added and the second spot was 
observed after 10 minutes of stirring, the reaction was stopped. To remove excess TFA the 
crude product was dissolved in ethanol twice and put on the rotary evaporator. The advantage 
of using an acid such as TFA for the boc deprotection is that it is soluble in a wide range of 
organic solvents and because of its volatility is easily removed without any work up 
procedures (180). The NMR of 2-amino-N-(anthracen-2-yl)acetamide is shown below in 
Figure 5.8. 
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                                 Figure 5.8: 
1
H NMR spectrum of 2-amino-N-(anthracen-2-yl)acetamide 
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5.4.4 Synthesis of synthon 2 
 
Synthon 2 was obtained by hydrogenation of 3,5-dihydroxybenzoic acid (61). Hydrogenation 
typically constitutes of the addition of pairs of hydrogen atoms to a molecule. Normally 
catalysts are required for the reaction to occur, as there is a high free energy of activation. 
There are two types of hydrogenation catalysts, homogenous and heterogeneous catalysts. 
Heterogeneous catalysts are the type that is mostly used for the majority of hydrogenation 
reactions. They are solids that form a distinct phase in the gas or liquid environment (181). 
Homogenous catalysts tend to dissolve in the liquid phase forming one single phase. 
Experiments for the hydrogenation of 3,5-dihydroxybenzoic acid were carried out using both 
types of catalysts. Palladium on carbon, palladium hydroxide on carbon, rhodium on carbon 
and Raney-Ni were used as heterogeneous catalysts and 
chlorotris(triphenylphosphine)rhodium(I) (Wilkinson’s catalyst) was used to represent 
homogenous catalysts. The reaction conditions and corresponding yields are shown in the 
Table 5.1 below.  
 
Catalyst Reaction conditions Yield (%)  
    
Pd/C H2O, 50 ˚C, 42 bar, overnight 0  
    
Pd (OH)2/C H2O, 50 ˚C, 42 bar, overnight 0  
    
Rh/C H2O, 50 ˚C, 42 bar, overnight 0   
    
Raney-Ni H2O, NaOH, 50 ˚C, 42 bar, overnight 62.3  
    
Wilkinson's H2O, 50 ˚C, 42 bar, overnight 0  
   
 
 
 
Table 5.1: Hydrogenation using different catalysts 
 
 
A hydrogenation bomb was used to run each of these reactions. TLC analysis of the reaction 
mixtures suggested that only Raney-nickel was able to convert the starting material. The 
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identity of the product was confirmed by NMR. For the NMR of 3,5-diketohexahydrobenzoic 
acid a singlet for hydrogens 1 (with an integration of 2 for 2 protons), 1 Doublet for 
hydrogens 2 and 3 and 1 quintet for hydrogen 4 was expected (Figure 5.9,A). However the 
NMR of the synthesised product had only three peaks visible with a singlet at 5.20, which 
integrated for 1 proton. The CH2 peaks are possibly around 2.5 and cannot be detected as the 
DMSO peak is also at 2.5. This suggests that in solution it mainly exists as its tautomeric 
form (B, Figure 5.9). The B form is more stable than the A form due to the formation of a 
hydroxyl-enone system where electrons can be delocalized, thus reducing the global energy 
of the system. 
 
OH O
OO
OH O
OOH
A B
1
2 34
1'
2' 3'4'
 
Figure 5.9: Tautomeric structures of 3,5-diketohexahydrobenzoic acid in solution. 
 
5.4.5 Synthesis of the probe 
 
 
Both synthons 2 and 3 had been obtained at this stage and needed to be coupled together. 
However, synthon 2 needed to be protected beforehand. Indeed, it holds two potential keto 
moieties which are highly electrophilic centers and can potentially react with the free amine 
of synthon 3 during the coupling step, leading to poor yields. Synthon 2 was thus protected 
using an enol ether function that was introduced by reacting it with catalytic amount of PTSA 
in methanol for 10 minutes at room temperature (Figure 5.10). This led to compound 6 in a 
93% yield. 
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Figure 5.10: Protection of 3,5-diketohexahydrobenzoic acid 
 
One possibility for the reaction mechanism is that PTSA forms a tosylate ester with methanol 
and then that the enol reacts with the methyl group, as tosylate is a good leaving group. The 
reaction time is very important for this reaction. When the reaction was left for longer period 
of time a second spot could be observed on the TLC. This is certainly due to the fact the 
carboxylic acid function can undergo esterification in the presence of a large excess of 
methanol and acidic catalysis. The proton NMR of the protected compound is shown below in 
Figure 5.11. The peak at 2.5 corresponds to the DMSO peak, which is the solvent used for 
the NMR. Proton a is the most deshielded proton as its situated between two electron 
withdrawing groups and therefore is found downfield on the spectrum. Next are the CH3- 
protons as they are attached directly to electon withdrawing oxygen. The integration or the 
area under the peak indicates the number of protons present, which in this case are 3. The d 
proton is present as a multiplet because it has 4 other protons in its vicinity, which results 
from spin coupling. The protons b, c are the least deshieled and they appear the most upfield 
on the spectrum (182).  
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Figure 5.11: 
1
H NMR spectrum of 3-methoxy-5-oxocyclohex-3-ene-1-carboxylic acid 
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Now that synthon had been protected and converted to 6 (Figure 5.12), it could be coupled to 
synthon 3. For this, the same ethyl chloroformate method as described earlier was used, in 
DMF since compound 3 was poorly soluble in THF. Addition of the amine to the mixture led 
to the desired amide 7 (Figure 5.12) in a 43% yield after purification by dry column 
chromatography. Final deprotection of the enol ether using 1 M HCl led to the desired probe 
1 with a 23% yield (Figure 5.12). 
 
Figure 5.12: Reaction conditions for the synthesis of N-[2-(anthracen-2-ylamino)-2-
oxoethyl]-3,5-dioxocyclohexanecarboxamide: 
 
One of the challenges faced was when it came to the purification of the compound because 
DMF has a high boiling point the compound had to be heated to around 80 ˚C to evaporate all 
the solvent. When the compound was then checked on TLC the number of spots increased 
and the main spot, which could have been the compound, had disappeared as well. This could 
mean that the compound is not stable at high temperatures. To overcome this, a stronger 
vacuum pump was employed that could evaporate the solvent at 30 ˚C. TLC confirmed that 
the compound did not degrade at this temperature. The NMR with the assigned peaks of 
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compound 7 is shown in Figure 5.13. The final compound was characterised by 
1
H NMR and 
will be used in the future to test on a single protein as well as on T cells to test its reactivity. 
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                                Figure 5.13: 
1
H NMR spectrum of N-[(2-anthracen-2-ylamino)-2-oxoethyl]-3-methoxy-5-oxocyclohex-3-ene-1-carboxamide 
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5.4.6 Synthesis of sulphenic acid detecting magnetic probe: 
 
Since the magnetic probe could not be characterised by NMR or mass spectrometry, infrared 
spectrometry was performed and compared with the starting material which is shown in 
Figure 5.14 below. The red spectrum is the magnetic bead starting material, which has a 
broad peak around 3200 cm
-1
 that corresponds to the N-H stretch of amines. The product, 
which is shown in the blue spectrum lacks this peak but has two peaks, which correspond to 
the amine N-H stretch. The CO stretch from the carbonyl group of 3-methoxy-5-
oxocyclohex-3-ene-1-carboxylic can be observed ~1600 cm
-1
 as well as the aromatic ring 
vibrations ~1500-1400 cm
-1
. Dissociation of amide bonds can be achieved using acids such as 
TFA and HCl. Therefore to cleave the amide bond 6 M HCl (10 mL) was added to the 
compound and left to react for 2 hours. Unfortunately these conditions proved to be too harsh 
and the magnetic beads were dissolved. The concentration of the acid was reduced to 2 M and 
the reaction was again carried out for 2 hours. The beads were isolated and washed and an IR 
was taken and compared to the starting material, which is shown in Figure 5.15. 
 
Figure 5.14: Infrared spectra of magnetic bead product with magnetic bead starting 
material. 
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Figure 5.15: Infrared spectra comparison of starting material with material cleaved off 
with 2 M HCl.  
 
The starting material (purple spectrum) and the beads after amide bond cleavage (red 
spectrum) look very similar which is indicative that the bond can be cleaved off with 2 M 
HCl and also that the peptide bond had previously been formed. EDC is used as a coupling 
agent in this reaction as it is a water soluble carbodiimide. NHS is used to stabilise the 
intermediate that is formed (178,183). The main disadvantage of this probe is that it cannot be 
characterised fully and can’t be used in mass spectrometry. If the probe is to be used to isolate 
proteins from cells, that have sulphenic acid modifications it is important to cleave off the 
magnetic bead prior to mass spectrometric analysis. However, using acid in high 
concentrations would be harmful to the proteins. Therefore more work needs to be done in 
order to optimise this probe before it is ready to be tested. 
In conclusion, two novel probes have been synthesised that have the potential to be used as 
tools in real time subcellular identification of sulphenic acid modified proteins.   
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Chapter 6.0 General Discussion 
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6.1 Discussion: 
 
RSOH due to its unstable nature and high reactivity has been challenging to study until 
recently. The oxidation state of sulphur in SOH is 0 and therefore chemically it has both 
electrophilic and nucleophilic characteristics. The self-condensation to form thiosulphinate is 
an example of this dual nature (184). In cells oxidation to RSO2H shows the nucleophilic 
nature of sulphenic acids. However RSOH exhibit a high reactivity towards nucleophiles and 
disulphide bond formation is an important function by which proteins are stabilised (185). 
Since sulphenic acids were first reported by Allison (140), they have only been identified in a 
small number of proteins. This is due to the fact that capturing these modifications remains 
difficult. Both direct and indirect methods have been employed to identify these 
modifications. Indirect methods rely on the reactivity of alkylating agents such as IAM and 
NEM to block thiols, reduction of SOH groups and consequent labelling of the reduced thiols 
with biotin maleimide (47). Since these methods are not very selective towards SOH, more 
recently dimedone based probes such as DCP-Bio1,DCP-Bio2,DCP-FL1 and Daz-1 have 
been employed to identify sulphenic acid modifications (1,10,56). 
This thesis describes the optimisation of conditions for sulphenic acid modification in the 
purified protein human serum albumin (HSA) using the biotin tag probe DCP-Bio1. Mass 
spectrometry and dot blot experiments performed on GSH showed that sulphenic acid 
formation did not occur and that it favours disulphide bond formation. In contrast, under 
specific conditions sulphenic acid formation was observed in HSA using western blotting and 
mass spectrometry. Initial experiments using a modified ELSPA with HSA gave the first 
indication of SOH formation. Using this ELSPA it was demonstrated that addition of oxidants 
such as hydrogen peroxide could lead to the formation of sulphenic acids in a dose dependent 
manner. The addition of excess H2O2 lead to over oxidation to form sulphinic and sulphonic 
acids, which are not detectable by DCP-Bio1. It was also concluded from the results of the 
ELSPA that addition of DCP-Bio1 and H2O2 simultaneously resulted in more SOH being 
detected. Therefore for all experiments throughout this thesis this method was adapted. Using 
the electrophilic reagent NBD-Cl, previous studies have shown that HSA reacts with 
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hydrogen peroxide in a 1:1 ratio to form SOH (64). The disadvantages of using NBD-Cl are 
that this reagent lacks specificity to only detect SOH and therefore can lead to false positive 
detection. Using different concentrations of the probe as well as different concentrations of 
hydrogen peroxide it was possible to demonstrate that HSA reacts with hydrogen peroxide 
and DCP-Bio1 in a 1:1:1 ratio. To determine the effects of alkylating agents such as IAM on 
the formation of sulphenic acids experiments were done where excess of IAM was added 
before the and after the addition of DCP-Bio1. Results indicated that addition of IAM before 
DCP-Bio1 addition blocks thiols thus preventing oxidation. However, research done by Reisz 
and co workers suggest that alkylating agents could potentially react with SOH groups and 
thus compete with the probe for sulphenic acid binding (159). This could be another 
possibility for absence of a band. 
Earlier studies which have used the nucleophilic reagent dimedone for mass spectral analysis 
showed that the site of modification in HSA is Cys34, which is the only free thiol available 
(118). The stability of this SOH moiety stems from the fact that it is situated in a hydrophobic 
crevice thereby protecting it from solvents and other thiols, thus preventing disulphide bond 
formations. This was confirmed by X-ray diffraction, which provided a three dimensional 
structure of HSA (143). Although mass spectrometric analysis of HSA using DCP-Bio1 did 
not show a modification at Cys34, it revealed modifications at Cys200 which normally takes 
part in disulphide bond formation. A possible explanation for this is that the Cys34 
modification is in low abundance and therefore could not be detected by mass spectrometry. 
Since reducing agents are used prior to treatment of HSA, if some of it was still present in the 
sample this could potentially lead to the dissociation of some disulphide bonds and SOH 
formation.  
This thesis also identifies sulphenic acid formation in human primary T cells for the first time 
and has shown that activation and oxidative stress can affect the formation of SOH. Under 
normal conditions cells maintain a reducing environment (Figure 6.1, A). Glutathione is a 
major antioxidant that helps in maintaining the redox status in the cells. Therefore it was 
hypothesised that if GSH was depleted in the cells it would cause oxidative stress in cells and 
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therefore led to an increase in SOH formation (Figure 6.1, B). BSO, which is widely used to 
deplete GSH in cells was used as it does not appear to have any toxicity towards primary cells 
(161). There was no loss of cell viability after treatment of primary T cells with BSO for 24 
hours. Data obtained from both flow cytometry and DTNB assay indicated a significant 
decrease in surface thiols, which suggesting a more oxidised environment and therefore more 
SOH formation. Using DCP-Bio1 and western blotting techniques 5 bands were observed in 
primary T cells treated with BSO, at 25, 40, 45, 50 and 65 kDa. In resting T cells only three 
bands were observed at 25, 45 and 65 kDa. A non-specific band was detected in cell lysates 
following labelling with streptavidin-HRP. Carroll and co-workers have also reported these 
observations in Jurkat cell lysates and it was suggested that it could be an endogenously 
biotinylated protein (1). 
Since ROS are generated in response to mitogen-induced activation in resting T cells the next 
hypothesis was that when T cells were activated the number of sulphenic acid modified 
proteins would increase (Figure 6.1, C). In order to activate T cells 5 µg/mL PHA-L was 
used as it showed both increased levels of CD25 expression and IL-2 secretion after 24 hours 
of treatment. When T cells were activated to examine sulphenic acid modifications, although 
an increase in the number of protein bands was expected, only two bands could be observed 
at 25 kDa and 65 kDa. However, when cells were activated under oxidative stress, the number 
of bands increased. Mass spectrometry performed on the individual bands has identified some 
interesting proteins such as Flavin reductase (NADPH) for 25 kDa band, peroxiredoxin-1, 
arginase1, actin1 for 40 KDa band and HSA for 65 KDa band.  
To visualise sulphenic acid formation in T cell, microscopy of the DCP-Bio1 and maleimide-
labelled T cells was undertaken. The findings of this thesis suggests that DCP-Bio1 is cell 
permeable but perhaps could have some toxic effects on the cells which may limit the use of 
this probe in real time studies of sulphenic acid formation.  
Finally, this thesis also looks at synthesising two novel probes; one fluorescent probe and one 
magnetic bead bound probe which have the potential to target sulphenic acid protein 
modifications. New probes are needed to visualise SOH formation in real time as the existing 
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probes exhibit certain limitations. The biotinylated DCP-Bio1, which was used throughout 
this thesis, showed some toxicity when confocal microscopy was performed on primary T 
cells. Although Poole and co-workers have developed a few fluorescent-tagged probes their 
bulky nature could mean limited cell permeability and steric hindrance prevent certain 
modifications from being detected. Therefore it was important to synthesise a fluorescent 
probe that is small to be cell permeable to visualise SOH formation in real time.  
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Figure 6.1: Schematic representation of T cells. A) resting B) oxidative stress and C) 
activated conditions. 
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6.2 Conclusion: 
 
This thesis has described detection of sulphenic acid modifications in purified HSA using the 
biotinylated probe DCP-Bio1. It also describes the isolation of sulphenic acid modified 
proteins in resting; BSO depleted and activated human primary T cells for the first time. In 
addition, two novel probes, which have the potential to be used for sulphenic acid detection in 
real time, have been successfully synthesised. 
 
6.3 Future work: 
 
 
Although a fluorescent probe and a magnetic bead bound probe have successfully been 
synthesised they have not been tested on a purified protein or in cells. The first step towards 
establishing the usefulness of these molecules would be to investigate if they are able to 
detect sulphenic acids in a purified protein that has been well characterised such as HSA. It is 
also important to test the toxicity of the probe as it will be used to identify sub cellular 
sulphenic acids in real time. One of the limitations of the magnetic bead bound probe is that 
the magnetic bead has to be cleaved off prior to protein identification by mass spectrometry if 
it is able to identify modified proteins. However, the technique used in this thesis required 2 
M HCl for cleavage which would be too harsh on proteins causing them to denature. 
Therefore alternative cleaving methods need to be investigated. 
As a method has been developed to identify SOH in CD4+ T cells under resting, oxidative 
stress and activated conditions. This model could be used in the future to investigate changes 
in SOH formation in healthy controls versus patients with inflammatory disease. Although 
several proteins have been identified as potential targets for SOH modifications work needs to 
be done to confirm the specific proteins. For this, antibodies against specific proteins can be 
used and after immune precipitation, the PVDF membranes could be probed for each of them. 
Further work should also be done to improve the mass spectrometric detection methods in 
order that the probe-bound sulphenate is seen in tryptic peptides from probe precipitated 
specific proteins. 
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